From: <Salvato da Windows Internet Explorer 7>
Subject: Stem Cell-like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor -- Bao et al. 66 (16): 7843 -- Cancer Research
Date: Tue, 15 Jan 2008 15:00:56 +0100
MIME-Version: 1.0
Content-Type: multipart/related;
	type="text/html";
	boundary="----=_NextPart_000_0000_01C85787.6EAC82A0"
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.3198

This is a multi-part message in MIME format.

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: text/html;
	charset="Windows-1252"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD><TITLE>Stem Cell-like Glioma Cells Promote Tumor =
Angiogenesis through Vascular Endothelial Growth Factor -- Bao et al. 66 =
(16): 7843 -- Cancer Research</TITLE>
<META http-equiv=3DContent-Type content=3D"text/html; =
charset=3Dwindows-1252">
<SCRIPT language=3DJavaScript>=0A=
	<!--=0A=
	function startTarget(windowname,wid,hei) {=0A=
	=0A=
	var dotpos =3D windowname.indexOf(".");=0A=
	if (dotpos > -1)=0A=
	{=0A=
	var tempwn =3D windowname.substring(0,dotpos) +=0A=
		windowname.substring(dotpos + 1, windowname.length);=0A=
	windowname =3D tempwn;=0A=
	}=0A=
	var sizestring =3D 'width=3D' + wid + ',height=3D' + hei;=0A=
	window.open('',windowname,'scrollbars,resizable,' + sizestring + '\'');=0A=
	}=0A=
	// -->=0A=
	</SCRIPT>
<!-- has inhead tag -->
<SCRIPT language=3DJavaScript>=0A=
	<!--=0A=
	if ( top !=3D self )=0A=
	{=0A=
		top.location.href =3D unescape(window.location.pathname);=0A=
	}=0A=
	//-->=0A=
	</SCRIPT>

<STYLE type=3Dtext/css>TABLE.content_box_outer_table {
	PADDING-RIGHT: 0px; PADDING-LEFT: 10px; PADDING-BOTTOM: 5px; =
PADDING-TOP: 0px
}
TABLE.content_box_outer_table_in_sidebar_frame {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 10px
}
TABLE.content_box_inner_table {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 65%; PADDING-BOTTOM: =
5px; PADDING-TOP: 0px; FONT-FAMILY: Verdana,Arial,Helvetica,sans-serif; =
BACKGROUND-COLOR: #f0f0f0
}
TABLE.content_box_pdfinframes {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 4px; =
PADDING-TOP: 0px
}
TD.content_box_title_highlight {
	PADDING-RIGHT: 1px; PADDING-LEFT: 1px; FONT-WEIGHT: bold; FONT-SIZE: =
120%; PADDING-BOTTOM: 1px; VERTICAL-ALIGN: middle; COLOR: #ffffff; =
PADDING-TOP: 1px; FONT-STYLE: italic; FONT-FAMILY: "Trebuchet =
MS",Verdana,Arial,Helvetica,sans-serif; BACKGROUND-COLOR: #000099; =
TEXT-ALIGN: center
}
TD.content_box_title {
	PADDING-RIGHT: 1px; PADDING-LEFT: 1px; FONT-WEIGHT: bold; FONT-SIZE: =
120%; PADDING-BOTTOM: 1px; VERTICAL-ALIGN: middle; COLOR: #ffffff; =
PADDING-TOP: 1px; FONT-STYLE: italic; FONT-FAMILY: "Trebuchet =
MS",Verdana,Arial,Helvetica,sans-serif; BACKGROUND-COLOR: #828282; =
TEXT-ALIGN: center
}
TD.content_box_space_between_sections {
	PADDING-TOP: 2px
}
TD.content_box_arrow {
	PADDING-RIGHT: 0px; PADDING-LEFT: 5px; PADDING-BOTTOM: 3px; =
PADDING-TOP: 0px; TEXT-ALIGN: right
}
TD.content_box_item {
	PADDING-RIGHT: 5px; PADDING-LEFT: 3px; PADDING-BOTTOM: 3px; =
VERTICAL-ALIGN: top; PADDING-TOP: 0px; TEXT-ALIGN: left
}
TD.content_box_pdfinframes_citation_cell {
	BORDER-RIGHT: #000000 1px solid; PADDING-RIGHT: 3px; BORDER-TOP: =
#000000 1px solid; PADDING-LEFT: 3px; FONT-SIZE: 65%; PADDING-BOTTOM: =
3px; BORDER-LEFT: #000000 1px solid; PADDING-TOP: 3px; BORDER-BOTTOM: =
#000000 1px solid; FONT-FAMILY: Verdana,Arial,Helvetica,sans-serif; =
BACKGROUND-COLOR: #ffffff; TEXT-ALIGN: left
}
FONT.openaccess {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; FONT-WEIGHT: bold; =
BACKGROUND-COLOR: #ffffff
}
FONT.openaccess_open {
	COLOR: #000000
}
FONT.openaccess_access {
	COLOR: #cc0000
}
FONT.openaccess_oa {
=09
}
.content_box_openaccess_title {
	WHITE-SPACE: nowrap; BACKGROUND-COLOR: #bababa; TEXT-ALIGN: center
}
DIV.referrer-based-search-line {
	PADDING-RIGHT: 25px; PADDING-LEFT: 25px; FONT-SIZE: 0.75em; =
PADDING-BOTTOM: 3px; MARGIN: 0px 4px 5px 0px; PADDING-TOP: 3px; =
FONT-FAMILY: arial,sans-serif; BACKGROUND-COLOR: #009918
}
DIV.referrer-based-search-line .search-terms {
	FONT-WEIGHT: bold
}
DIV.referrer-based-search-line .collection-name {
	FONT-STYLE: italic
}

@media Print, Screen, Handheld   =20
{
.notonscreen {
	DISPLAY: none
}

}
</STYLE>

<STYLE type=3Dtext/css>
@media Print, Screen, Handheld   =20
{
.notonscreen {
	DISPLAY: none
}

}
</STYLE>
<!-- ac in the head available -->
<SCRIPT language=3Djavascript>=0A=
		<!-- =0A=
	function popwin(url,wid,hei,fromtop,fromleft) {=0A=
		var winPref =3D =
"channelmode=3Dno,toolbar=3Dno,location=3Dno,directories=3Dno,status=3Dno=
,menubar=3Dno,scrollbars=3Dauto,resizable=3Dno,width=3D" + wid + =
",height=3D" + hei + ",top=3D" + fromtop + ",left=3D" + fromleft;=0A=
		window.open(url, "popwin", winPref);=0A=
	}=0A=
	// -->=0A=
	</SCRIPT>

<SCRIPT=20
src=3D"http://cancerres.aacrjournals.org/javascript/ajax/xmlhttprequest.j=
s"=20
type=3Dtext/javascript></SCRIPT>

<SCRIPT =
src=3D"http://cancerres.aacrjournals.org/javascript/ajax/utility.js"=20
type=3Dtext/javascript></SCRIPT>

<SCRIPT =
src=3D"http://cancerres.aacrjournals.org/javascript/entrez/callback.js"=20
type=3Dtext/javascript></SCRIPT>

<META content=3Dnofollow name=3Drobots>
<META content=3D"Cancer Research" name=3Dcitation_journal_title>
<META=20
content=3D"Bao, Shideng; Wu, Qiulian; Sathornsumetee, Sith; Hao, =
Yueling; Li, Zhizhong; Hjelmeland, Anita B.; Shi, Qing; McLendon, Roger =
E.; Bigner, Darell D.; Rich, Jeremy N."=20
name=3Dcitation_authors>
<META=20
content=3D"Stem Cell-like Glioma Cells Promote Tumor Angiogenesis =
through Vascular Endothelial Growth Factor"=20
name=3Dcitation_title>
<META content=3D08/15/2006 name=3Dcitation_date>
<META content=3D66 name=3Dcitation_volume>
<META content=3D16 name=3Dcitation_issue>
<META content=3D7843 name=3Dcitation_firstpage>
<META content=3D10.1158/0008-5472.CAN-06-1010 name=3Dcitation_doi>
<META =
content=3Dhttp://cancerres.aacrjournals.org/cgi/reprint/66/16/7843.pdf=20
name=3Dcitation_pdf_url>
<META =
content=3Dhttp://cancerres.aacrjournals.org/cgi/content/abstract/66/16/78=
43=20
name=3Dcitation_abstract_html_url>
<META =
content=3Dhttp://cancerres.aacrjournals.org/cgi/content/full/66/16/7843=20
name=3Dcitation_fulltext_html_url>
<META content=3D16912155 name=3Dcitation_pmid>
<META content=3D"Bao, Shideng" name=3Ddc.Contributor>
<META content=3D"Wu, Qiulian" name=3Ddc.Contributor>
<META content=3D"Sathornsumetee, Sith" name=3Ddc.Contributor>
<META content=3D"Hao, Yueling" name=3Ddc.Contributor>
<META content=3D"Li, Zhizhong" name=3Ddc.Contributor>
<META content=3D"Hjelmeland, Anita B." name=3Ddc.Contributor>
<META content=3D"Shi, Qing" name=3Ddc.Contributor>
<META content=3D"McLendon, Roger E." name=3Ddc.Contributor>
<META content=3D"Bigner, Darell D." name=3Ddc.Contributor>
<META content=3D"Rich, Jeremy N." name=3Ddc.Contributor>
<META=20
content=3D"Stem Cell-like Glioma Cells Promote Tumor Angiogenesis =
through Vascular Endothelial Growth Factor"=20
name=3Ddc.Title>
<META content=3D10.1158/0008-5472.CAN-06-1010 name=3Ddc.Identifier>
<META content=3D08/15/2006 name=3Ddc.Date>
<META content=3DAACR name=3Dcitation_publisher>
<META content=3DNOARCHIVE name=3DROBOTS>
<META content=3D"MSHTML 6.00.6000.16587" name=3DGENERATOR></HEAD>
<BODY bgColor=3D#ffffff><A name=3Dtop><!-- null --></A><NOBR><A=20
style=3D"TEXT-DECORATION: none" =
href=3D"http://cancerres.aacrjournals.org/"=20
target=3D_top><IMG height=3D80 alt=3D"Cancer Research"=20
src=3D"http://cancerres.aacrjournals.org/icons/banner/title.gif" =
width=3D450=20
border=3D0></A> <NOBR><A=20
href=3D"http://cancerres.aacrjournals.org/cgi/adclick/?ad=3D16609&amp;adc=
lick=3Dtrue&amp;url=3Dhttp%3A%2F%2Fwww.aacr.org%2Fhome%2Fscientists%2Fmee=
tings--workshops%2Fspecial-conferences%2Fubiquitin-and-cancer.aspx"><IMG =

alt=3D"Ubiquitin and Cancer"=20
src=3D"http://cancerres.aacrjournals.org/adsystem/graphics/1200405603390/=
canres/UbiquitinConf_256x80.gif?ad=3D16609&amp;adview=3Dtrue"=20
border=3D0></A> <IMG height=3D80 alt=3D" "=20
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" width=3D10 =
border=3D0><A=20
href=3D"http://cancerres.aacrjournals.org/cgi/adclick/?ad=3D16616&amp;adc=
lick=3Dtrue&amp;url=3Dhttp%3A%2F%2Fwww.aacr.org%2Fhome%2Fscientists%2Fmee=
tings--workshops%2Fspecial-conferences%2Fcancer-stem-cells.aspx"><IMG=20
alt=3D"The Role of Cancer Stem Cells in the Initiation and Propagation =
of Tumorigenesis"=20
src=3D"http://cancerres.aacrjournals.org/adsystem/graphics/1200405603390/=
canres/stemcellconf_256x80.gif?ad=3D16616&amp;adview=3Dtrue"=20
border=3D0></A> </NOBR></NOBR><BR><NOBR>
<TABLE cellSpacing=3D2 cellPadding=3D2 width=3D450>
  <TBODY>
  <TR>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://cancerres.aacrjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff=20
      size=3D-2>HOME</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://cancerres.aacrjournals.org/help/" =
target=3D_top><FONT=20
      face=3Darial,helvetica color=3D#ffffff =
size=3D-2>HELP</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://cancerres.aacrjournals.org/cgi/feedback" =
target=3D_top><FONT=20
      face=3Darial,helvetica color=3D#ffffff =
size=3D-2>FEEDBACK</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://cancerres.aacrjournals.org/subscriptions/" =
target=3D_top><FONT=20
      face=3Darial,helvetica color=3D#ffffff =
size=3D-2>SUBSCRIPTIONS</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none"=20
      =
href=3D"http://cancerres.aacrjournals.org/contents-by-date.0.shtml"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff=20
      size=3D-2>ARCHIVE</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://cancerres.aacrjournals.org/search.dtl" =
target=3D_top><FONT=20
      face=3Darial,helvetica color=3D#ffffff =
size=3D-2>SEARCH</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://cancerres.aacrjournals.org/content/vol66/issue16/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>TABLE OF=20
      CONTENTS</FONT></A></TD></TR></TBODY></TABLE></NOBR><NOBR>
<TABLE cellSpacing=3D2 cellPadding=3D2 width=3D450>
  <TBODY>
  <TR>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#e1e1e1><FONT=20
      face=3Darial,helvetica color=3D#000000 size=3D-2>Cancer =
Research</FONT></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://clincancerres.aacrjournals.org/" =
target=3D_top><FONT=20
      face=3Darial,helvetica color=3D#ffffff size=3D-2>Clinical Cancer=20
      Research</FONT></A></TD></TR>
  <TR>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://cebp.aacrjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>Cancer=20
      Epidemiology Biomarkers &amp; Prevention</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://mct.aacrjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>Molecular=20
      Cancer Therapeutics</FONT></A></TD></TR>
  <TR>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://mcr.aacrjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>Molecular=20
      Cancer Research</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://cgd.aacrjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>Cell Growth=20
      &amp; =
Differentiation</FONT></A></TD></TR></TBODY></TABLE></NOBR><FONT=20
face=3Dverdana,arial,helvetica size=3D-2></FONT><!-- debug:  -->
<HR align=3Dleft width=3D450 noShade SIZE=3D1>

<TABLE class=3Dcontent_box_outer_table align=3Dright>
  <TBODY>
  <TR>
    <TD><!-- beginning of inner table -->
      <TABLE class=3Dcontent_box_inner_table><!-- citation -->
        <TBODY>
        <TR>
          <TD class=3Dcontent_box_title_highlight colSpan=3D2>This =
Article</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content/abstract/66/16/7843=
">Abstract</A></STRONG>=20
            <IMG height=3D7 alt=3D"Freely available"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/toc/free.gif"=20
            width=3D32 border=3D0> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/reprint/66/16/7843"><STRONG=
>Full=20
            Text</STRONG> (PDF)</A> </STRONG></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843/DC1=
">Supplementary=20
            Data</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/alerts/ctalert?alertType=3D=
citedby&amp;addAlert=3Dcited_by&amp;saveAlert=3Dno&amp;cited_by_criteria_=
resid=3Dcanres;66/16/7843&amp;return_type=3Darticle&amp;return_url=3Dhttp=
%3A%2F%2Fcancerres.aacrjournals.org%2Fcgi%2Fcontent%2Ffull%2F66%2F16%2F78=
43">Alert=20
            me when this article is cited</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/alerts/ctalert?alertType=3D=
correction&amp;addAlert=3Dcorrection&amp;saveAlert=3Dno&amp;correction_cr=
iteria_value=3D66/16/7843&amp;return_type=3Darticle&amp;return_url=3Dhttp=
%3A%2F%2Fcancerres.aacrjournals.org%2Fcgi%2Fcontent%2Ffull%2F66%2F16%2F78=
43">Alert=20
            me if a correction is posted</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>Services</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/search?qbe=3Dcanres;66/16/7=
843&amp;journalcode=3Dcanres&amp;minscore=3D5000">Similar=20
            articles in this journal</A> </STRONG></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3D1=
6912155&amp;link_type=3DMED_NBRS">Similar=20
            articles in PubMed</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/alerts/etoc">Alert me to=20
            new issues of the journal</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/citmgr?gca=3Dcanres;66/16/7=
843">Download=20
            to citation manager</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?&amp;link_type=
=3DPERMISSIONDIRECT"=20
            target=3D_new><IMG alt=3D"reprints &amp; permissions"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/misc/permissions.gif"=20
            border=3D0></A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>Citing =
Articles</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#oth=
erarticles">Citing=20
            Articles via HighWire</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3Dh=
ttp://cancerres.aacrjournals.org/cgi/content/abstract/66/16/7843&amp;link=
_type=3DGOOGLESCHOLAR"=20
            target=3D_blank>Citing Articles via Google =
Scholar</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>Google =
Scholar</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://scholar.google.com/scholar?q=3D%22author%3AS.+author%3ABao=
%22"=20
            target=3D_blank>Articles by Bao, S.</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            href=3D"http://scholar.google.com/scholar?q=3D%22author%3AJ. =
N.+author%3ARich%22"=20
            target=3D_blank>Articles by Rich, J. N.</A></STRONG> =
</TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3Dh=
ttp://cancerres.aacrjournals.org/cgi/content/abstract/66/16/7843&amp;link=
_type=3DGOOGLESCHOLARRELATED"=20
            target=3D_blank>Search for Related Content</A></STRONG> =
</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>PubMed</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3D1=
6912155&amp;link_type=3DPUBMED">PubMed=20
            Citation</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3DB=
ao+S&amp;link_type=3DAUTHORSEARCH"=20
            target=3D_blank>Articles by Bao, S.</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3DR=
ich+JN&amp;link_type=3DAUTHORSEARCH"=20
            target=3D_blank>Articles by Rich, J. N.</A></STRONG>=20
        =
</TD></TR></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE><FONT=20
size=3D-1>[<EM>Cancer Research</EM> 66, 7843-7848, August 15, =
2006]<BR>=A9 2006 <A=20
href=3D"http://cancerres.aacrjournals.org/misc/terms.shtml">American =
Association=20
for Cancer Research</A> </FONT><BR>
<TABLE cellSpacing=3D0 cellPadding=3D0>
  <TBODY>
  <TR>
    <TD>
      <HR noShade SIZE=3D1>

      <H3>Priority Reports</H3></TD></TR></TBODY></TABLE>
<H2>Stem Cell=96like Glioma Cells Promote Tumor Angiogenesis through =
Vascular=20
Endothelial Growth Factor </H2><STRONG></NOBR><NOBR>Shideng=20
Bao<SUP>1</SUP><SUP>,5</SUP></NOBR>, <NOBR>Qiulian=20
Wu<SUP>1</SUP><SUP>,5</SUP></NOBR>, <NOBR>Sith=20
Sathornsumetee<SUP>1</SUP><SUP>,5</SUP></NOBR>, <NOBR>Yueling=20
Hao<SUP>1</SUP><SUP>,5</SUP></NOBR>, <NOBR>Zhizhong =
Li<SUP>6</SUP></NOBR>,=20
<NOBR>Anita B. Hjelmeland<SUP>1</SUP><SUP>,5</SUP></NOBR>, <NOBR>Qing=20
Shi<SUP>1</SUP><SUP>,5</SUP></NOBR>, <NOBR>Roger E. =
McLendon<SUP>2</SUP></NOBR>,=20
<NOBR>Darell D. Bigner<SUP>1</SUP><SUP>,2</SUP><SUP>,5</SUP></NOBR> and=20
<NOBR>Jeremy N.=20
Rich<SUP>1</SUP><SUP>,3</SUP><SUP>,4</SUP><SUP>,5</SUP><SUP>,6</SUP></NOB=
R>=20
</STRONG>
<P><FONT size=3D-1>Departments of <SUP>1</SUP> Surgery, <SUP>2</SUP> =
Pathology,=20
<SUP>3</SUP> Medicine, and <SUP>4</SUP> Neurobiology; <SUP>5</SUP> =
Preston=20
Robert Tisch Brain Tumor Center; and <SUP>6</SUP> Molecular Cancer =
Biology=20
Program, Duke University Medical Center, Durham, North Carolina </FONT>
<P><FONT size=3D-1><B>Requests for reprints:</B> Jeremy N. Rich, Preston =
Robert=20
Tisch Brain Tumor Center, Duke University Medical Center, Box 2900, =
Durham, NC=20
27710. Phone: 919-681-1693; Fax: 919-684-6514; E-mail: <SPAN=20
id=3Dem0>rich0001{at}mc.duke.edu</SPAN>
<SCRIPT type=3Dtext/javascript><!--=0A=
 var u =3D "rich0001", d =3D "mc.duke.edu"; =
document.getElementById("em0").innerHTML =3D '<a href=3D"mailto:' + u + =
'@' + d + '">' + u + '@' + d + '<\/a>'//--></SCRIPT>
.</FONT>
<P>
<P><A name=3DABS><!-- null --></A><BR clear=3Dright>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG =
height=3D21=20
      alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/rarrow.gif" =
width=3D10></TD>
    <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT =
size=3D+2>&nbsp;&nbsp;=20
      Abstract </FONT></TH></TR></TBODY></TABLE>
<TABLE cellPadding=3D5 align=3Dright border=3D1>
  <TBODY>
  <TR>
    <TH align=3Dleft><FONT size=3D-1><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#top=
"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Top<BR></A><IMG height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/dot.gif" =
width=3D11=20
      border=3D0><FONT color=3D#464c53>Abstract</FONT><BR><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#SEC=
1"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Introduction<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#SEC=
2"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Materials and Methods<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#SEC=
3"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Results and Discussion<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#BIB=
L"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      =
border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR>M=
alignant=20
gliomas are highly lethal cancers dependent on angiogenesis.<SUP> =
</SUP>Critical=20
tumor subpopulations within gliomas share characteristics<SUP> =
</SUP>with neural=20
stem cells. We examined the potential of stem cell=96like<SUP> =
</SUP>glioma cells=20
(SCLGC) to support tumor angiogenesis. SCLGC isolated<SUP> </SUP>from =
human=20
glioblastoma biopsy specimens and xenografts potently<SUP> =
</SUP>generated=20
tumors when implanted into the brains of immunocompromised<SUP> =
</SUP>mice,=20
whereas non-SCLGC tumor cells isolated from only a few<SUP> </SUP>tumors =
formed=20
secondary tumors when xenotransplanted. Tumors<SUP> </SUP>derived from =
SCLGC=20
were morphologically distinguishable from<SUP> </SUP>non-SCLGC tumor =
populations=20
by widespread tumor angiogenesis,<SUP> </SUP>necrosis, and hemorrhage. =
To=20
determine a potential molecular<SUP> </SUP>mechanism for SCLGC in =
angiogenesis,=20
we measured the expression<SUP> </SUP>of a panel of angiogenic factors =
secreted=20
by SCLGC. In comparison<SUP> </SUP>with matched non-SCLGC populations, =
SCLGC=20
consistently secreted<SUP> </SUP>markedly elevated levels of vascular=20
endothelial growth factor<SUP> </SUP>(VEGF), which were further induced =
by=20
hypoxia. In an <I>in vitro</I><SUP> </SUP>model of angiogenesis,=20
SCLGC-conditioned medium significantly<SUP> </SUP>increased endothelial =
cell=20
migration and tube formation compared<SUP> </SUP>with non-SCLGC tumor=20
cell=96conditioned medium. The proangiogenic<SUP> </SUP>effects of =
glioma SCLGC on=20
endothelial cells were specifically<SUP> </SUP>abolished by the =
anti-VEGF=20
neutralizing antibody bevacizumab,<SUP> </SUP>which is in clinical use =
for=20
cancer therapy. Furthermore, bevacizumab<SUP> </SUP>displayed potent=20
antiangiogenic efficacy <I>in vivo</I> and suppressed<SUP> </SUP>growth =
of=20
xenografts derived from SCLGC but limited efficacy<SUP> </SUP>against =
xenografts=20
derived from a matched non-SCLGC population.<SUP> </SUP>Together these =
data=20
indicate that stem cell=96like tumor<SUP> </SUP>cells can be a crucial =
source of=20
key angiogenic factors in cancers<SUP> </SUP>and that targeting =
proangiogenic=20
factors from stem cell=96like<SUP> </SUP>tumor populations may be =
critical for=20
patient therapy. (Cancer<SUP> </SUP>Res 2006; 66(16): 7843-8)<SUP> =
</SUP>
<P><A name=3DSEC1><!-- null --></A><BR clear=3Dright>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG =
height=3D21=20
      alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/rarrow.gif" =
width=3D10></TD>
    <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT =
size=3D+2>&nbsp;&nbsp;=20
      Introduction </FONT></TH></TR></TBODY></TABLE>
<TABLE cellPadding=3D5 align=3Dright border=3D1>
  <TBODY>
  <TR>
    <TH align=3Dleft><FONT size=3D-1><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#top=
"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Top<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#ABS=
"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Abstract<BR></A><IMG height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/dot.gif" =
width=3D11=20
      border=3D0><FONT color=3D#464c53>Introduction</FONT><BR><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#SEC=
2"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Materials and Methods<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#SEC=
3"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Results and Discussion<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#BIB=
L"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      =
border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR>A=
ngiogenesis=20
is critical to tumor formation and maintenance<SUP> </SUP>(<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B1"=
>1</A>).=20
Regulation of angiogenesis represents a complex process<SUP> =
</SUP>involving=20
autocrine and paracrine growth factor loops with an<SUP> </SUP>interplay =
between=20
tumor cells and the neovasculature (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B2"=
>2</A>).=20
Malignant<SUP> </SUP>gliomas are highly lethal neoplasms that exhibit =
striking=20
angiogenesis<SUP> </SUP>with elevated expression of vascular endothelial =
growth=20
factors<SUP> </SUP>(VEGFs), which promote blood vessel formation by=20
endothelial<SUP> </SUP>precursors (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B3"=
>3</A>,=20
<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B4"=
>4</A>).=20
VEGFs are secreted or cell surface=96bound<SUP> </SUP>proteins expressed =
by tumor=20
cells that bind to specific high-affinity<SUP> </SUP>transmembrane =
receptors=20
primarily expressed on endothelial cells<SUP> </SUP>(<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B5"=
>5</A>)=20
to promote endothelial cell proliferation, migration, and<SUP> =
</SUP>survival.=20
We recently showed that a novel antiangiogenic receptor<SUP> =
</SUP>kinase=20
inhibitor (ZD6474) was highly effective against multiple<SUP> =
</SUP>central=20
nervous system cancer xenografts, including gliomas<SUP> </SUP>(<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B6"=
>6</A>).=20
Receptor kinase inhibitors had limited benefit in clinical<SUP> =
</SUP>trials in=20
gliomas (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B7"=
>7</A>,=20
<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B8"=
>8</A>),=20
but frequent glioblastoma patient<SUP> </SUP>tumor responses were =
observed using=20
a neutralizing anti-VEGF<SUP> </SUP>monoclonal antibody, bevacizumab =
(Avastin),=20
in combination with<SUP> </SUP>the topoisomerase I inhibitor irinotecan =
(<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B9"=
>9</A>).=20
Improvements in<SUP> </SUP>the efficacy of these treatments will require =

advances in our<SUP> </SUP>understanding of the molecular mechanisms =
promoting=20
glioblastoma<SUP> </SUP>angiogenesis. Recent studies of glioblastomas =
and other=20
brain<SUP> </SUP>cancers identified tumor subpopulations that share=20
characteristics<SUP> </SUP>with normal neural stem cells (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B10=
">10</A>=96<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B14=
">14</A>).=20
Stem cell=96like<SUP> </SUP>glioma cells (SCLGC) express neural stem =
cell markers=20
(including<SUP> </SUP>the cell-surface antigen prominin-1/CD133), are =
capable of=20
self-renewal,<SUP> </SUP>form neurosphere-like spheroids, and =
differentiate into=20
multiple<SUP> </SUP>nervous system lineages (neurons, astrocytes, and=20
oligodendrocytes;<SUP> </SUP>refs. <A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B10=
">10</A>=96<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B13=
">13</A>).=20
When xenotransplanted into the brains of<SUP> </SUP>immunocompromised =
rodents,=20
human SCLGC show greater potential<SUP> </SUP>than non-SCLGC cancer =
cells to=20
initiate tumor formation (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B12=
">12</A>,<SUP>=20
</SUP><A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B13=
">13</A>).=20
The mechanisms responsible for the differential tumorigenic<SUP> =
</SUP>capacity=20
of SCLGC remain unknown, but non-SCLGC do survive when<SUP> =
</SUP>transplanted=20
intracranially (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B13=
">13</A>).=20
As angiogenesis represents<SUP> </SUP>a critical step in tumor formation =
(the=20
"angiogenic switch"),<SUP> </SUP>we examined whether SCLGC contribute to =
tumor=20
formation through<SUP> </SUP>promoting angiogenesis. We now report that =
SCLGC=20
enhance glioma<SUP> </SUP>angiogenesis through a VEGF-dependent =
mechanism.<SUP>=20
</SUP>
<P><A name=3DSEC2><!-- null --></A><BR clear=3Dright>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG =
height=3D21=20
      alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/rarrow.gif" =
width=3D10></TD>
    <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT =
size=3D+2>&nbsp;&nbsp;=20
      Materials and Methods </FONT></TH></TR></TBODY></TABLE>
<TABLE cellPadding=3D5 align=3Dright border=3D1>
  <TBODY>
  <TR>
    <TH align=3Dleft><FONT size=3D-1><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#top=
"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Top<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#ABS=
"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Abstract<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#SEC=
1"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Introduction<BR></A><IMG height=3D9 alt=3D" " =
hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/dot.gif" =
width=3D11=20
      border=3D0><FONT color=3D#464c53>Materials and =
Methods</FONT><BR><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#SEC=
3"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Results and Discussion<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#BIB=
L"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      =
border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR><=
B>Chemicals=20
and reagents.</B> Neutralizing anti-VEGF antibody, bevacizumab<SUP>=20
</SUP>(Avastin, Genentech, South San Francisco, CA), was purchased<SUP>=20
</SUP>from the Duke Hospital clinical pharmacy (Durham, NC). All =
other<SUP>=20
</SUP>chemicals were purchased from Sigma (St. Louis, MO) unless =
otherwise<SUP>=20
</SUP>specified.<SUP> </SUP>
<P><B>Patient biopsy specimens.</B> Specimens from patients =
undergoing<SUP>=20
</SUP>biopsy for newly diagnosed or recurrent glioblastoma were =
collected<SUP>=20
</SUP>under a Duke University Institutional Review Board=96approved<SUP> =

</SUP>protocol. Pathologic diagnosis was confirmed by R.E.M.<SUP> </SUP>
<P><B>Human glioma xenografts.</B> D456MG xenograft was derived from =
a<SUP>=20
</SUP>biopsy specimen from a 4-year-old child with glioblastoma. =
D54MG<SUP>=20
</SUP>xenograft is the Duke subline of A-172, which was derived =
from<SUP>=20
</SUP>a 54-year-old male with glioblastoma. Xenografts were =
maintained<SUP>=20
</SUP>in the flanks of athymic BALB/c <I>nu/nu</I> mice and early =
passages<SUP>=20
</SUP>were used to minimize genetic drift.<SUP> </SUP>
<P><B>Purification and characterization of stem cell=96like =
glioblastoma<SUP>=20
</SUP>cells.</B> SCLGC were derived from tumors from patients or =
xenografts<SUP>=20
</SUP>as previously described (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B10=
">10</A>=96<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B13=
">13</A>).=20
Briefly, tumors were<SUP> </SUP>disaggregated, labeled with an =
allophycocyanin-=20
or phycoerythrin-conjugated<SUP> </SUP>CD133 antibody (Miltenyi Biotec, =
Auburn,=20
CA), and sorted by<SUP> </SUP>fluorescence-activated cell sorting =
(FACS). Glioma=20
cells derived<SUP> </SUP>from xenografts were confirmed to be human =
through FACS=20
analysis<SUP> </SUP>with the FITC-labeled 3B4 human specific antibody =
(<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B15=
">15</A>).=20
Tumor<SUP> </SUP>spheroids were maintained and passaged as previously=20
described<SUP> </SUP>(<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B13=
">13</A>).=20
Immunofluorescence studies confirmed spheroid expression<SUP> </SUP>of =
stem cell=20
markers and lineage markers when subjected to differentiation<SUP>=20
</SUP>conditions as previously described (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B16=
">16</A>).<SUP>=20
</SUP>
<P><B>Intracranial tumor assays.</B> CD133<SUP>+</SUP> and =
CD133<SUP>=96</SUP>=20
tumor cell<SUP> </SUP>populations were segregated by cell sorting. After =

short-term<SUP> </SUP>culture, 10,000 cells were implanted into the =
right=20
frontal<SUP> </SUP>lobes of athymic BALB/c <I>nu/nu</I> mice under a =
Duke=20
University Institutional<SUP> </SUP>Animal Care and Use =
Committee=96approved=20
protocol as previously<SUP> </SUP>described (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B6"=
>6</A>).=20
Mice were maintained for 4 weeks or until the<SUP> </SUP>development of=20
neurologic symptoms. Brains of euthanized mice<SUP> </SUP>were =
collected, fixed=20
in formalin, paraffin embedded, and sectioned,<SUP> </SUP>or were frozen =
rapidly=20
in liquid nitrogen for sections.<SUP> </SUP>
<P><B>Tumor vascular quantification.</B> Blood vessel density in =
frozen<SUP>=20
</SUP>tumor sections was quantified as previously described (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B17=
">17</A>).<SUP>=20
</SUP>
<P><B>Angiogenesis antibody array analysis.</B> Conditioned media =
were<SUP>=20
</SUP>harvested from matched CD133<SUP>+</SUP> and CD133<SUP>=96</SUP>=20
glioblastoma<SUP> </SUP>tumor cell cultures grown in 60-mm plates in =
neural=20
basal medium<SUP> </SUP>without growth factors for 24 hours. Hypoxia was =
induced=20
through<SUP> </SUP>maintenance of cells in a closed syringe for 24 =
hours.=20
TranSignal<SUP> </SUP>Human Angiogenesis Antibody Arrays (Panomics, =
Fremont, CA)=20
were<SUP> </SUP>incubated with 2 mL of conditioned medium for 1.5 hours =
and<SUP>=20
</SUP>then replaced with another 2 mL for 1.5 hours (total, 4 mL=20
conditioned<SUP> </SUP>medium, 3 hours of incubation) and processed =
according to=20
the<SUP> </SUP>instructions of the manufacturer. Intensity of VEGF=20
expression<SUP> </SUP>was quantified with ImageJ software.<A=20
name=3DRFN1></A><SUP><A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#FN1=
">7</A></SUP>=20
Total mean intensity =3D<SUP> </SUP>area <FONT =
face=3Darial,helvetica>x</FONT> mean=20
intensity.<SUP> </SUP>
<P><B>VEGF ELISA.</B> Human VEGF Quantikine ELISA Kits (R&amp;D =
Systems,<SUP>=20
</SUP>Minneapolis, MN) were used according to the directions of the<SUP> =

</SUP>manufacturer. Two-hundred microliters of conditioned media =
were<SUP>=20
</SUP>collected from triplicate samples.<SUP> </SUP>
<P><B>Endothelial migration assays.</B> Media conditioned by =
CD133<SUP>+</SUP>=20
or<SUP> </SUP>CD133<SUP>=96</SUP> populations for 24 hours were added to =
the=20
bottom<SUP> </SUP>chambers of 24-well tissue culture plates in =
triplicate.=20
Human<SUP> </SUP>microvascular endothelial cells (20,000) were added to =
the=20
upper<SUP> </SUP>chambers of Transwell assays (BD Biosciences, Franklin=20
Lakes,<SUP> </SUP>NJ). In experiments with a VEGF neutralizing antibody, =

bevacizumab<SUP> </SUP>or immunoglobulin G (IgG) control (final, 0.5 =
mg/mL) was=20
added<SUP> </SUP>to conditioned media 30 minutes before addition of=20
endothelial<SUP> </SUP>cells. Cells were allowed to invade for 14 hours =
and then=20
fixed,<SUP> </SUP>stained, and quantified.<SUP> </SUP>
<P><B>Endothelial tube formation assays.</B> Media conditioned by=20
CD133<SUP>+</SUP><SUP> </SUP>or CD133<SUP>=96</SUP> populations for 24 =
hours were=20
added to 2,000<SUP> </SUP>human microvascular endothelial cells in =
sextuplicate=20
wells<SUP> </SUP>of Matrigel-coated 96-well plates (BD Biosciences). In=20
VEGF<SUP> </SUP>neutralizing experiments, bevacizumab or IgG control=20
(final,<SUP> </SUP>0.5 mg/mL) was added to conditioned media 30 minutes=20
before<SUP> </SUP>addition to endothelial cell cultures in triplicate. =
Cells=20
were<SUP> </SUP>incubated for 16 hours, imaged, and quantified.<SUP> =
</SUP>
<P><B>Xenograft assays.</B> Matched CD133<SUP>+</SUP> and =
CD133<SUP>=96</SUP>=20
glioma cellular<SUP> </SUP>populations were implanted in either s.c. or=20
intracranial locations<SUP> </SUP>with the specified cell number. After=20
establishment, tumor-bearing<SUP> </SUP>animals were treated with either =

bevacizumab or a control IgG<SUP> </SUP>(5 mg/kg i.p. qd) for a total of =
21 days=20
(s.c.) or 19 days (intracranial)<SUP> </SUP>until harvest. Mice were =
euthanized=20
and tumors or tumor-bearing<SUP> </SUP>brains were harvested, weighed, =
and=20
examined.<SUP> </SUP>
<P><B>Statistical analysis.</B> Descriptive statistics were =
generated<SUP>=20
</SUP>for all quantitative data with presentation of means =B1<SUP> =
</SUP>SEs.=20
Significance was tested by one-way ANOVA using the SAS<SUP> =
</SUP>Enterprise=20
Guide 3.0 (Cary, NC).<SUP> </SUP>
<P><A name=3DSEC3><!-- null --></A><BR clear=3Dright>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG =
height=3D21=20
      alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/rarrow.gif" =
width=3D10></TD>
    <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT =
size=3D+2>&nbsp;&nbsp;=20
      Results and Discussion </FONT></TH></TR></TBODY></TABLE>
<TABLE cellPadding=3D5 align=3Dright border=3D1>
  <TBODY>
  <TR>
    <TH align=3Dleft><FONT size=3D-1><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#top=
"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Top<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#ABS=
"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Abstract<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#SEC=
1"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Introduction<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#SEC=
2"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Materials and Methods<BR></A><IMG height=3D9 alt=3D" " =
hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/dot.gif" =
width=3D11=20
      border=3D0><FONT color=3D#464c53>Results and =
Discussion</FONT><BR><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#BIB=
L"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      =
border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR><=
B>Derivation=20
of SCLGC.</B> Central nervous system neoplastic stem<SUP> </SUP>cells =
were=20
defined through their phenotypic similarities to<SUP> </SUP>neural stem =
cells=20
(<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B10=
">10</A>=96<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B14=
">14</A>).=20
Prior reports investigated<SUP> </SUP>SCLGC from patient tumor biopsy =
specimens=20
(<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B10=
">10</A>=96<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B13=
">13</A>),=20
but<SUP> </SUP>we additionally generated short-term cultures from=20
glioblastoma<SUP> </SUP>xenografts derived from human patient biopsy =
specimens=20
that<SUP> </SUP>were maintained in immunocompromised mice in either s.c. =
or<SUP>=20
</SUP>intracranial locations. Human biopsy specimens validate =
biological<SUP>=20
</SUP>processes directly in patient cancers, whereas human glioma<SUP>=20
</SUP>xenografts permit the purification of large numbers of viable<SUP> =

</SUP>tumor cells. The CD133 cell-surface stem cell marker was used<SUP> =

</SUP>to select for a cell population enriched for SCLGC (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B13=
">13</A>).=20
Although<SUP> </SUP>the fraction of CD133<SUP>+</SUP> tumor cells varied =
between=20
sources, we<SUP> </SUP>detected between 2.9% and 4.3% of tumor cells =
expressed=20
the<SUP> </SUP>CD133<SUP>+</SUP> marker and formed spheroids (data not =
shown).=20
We derived<SUP> </SUP>separate short-term cultures of CD133<SUP>+</SUP> =
and=20
CD133<SUP>=96</SUP> tumor<SUP> </SUP>cells through tumor disaggregation, =
labeling=20
with CD133 antibody,<SUP> </SUP>and FACS sorting. The CD133<SUP>+</SUP>=20
population was &gt;95% pure in<SUP> </SUP>repeated FACS analysis (data =
not=20
shown). The tumor cell populations<SUP> </SUP>derived from human glioma=20
xenografts grown in mice were composed<SUP> </SUP>nearly exclusively of =
human=20
tumor cells (&gt;99%) without significant<SUP> </SUP>contamination from =
murine=20
cells through analysis with 3B4 antihuman<SUP> </SUP>antibody (data not=20
shown).<SUP> </SUP>
<P>Cultured CD133<SUP>+</SUP> glioma cells from biopsy specimens and=20
xenografts<SUP> </SUP>formed neurosphere-like spheroids when grown in =
stem cell=20
medium<SUP> </SUP>(Supplementary Fig. S1<I>A</I>). These spheroids were =
capable=20
of generating<SUP> </SUP>new spheroids under limiting passage conditions =

consistent with<SUP> </SUP>self-renewal (data not shown), expressed =
neural stem=20
cell markers<SUP> </SUP>(CD133, Nestin, Sox 2, and Musashi 1; =
Supplementary Fig.=20
S1<I>B</I>),<SUP> </SUP>and underwent multilineage differentiation =
(neuronal,=20
astrocytic,<SUP> </SUP>and oligodendrocytic) under prodifferentiation =
conditions=20
(Supplementary<SUP> </SUP>Fig. S2). In contrast, CD133<SUP>=96</SUP> =
tumor cells=20
grew in an adherent<SUP> </SUP>fashion without spheroid formation, =
expressed=20
only astrocytic<SUP> </SUP>markers, and underwent senescence on =
fulfilling the=20
criteria<SUP> </SUP>of two distinct tumor cell populations: SCLGC and=20
non-SCLGC.<SUP> </SUP>
<P><B>Tumors generated from CD133<SUP>+</SUP> glioma population display=20
increased<SUP> </SUP>tumor vascularity, necrosis, and hemorrhage.</B> =
Recent=20
studies<SUP> </SUP>of stem cell=96like cancer cells have suggested that=20
tumorigenesis<SUP> </SUP>is dichotomized between the SCLGC and non-SCLGC =

populations<SUP> </SUP>(<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B12=
">12</A>,=20
<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B13=
">13</A>).=20
To investigate the tumorigenic capacity of our glioma<SUP> =
</SUP>subpopulations,=20
10,000 CD133<SUP>=96</SUP> or CD133<SUP>+</SUP> glioma cells =
derived<SUP>=20
</SUP>from multiple human glioblastoma patient specimens or two =
human<SUP>=20
</SUP>glioma xenografts (D456MG and D54MG) were implanted into the<SUP>=20
</SUP>right frontal lobes of athymic nude mice. Regardless of tumor<SUP> =

</SUP>source, every brain implanted with the CD133<SUP>+</SUP> tumor =
cells=20
displayed<SUP> </SUP>gross evidence of highly angiogenic and hemorrhagic =

tumors,<SUP> </SUP>in stark contrast to the brains implanted with=20
CD133<SUP>=96</SUP><SUP> </SUP>tumor cells (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#FIG=
1">Fig.=20
1<I>A</I></A> and data not shown). Pathologic analysis<SUP> </SUP>of the =
brains=20
implanted with CD133<SUP>+</SUP> glioma cells showed large,<SUP> =
</SUP>highly=20
proliferative and vascular tumors with widespread necrosis<SUP> =
</SUP>and=20
hemorrhage (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#FIG=
1">Fig.=20
1<I>C</I></A> and data not shown). No mice implanted<SUP> </SUP>with=20
CD133<SUP>=96</SUP> tumor cells from human biopsy specimens or<SUP> =
</SUP>the=20
majority of xenografts displayed evidence of brain tumor<SUP> =
</SUP>formation=20
(data not shown). D456MG xenograft-derived CD133<SUP>=96</SUP><SUP> =
</SUP>tumor=20
cells formed small tumors (in two of six mice in replicate<SUP>=20
</SUP>experiments; <A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#FIG=
1">Fig.=20
1<I>B</I></A>), permitting a comparison of vascularity<SUP> =
</SUP>between brains=20
bearing CD133<SUP>+</SUP> and CD133<SUP>=96</SUP> xenografts. With<SUP> =
</SUP>CD31=20
immunostaining, we observed that tumors derived from =
CD133<SUP>+</SUP><SUP>=20
</SUP>cells were markedly more vascular than tumors from =
CD133<SUP>=96</SUP><SUP>=20
</SUP>tumor cells (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#FIG=
1">Fig.=20
1<I>D</I></A>). Therefore, angiogenic potential is a<SUP> </SUP>critical =

difference between the <I>in vivo</I> tumor phenotypes of<SUP> =
</SUP>glioma=20
SCLGC and non-SCLGC cells.<SUP> </SUP>
<P><A name=3DFIG1><!-- null --></A><BR clear=3Dall>
<CENTER>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"95%">
  <TBODY>
  <TR bgColor=3D#e1e1e1>
    <TD>
      <TABLE cellSpacing=3D2 cellPadding=3D2>
        <TBODY>
        <TR bgColor=3D#e1e1e1>
          <TD vAlign=3Dtop align=3Dmiddle bgColor=3D#ffffff><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843/FIG=
1"><IMG=20
            height=3D200 alt=3D"Figure 1" hspace=3D10=20
            =
src=3D"http://cancerres.aacrjournals.org/content/vol66/issue16/images/sma=
ll/7843fig01c.gif"=20
            width=3D163 vspace=3D5 border=3D2></A><BR><STRONG>View =
larger=20
            version</STRONG> (80K):<BR><NOBR><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843/FIG=
1">[in=20
            this window]</A><BR><A=20
            onmouseover=3D"window.status=3D'View figure in a separate =
window'; return true"=20
            onclick=3D"startTarget('FIG1', 508, 640); =
this.href=3D'/cgi/content-nw/full/66/16/7843/FIG1'"=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content-nw/full/66/16/7843/=
FIG1"=20
            target=3DFIG1>[in a new window]</A><BR>&nbsp;</NOBR> </TD>
          <TD vAlign=3Dtop align=3Dleft><B>Figure 1.</B> SCLGC form more =
vascular=20
            and necrotic tumors when grown in the brains of =
immunocompromised=20
            mice. Ten thousand cells derived from CD133<SUP>=96</SUP> or =

            CD133<SUP>+</SUP> tumor cell populations cultured from =
D456MG=20
            xenografts were implanted into the right frontal lobes of =
athymic=20
            nude BALB/c mice. Mice were sacrificed after 28 days. =
<I>A,</I> four=20
            pairs of representative brains bearing tumors derived from=20
            CD133<SUP>=96</SUP> and CD133<SUP>+</SUP> cells. <I>B</I> =
and=20
            <I>C,</I> pathologic morphology of brain tumors derived from =

            CD133<SUP>=96</SUP> and CD133<SUP>+</SUP> populations. The =
brains were=20
            fixed in formalin, paraffin embedded, cut into 5-=B5m =
sections, and=20
            then stained with H&amp;E. <I>B,</I> two of six brains with=20
            CD133<SUP>=96</SUP> tumor cells implanted had tumor =
formation (<FONT=20
            face=3Darial,helvetica>x</FONT>400). <I>C,</I> in contrast, =
all brains=20
            implanted with CD133<SUP>+</SUP> tumor cells displayed large =
tumors=20
            with widespread necrosis, hemorrhage, and neoangiogenesis =
(<FONT=20
            face=3Darial,helvetica>x</FONT>400). <I>D,</I> the blood =
vessel=20
            density in tumors derived from CD133<SUP>=96</SUP> and=20
            CD133<SUP>+</SUP> cells was measured. Tumor-bearing brains =
were snap=20
            frozen, cut into 6-=B5m frozen sections, fixed, =
immunostained with rat=20
            anti-mouse CD31 antibody (or IgG control antibody), and=20
            counterstained with hematoxylin. Representative images =
(<FONT=20
            face=3Darial,helvetica>x</FONT>400). The densities of CD31 =
stained=20
            blood vessels were quantified. *, <I>P</I> =3D 0.0002, =
vascular=20
            density of tumors derived from CD133<SUP>+</SUP> cells =
versus=20
            CD133<SUP>=96</SUP> cells (Student's <I>t</I> test).
            =
<P></P></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></CENTER>&nbsp=
;<BR><B>Stem=20
cell=96like glioma cancer cells express elevated levels<SUP> </SUP>of =
VEGF.</B> To=20
determine potential molecular mechanisms underlying<SUP> </SUP>the =
differential=20
vascular phenotypes of SCLGC and non-SCLGC<SUP> </SUP>derived tumors, we =

compared the expression of regulators of<SUP> </SUP>angiogenesis =
secreted by=20
CD133<SUP>+</SUP> and CD133-cells. Patterns of<SUP> </SUP>angiogenesis =
regulator=20
expression differed between specimens<SUP> </SUP>but revealed modest =
changes in=20
angiogenin, interleukin-8, interleukin-6,<SUP> </SUP>and basic =
fibroblast growth=20
factor (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#FIG=
2">Fig.=20
2</A> and Supplementary<SUP> </SUP>Fig. S3). However, VEGF levels in=20
CD133<SUP>+</SUP> glioma cell conditioned<SUP> </SUP>media were =
consistently=20
up-regulated 10- to 20-fold compared<SUP> </SUP>with CD133<SUP>=96</SUP> =
media (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#FIG=
2">Fig.=20
2</A> and Supplementary Fig. S3) in<SUP> </SUP>populations derived from =
both=20
patient biopsies and human glioma<SUP> </SUP>xenografts. Increased VEGF=20
secretion in CD133<SUP>+</SUP> versus CD133<SUP>=96</SUP><SUP> =
</SUP>cells was=20
also confirmed through VEGF ELISA (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#FIG=
2">Fig.=20
2<I>D</I></A> and Supplementary<SUP> </SUP>Fig. S3<I>C</I>). =
Furthermore, both=20
CD133<SUP>+</SUP> and CD133<SUP>=96</SUP> glioma<SUP> </SUP>tumor cells =
increased=20
VEGF expression in response to hypoxia,<SUP> </SUP>but CD133<SUP>+</SUP> =
tumor=20
cells expressed elevated VEGF levels relative<SUP> </SUP>to the=20
CD133<SUP>=96</SUP> cells under hypoxic conditions (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#FIG=
2">Fig.=20
2</A> and<SUP> </SUP>Supplementary Fig. S3<I>C</I>). In summary, SCLGC=20
consistently expressed<SUP> </SUP>higher levels of VEGF than the =
non-SCLGC under=20
normoxic and<SUP> </SUP>hypoxic conditions.<SUP> </SUP>
<P><A name=3DFIG2><!-- null --></A><BR clear=3Dall>
<CENTER>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"95%">
  <TBODY>
  <TR bgColor=3D#e1e1e1>
    <TD>
      <TABLE cellSpacing=3D2 cellPadding=3D2>
        <TBODY>
        <TR bgColor=3D#e1e1e1>
          <TD vAlign=3Dtop align=3Dmiddle bgColor=3D#ffffff><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843/FIG=
2"><IMG=20
            height=3D200 alt=3D"Figure 2" hspace=3D10=20
            =
src=3D"http://cancerres.aacrjournals.org/content/vol66/issue16/images/sma=
ll/7843fig02g.gif"=20
            width=3D105 vspace=3D5 border=3D2></A><BR><STRONG>View =
larger=20
            version</STRONG> (27K):<BR><NOBR><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843/FIG=
2">[in=20
            this window]</A><BR><A=20
            onmouseover=3D"window.status=3D'View figure in a separate =
window'; return true"=20
            onclick=3D"startTarget('FIG2', 381, 640); =
this.href=3D'/cgi/content-nw/full/66/16/7843/FIG2'"=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content-nw/full/66/16/7843/=
FIG2"=20
            target=3DFIG2>[in a new window]</A><BR>&nbsp;</NOBR> </TD>
          <TD vAlign=3Dtop align=3Dleft><B>Figure 2.</B> SCLGC express =
elevated=20
            level of VEGF and hypoxia induces increased VEGF expression. =

            <I>A</I> and <I>B,</I> to determine if SCLGC differentially =
express=20
            proangiogenic factors, we used commercial antibody arrays =
(Panomics=20
            TranSignal Human Angiogenesis Antibody Array) to compare the =

            expression levels of regulators of angiogenesis in =
conditioned media=20
            from matched CD133<SUP>+</SUP> and CD133<SUP>=96</SUP> =
glioma=20
            cultures. Media conditioned for 24 hours from short-term=20
            CD133<SUP>=96</SUP> or CD133<SUP>+</SUP> glioma cultures =
derived from=20
            a patient biopsy specimen under normoxic (<I>A</I>) or =
hypoxic=20
            (<I>B</I>) conditions were collected. Cells were maintained =
under=20
            hypoxic conditions for 24 hours. Membranes were processed =
based on=20
            kit instructions. The intensity of VEGF expression was =
quantified=20
            with ImageJ software. <I>C,</I> total mean intensity of VEGF =
blot=20
            was calculated based on the product of area and mean =
intensity. *,=20
            <I>P</I> =3D 0.0036, hypoxic versus normoxic conditions of=20
            CD133<SUP>=96</SUP> conditioned medium (ANOVA); **, <I>P</I> =
=3D 0.001,=20
            CD133<SUP>+</SUP> conditioned medium versus =
CD133<SUP>=96</SUP>=20
            conditioned medium (ANOVA); ***, <I>P</I> =3D 0.005, hypoxic =
versus=20
            normoxic conditions of CD133<SUP>+</SUP> conditioned medium =
(ANOVA).=20
            <I>D,</I> VEGF expression levels in media conditioned for 24 =
hours=20
            from glioblastoma patient specimen cell populations grown in =
24-well=20
            plates were measured using a VEGF Quantikine ELISA (R&amp;D =
Systems)=20
            according to the directions of the manufacturer. Triplicate =
samples=20
            were collected for each sample. *, <I>P</I> =3D 0.0002, =
normoxic=20
            CD133<SUP>+</SUP> medium versus CD133<SUP>=96</SUP> medium =
(ANOVA);=20
            **, <I>P</I> =3D 0.0094, hypoxic versus normoxic conditions =
of=20
            CD133<SUP>+</SUP> conditioned medium (ANOVA); <I>P</I> =3D =
0.011,=20
            hypoxic CD133<SUP>+</SUP> medium versus hypoxic =
CD133<SUP>=96</SUP>=20
            medium (ANOVA).
            =
<P></P></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></CENTER>&nbsp=
;<BR><B>SCLGC=20
induce endothelial cell migration and tube formation.</B><SUP> =
</SUP>VEGF and=20
other angiogenic factors potently regulate endothelial<SUP> =
</SUP>behavior in=20
new vasculature formation. In <I>in vitro</I> models of<SUP> =
</SUP>angiogenesis,=20
angiogenic factors promote endothelial cell migration<SUP> </SUP>and/or =
induce=20
formation of vascular tubular structures when<SUP> </SUP>cultured on =
Matrigel.=20
We tested the ability of conditioned media<SUP> </SUP>from both=20
CD133<SUP>+</SUP> and CD133<SUP>=96</SUP> cells to modify =
endothelial<SUP>=20
</SUP>cell phenotypes. CD133<SUP>+</SUP> glioma cell conditioned medium=20
consistently<SUP> </SUP>increased migration of human microvascular =
endothelial=20
cells<SUP> </SUP>as compared with CD133<SUP>=96</SUP> conditioned medium =

(Supplementary<SUP> </SUP>Fig. S4). The addition of conditioned medium =
from=20
CD133<SUP>+</SUP> glioma<SUP> </SUP>cultures also promoted endothelial =
cell tube=20
formation <I>in vitro</I><SUP> </SUP>by increasing human microvascular=20
endothelial cell tube length,<SUP> </SUP>number of branch points, and =
tube=20
complexity (Supplementary<SUP> </SUP>Fig. S5). Together these results =
suggest=20
that CD133<SUP>+</SUP> cells produce<SUP> </SUP>proangiogenic factors =
that can=20
directly modify endothelial cell<SUP> </SUP>behavior.<SUP> </SUP>
<P><B>Targeting VEGF inhibits effects of SCLGC on endothelial =
cells.</B><SUP>=20
</SUP>Methods to inhibit tumor-associated angiogenesis are under=20
development,<SUP> </SUP>including anti-VEGF antibodies and low molecular =
weight=20
VEGF<SUP> </SUP>receptor tyrosine kinase inhibitors. One neutralizing=20
anti-VEGF<SUP> </SUP>antibody, bevacizumab/Avastin, binds to human =
VEGF-A=20
ligand<SUP> </SUP>to prevent endothelial cell receptor activation and =
has=20
shown<SUP> </SUP>combinatorial efficacy with irinotecan (CPT-11) in=20
high-grade<SUP> </SUP>glioma patients (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B9"=
>9</A>).=20
To determine if the increased levels of<SUP> </SUP>VEGF in =
CD133<SUP>+</SUP>=20
glioma conditioned media represent the mechanism<SUP> </SUP>through =
which=20
CD133<SUP>+</SUP> glioma cells promote <I>in vitro</I> measures<SUP> =
</SUP>of=20
angiogenesis, we examined the effect of bevacizumab antibody<SUP> =
</SUP>in our=20
endothelial cell assays. Similar to the above studies,<SUP> =
</SUP>conditioned=20
medium from CD133<SUP>+</SUP> cells derived from a human =
glioblastoma<SUP>=20
</SUP>specimen or a human xenograft, mixed with the IgG control =
antibody,<SUP>=20
</SUP>induced a striking increase in human microvascular =
endothelial<SUP>=20
</SUP>cell migration (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#FIG=
3">Fig.=20
3<I>A</I></A> and Supplementary Fig. S6<I>A</I>) and tube<SUP> =
</SUP>formation=20
(<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#FIG=
3">Fig.=20
3<I>B</I></A> and Supplemental Fig. S6<I>B</I>). Addition of =
bevacizumab<SUP>=20
</SUP>to neutralize VEGF in CD133<SUP>+</SUP> glioma conditioned medium=20
blocked<SUP> </SUP>its proangiogenic effects on endothelial cell =
migration (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#FIG=
3">Fig.=20
3<I>A</I></A><SUP> </SUP>and Supplementary Fig. S6<I>A</I>) and tube =
formation=20
(<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#FIG=
3">Fig.=20
3<I>B</I></A> and<SUP> </SUP>Supplementary Fig. S6<I>B</I>) to levels =
equal to=20
the effects of CD133<SUP>=96</SUP><SUP> </SUP>glioma conditioned medium. =
In=20
contrast, bevacizumab displayed<SUP> </SUP>only marginal effects on =
human=20
microvascular endothelial cells<SUP> </SUP>exposed to non-SCLGC =
conditioned=20
medium. Thus, the effects of<SUP> </SUP>SCLGC on endothelial cell =
behavior are=20
dependent on VEGF activity<SUP> </SUP>and bevacizumab specifically =
blocks the=20
effects of SCLGC on<SUP> </SUP>endothelial cell behavior in cell culture =

assays.<SUP> </SUP>
<P><A name=3DFIG3><!-- null --></A><BR clear=3Dall>
<CENTER>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"95%">
  <TBODY>
  <TR bgColor=3D#e1e1e1>
    <TD>
      <TABLE cellSpacing=3D2 cellPadding=3D2>
        <TBODY>
        <TR bgColor=3D#e1e1e1>
          <TD vAlign=3Dtop align=3Dmiddle bgColor=3D#ffffff><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843/FIG=
3"><IMG=20
            height=3D200 alt=3D"Figure 3" hspace=3D10=20
            =
src=3D"http://cancerres.aacrjournals.org/content/vol66/issue16/images/sma=
ll/7843fig03g.gif"=20
            width=3D163 vspace=3D5 border=3D2></A><BR><STRONG>View =
larger=20
            version</STRONG> (52K):<BR><NOBR><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843/FIG=
3">[in=20
            this window]</A><BR><A=20
            onmouseover=3D"window.status=3D'View figure in a separate =
window'; return true"=20
            onclick=3D"startTarget('FIG3', 509, 640); =
this.href=3D'/cgi/content-nw/full/66/16/7843/FIG3'"=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content-nw/full/66/16/7843/=
FIG3"=20
            target=3DFIG3>[in a new window]</A><BR>&nbsp;</NOBR> </TD>
          <TD vAlign=3Dtop align=3Dleft><B>Figure 3.</B> VEGF =
neutralizing=20
            antibody blocks SCLGC-induced endothelial cell migration and =
tube=20
            formation. <I>A,</I> a VEGF neutralizing antibody, =
bevacizumab,=20
            blocks SCLGC-induced endothelial cell migration. Media =
conditioned=20
            for 24 hours by CD133<SUP>=96</SUP> or CD133<SUP>+</SUP> =
cultures=20
            isolated from a patient glioblastoma patient specimen were =
added to=20
            the bottom chambers of 24-well tissue culture plates. =
Bevacizumab or=20
            an IgG antibody control (antibody final concentration, 0.5 =
mg/mL)=20
            was added to conditioned media 30 minutes before addition to =

            endothelial cell cultures. Human microvascular endothelial =
cells=20
            (20,000) were added to the upper chambers of Transwell =
assays (BD=20
            Biosciences). Cells were allowed to invade for 14 hours, =
fixed,=20
            stained, imaged, and quantified. Representative images. *, =
<I>P</I>=20
            =3D 0.0003, CD133<SUP>+</SUP> conditioned medium versus=20
            CD133<SUP>=96</SUP> conditioned medium (ANOVA); **, <I>P</I> =
=3D 0.0005,=20
            bevacizumab-treated CD133<SUP>+</SUP> conditioned medium =
versus IgG=20
            control (ANOVA). <I>B,</I> VEGF neutralizing antibody blocks =

            SCLGC-induced endothelial cell tube formation. Cultures of=20
            CD133<SUP>=96</SUP> or CD133<SUP>+</SUP> glioma cells =
derived from a=20
            patient glioblastoma patient specimen were used to condition =
media=20
            for 24 hours. To these media were added human microvascular=20
            endothelial cells grown at a density of 40,000 cells/mL with =
50 =B5L=20
            of cells added to sextuplicate wells of Matrigel-coated =
96-well=20
            plates (BD Biosciences). Bevacizumab or an IgG antibody =
control=20
            (final concentration, 0.5 mg/mL) was added to conditioned =
media 30=20
            minutes before addition to endothelial cell cultures. The=20
            endothelial cells were incubated in the conditioned media =
for 16=20
            hours and then imaged. Representative images. *, <I>P</I> =
&lt;=20
            0.0001, CD133<SUP>+</SUP> conditioned medium versus=20
            CD133<SUP>=96</SUP> conditioned medium (ANOVA); **, <I>P</I> =
&lt;=20
            0.0001 bevacizumab-treated CD133<SUP>+</SUP> conditioned =
medium=20
            versus IgG control (ANOVA).
            =
<P></P></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></CENTER>&nbsp=
;<BR><B>Bevacizumab=20
specifically targets SCLGC tumor growth <I>in vivo.</I></B><SUP> =
</SUP>To=20
confirm the relevance of the <I>in vitro</I> results, we examined<SUP> =
</SUP>the=20
effects of inhibiting the VEGF axis through the use of bevacizumab.<SUP> =

</SUP>We quantified the therapeutic effects of bevacizumab on s.c.<SUP>=20
</SUP>xenografts derived from matched SCLGC and non-SCLGC tumor =
cell<SUP>=20
</SUP>populations. Bevacizumab potently inhibited the growth of=20
SCLGC-derived<SUP> </SUP>xenografts with a reduction in tumor weight,=20
vascularity, and<SUP> </SUP>hemorrhage (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#FIG=
4">Fig.=20
4</A> ). In contrast, the small tumors derived<SUP> </SUP>from non-SCLGC =
tumor=20
cells were not significantly inhibited<SUP> </SUP>in growth by =
bevacizumab.=20
Parallel results were noted in intracranial<SUP> </SUP>studies =
(Supplementary=20
Fig. S7<I>A</I>).<SUP> </SUP>
<P><A name=3DFIG4><!-- null --></A><BR clear=3Dall>
<CENTER>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"95%">
  <TBODY>
  <TR bgColor=3D#e1e1e1>
    <TD>
      <TABLE cellSpacing=3D2 cellPadding=3D2>
        <TBODY>
        <TR bgColor=3D#e1e1e1>
          <TD vAlign=3Dtop align=3Dmiddle bgColor=3D#ffffff><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843/FIG=
4"><IMG=20
            height=3D200 alt=3D"Figure 4" hspace=3D10=20
            =
src=3D"http://cancerres.aacrjournals.org/content/vol66/issue16/images/sma=
ll/7843fig04c.gif"=20
            width=3D95 vspace=3D5 border=3D2></A><BR><STRONG>View larger =

            version</STRONG> (46K):<BR><NOBR><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843/FIG=
4">[in=20
            this window]</A><BR><A=20
            onmouseover=3D"window.status=3D'View figure in a separate =
window'; return true"=20
            onclick=3D"startTarget('FIG4', 359, 640); =
this.href=3D'/cgi/content-nw/full/66/16/7843/FIG4'"=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content-nw/full/66/16/7843/=
FIG4"=20
            target=3DFIG4>[in a new window]</A><BR>&nbsp;</NOBR> </TD>
          <TD vAlign=3Dtop align=3Dleft><B>Figure 4.</B> VEGF =
neutralizing=20
            antibody bevacizumab specifically suppresses SCLGC tumor =
growth and=20
            hemorrhage <I>in vivo. A,</I> treatment with =
VEGF-neutralizing=20
            antibody, bevacizumab, inhibits the <I>in vivo</I> tumor =
growth of=20
            xenografts derived from SCLGC and blocks the SCLGC-induced =
tumor=20
            hemorrhage <I>in vivo</I>. CD133<SUP>+</SUP> cells (100,000) =

            isolated from D456MG xenografts were implanted s.c. into two =
groups=20
            (five animals per group) of athymic nude BALB/c mice. =
Tumor-bearing=20
            animals were treated with either bevacizumab (5 mg/kg i.p. =
qd) or=20
            control IgG (5 mg/kg i.p. qd) for a total of 21 days until =
harvest.=20
            Mice were euthanized and tumors were harvested, weighed, and =

            examined. Representative tumor-bearing mice and dissected =
tumors=20
            from the two groups. SCLGC-derived tumors from the control =
IgG group=20
            showed rapid tumor growth with extensive hemorrhage, but =
treatment=20
            with the VEGF neutralizing antibody bevacizumab =
significantly=20
            suppressed SCLGC tumor growth <I>in vivo</I> and =
dramatically=20
            reduced the tumor hemorrhage of xenografts derived from =
SCLGC.=20
            <I>B,</I> the VEGF neutralizing antibody bevacizumab shows =
limited=20
            efficacy against xenografts derived from non-SCLGC tumor =
cells.=20
            CD133<SUP>=96</SUP> cells (100,000) derived from D456MG =
xenografts=20
            were implanted s.c. into two groups of athymic nude BALB/c =
mice.=20
            Tumor-bearing animals (five animals per group) were treated =
with=20
            either bevacizumab (5 mg/kg i.p. qd) or control IgG (5 mg/kg =
i.p.=20
            qd) for a total of 21 days until harvest. Mice were =
euthanized and=20
            tumors were harvested, weighed, and examined. Representative =

            tumor-bearing animals and dissected tumors from the two =
groups. The=20
            tumors derived from CD133<SUP>=96</SUP> cells were small and =
did not=20
            display significant hemorrhage. Bevacizumab treatment did =
not=20
            significantly inhibit the growth of the xenografts derived =
from=20
            CD133<SUP>=96</SUP> cells. <I>C,</I> the tumor weights for =
tumors from=20
            (<I>A</I>) and (<I>B</I>) were quantified. *, <I>P</I> &lt; =
0.001,=20
            bevacizumab treatment versus control IgG. **, <I>P</I> &gt; =
0.5,=20
            bevacizumab treatment versus control IgG.
            =
<P></P></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></CENTER>&nbsp=
;<BR>The=20
limited fraction of stem-like cells in gliomas may be critical<SUP> =
</SUP>for=20
tumor growth not only through their capacity for self-replication<SUP> =
</SUP>but=20
also through a paracrine effect supporting non-stemlike<SUP> </SUP>tumor =
cells=20
by inducing neovascularization. Although the VEGF<SUP> </SUP>axis is a=20
particularly appealing molecular target in cancer,<SUP> </SUP>the =
determinants=20
of patient response to these agents remain<SUP> </SUP>unclear. VEGF =
levels and=20
microvascular density have not been<SUP> </SUP>correlated with patient =
response=20
in clinical trials of bevacizumab<SUP> </SUP>for systemic cancers (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B18=
">18</A>).=20
Our results suggest that only a subpopulation<SUP> </SUP>of the tumor =
may be=20
critical for driving VEGF-mediated tumor<SUP> </SUP>angiogenesis as the =
effects=20
of a VEGF neutralizing antibody<SUP> </SUP>(bevacizumab) predominantly =
disrupt=20
the angiogenic effects of<SUP> </SUP>a fraction of the tumor, the stem =
cell=96like=20
cancer cells.<SUP> </SUP>
<P>Jain (<A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#B19=
">19</A>)=20
has established vascular "normalization" as a potential<SUP> </SUP>key =
response=20
to antiangiogenic therapies, in addition to the<SUP> </SUP>vascular =
pruning=20
caused through targeting angiogenesis. Bevacizumab<SUP> </SUP>may be =
effective=20
as a cancer therapy when combined with chemotherapy<SUP> </SUP>by =
improving=20
chemotherapy delivery specifically to the stem<SUP> </SUP>cell=96like =
tumor cells=20
that would be expected to be proximal<SUP> </SUP>to the tumor =
vasculature due to=20
VEGF expression. Indeed, we<SUP> </SUP>frequently detect =
CD133<SUP>+</SUP> tumor=20
cells in locations proximal to<SUP> </SUP>blood vessels (Supplementary =
Fig.=20
S7<I>B</I>). Therapies directed to<SUP> </SUP>target VEGF-expressing =
cells may=20
exhibit specificity against<SUP> </SUP>cancer stem cells. VEGF receptors =
are not=20
expressed by SCLGC<SUP> </SUP>(data not shown); thus, targeting VEGF may =
not=20
have a direct<SUP> </SUP>effect on cancer stem cells but rather =
paracrine=20
effects on<SUP> </SUP>endothelial cells and (possibly) other cancer =
cells. In=20
conclusion,<SUP> </SUP>our studies suggest that the tumor subpopulation =
that=20
shares<SUP> </SUP>characteristics with stem cells can contribute to =
tumor=20
malignancy<SUP> </SUP>and may be a key target of antiangiogenic =
therapies.<SUP>=20
</SUP>
<P><A name=3DACK><!-- null --></A><BR clear=3Dright>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG =
height=3D21=20
      alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/rarrow.gif" =
width=3D10></TD>
    <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT =
size=3D+2>&nbsp;&nbsp;=20
      Acknowledgments =
</FONT></TH></TR></TBODY></TABLE>&nbsp;<BR><B>Grant support:</B>=20
Pediatric Brain Tumor Foundation of the United<SUP> </SUP>States, =
Accelerate=20
Brain Cancer Cure, Childhood Brain Tumor<SUP> </SUP>Foundation (J.N. =
Rich), and=20
Southeastern Brain Tumor Foundation<SUP> </SUP>(A.B. Hjelmeland); NIH =
grants=20
NS047409, NS054276, and 1 P50<SUP> </SUP>CA 108786 (J.N. Rich) and NIH =
grants=20
NS20023 and CA11898 and<SUP> </SUP>NIH grant M01 RR 30, General Clinical =

Research Center Program,<SUP> </SUP>National Center for Research =
Resources,=20
National Cancer Institute<SUP> </SUP>Specialized Program of Research =
Excellence=20
1 P20 CA096890, Federal<SUP> </SUP>Consulting Group grants, and a grant =
from the=20
Pediatric Brain<SUP> </SUP>Tumor Foundation of the United States (D.D.=20
Bigner).<SUP> </SUP>
<P>The costs of publication of this article were defrayed in part<SUP> =
</SUP>by=20
the payment of page charges. This article must therefore<SUP> </SUP>be =
hereby=20
marked <I>advertisement</I> in accordance with 18 U.S.C.<SUP> =
</SUP>Section 1734=20
solely to indicate this fact.<SUP> </SUP>
<P><A name=3DFN><!-- null --></A><BR clear=3Dright>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG =
height=3D21=20
      alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/rarrow.gif" =
width=3D10></TD>
    <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT =
size=3D+2>&nbsp;&nbsp;=20
      Footnotes </FONT></TH></TR></TBODY></TABLE>&nbsp;<BR><A=20
name=3D""><!-- null --></A><B>Note:</B> Supplementary data for this =
article are=20
available at Cancer<SUP> </SUP>Research Online (<A=20
href=3D"http://cancerres.aacrjournals.org/">http://cancerres.aacrjournals=
.org/</A>).<SUP>=20
</SUP>
<P><A name=3D""><!-- null --></A>A.B. Hjelmeland is a Paul =
Brazen/American Brain=20
Tumor Association<SUP> </SUP>Fellow. J.N. Rich is a Damon Runyon-Lilly =
Clinical=20
Investigator,<SUP> </SUP>supported by the Damon Runyon Cancer Research=20
Foundation, and<SUP> </SUP>a Sidney Kimmel Cancer Foundation =
Translational=20
Scholar.<SUP> </SUP>
<P><A name=3DFN1><!-- null --></A><SUP>7</SUP> <A=20
href=3D"http://rsb.info.nih.gov/ij/">http://rsb.info.nih.gov/ij/</A>.<SUP=
>=20
</SUP><A=20
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#RFN=
1"><IMG=20
height=3D12 alt=3DBack =
src=3D"http://cancerres.aacrjournals.org/icons/back.gif"=20
width=3D12 border=3D0></A>
<P>Received 3/17/06. Revised 5/25/06. Accepted 7/ 6/06.
<P><A name=3DBIBL><!-- null --></A><BR clear=3Dright>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG =
height=3D21=20
      alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/rarrow.gif" =
width=3D10></TD>
    <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT =
size=3D+2>&nbsp;&nbsp;=20
      References </FONT></TH></TR></TBODY></TABLE>
<TABLE cellPadding=3D5 align=3Dright border=3D1>
  <TBODY>
  <TR>
    <TH align=3Dleft><FONT size=3D-1><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#top=
"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Top<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#ABS=
"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Abstract<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#SEC=
1"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Introduction<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#SEC=
2"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Materials and Methods<BR></A><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#SEC=
3"><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Results and Discussion<BR></A><IMG height=3D9 alt=3D" " =
hspace=3D5=20
      src=3D"http://cancerres.aacrjournals.org/icons/toc/dot.gif" =
width=3D11=20
      border=3D0><FONT=20
color=3D#464c53>References</FONT><BR></FONT></TH></TR></TBODY></TABLE>&nb=
sp;<BR>
<OL compact><A name=3DB1><!-- null --></A>
  <LI value=3D1>Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van =
Meir EG.=20
  Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and=20
  angiogenesis. Neuro-oncol 2005;7:134=9653.<!-- HIGHWIRE =
ID=3D"66:16:7843:1" --><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/ijlink?linkType=3DABST&amp;=
journalCode=3Dddno&amp;resid=3D7/2/134">[Abstract]</A><!-- /HIGHWIRE =
--><A=20
  name=3DB2><!-- null --></A>
  <LI value=3D2>Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, =
Holash J.=20
  Vascular-specific growth factors and blood vessel formation. Nature=20
  2000;407:242=968.<!-- HIGHWIRE ID=3D"66:16:7843:2" --><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3D1=
0.1038/35025215&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3D1=
1001067&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DB3><!-- null --></A>
  <LI value=3D3>Plate KH, Breier G, Weich HA, Risau W. Vascular =
endothelial growth=20
  factor is a potential tumour angiogenesis factor in human gliomas =
<I>in=20
  vivo</I>. Nature 1992;359:845=968.<!-- HIGHWIRE ID=3D"66:16:7843:3" =
--><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3D1=
0.1038/359845a0&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3D1=
279432&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DB4><!-- null --></A>
  <LI value=3D4>Plate KH, Breier G, Weich HA, Mennel HD, Risau W. =
Vascular=20
  endothelial growth factor and glioma angiogenesis: coordinate =
induction of=20
  VEGF receptors, distribution of VEGF protein and possible <I>in =
vivo</I>=20
  regulatory mechanisms. Int J Cancer 1994;59:520=969.<!-- HIGHWIRE =
ID=3D"66:16:7843:4" --><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3D7=
525492&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DB5><!-- null --></A>
  <LI value=3D5>Hatva E, Kaipainen A, Mentula P, et al. Expression of =
endothelial=20
  cell-specific receptor tyrosine kinases and growth factors in human =
brain=20
  tumors. Am J Pathol 1995;146:368=9678.<!-- HIGHWIRE =
ID=3D"66:16:7843:5" --><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/ijlink?linkType=3DABST&amp;=
journalCode=3Damjpathol&amp;resid=3D146/2/368">[Abstract]</A><!-- =
/HIGHWIRE --><A=20
  name=3DB6><!-- null --></A>
  <LI value=3D6>Rich JN, Sathornsumetee S, Keir ST, et al. ZD6474, a =
novel=20
  tyrosine kinase inhibitor of vascular endothelial growth factor =
receptor and=20
  epidermal growth factor receptor, inhibits tumor growth of multiple =
nervous=20
  system tumors. Clin Cancer Res 2005;11:8145=9657.<!-- HIGHWIRE =
ID=3D"66:16:7843:6" --><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/ijlink?linkType=3DABST&amp;=
journalCode=3Dclincanres&amp;resid=3D11/22/8145"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DB7><!-- null --></A>
  <LI value=3D7>Conrad C, Friedman H, Reardon D, et al. A phase I/II =
trial of=20
  single-agent PTK 787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis =
inhibitor,=20
  in patients with recurrent glioblastoma multiforme (GBM). J Clin Oncol =

  2004;22:110 (suppl; abstr 1512).<!-- HIGHWIRE ID=3D"66:16:7843:7" =
--><!-- /HIGHWIRE --><A name=3DB8><!-- null --></A>
  <LI value=3D8>Reardon D, Friedman HS, Yung WKA, et al. A phase I/II =
trial of=20
  PTK787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis inhibitor, in=20
  combination with either temozolomide or lomustine for patients with =
recurrent=20
  glioblastoma multiforme (GBM). J Clin Oncol 2004;22:110 (suppl; abstr =
1513).<!-- HIGHWIRE ID=3D"66:16:7843:8" --><!-- /HIGHWIRE --><A =
name=3DB9><!-- null --></A>
  <LI value=3D9>Stark-Vance V. Bevacizumab and CPT-11 in the treatment =
of relapsed=20
  malignant glioma [abstr 342]. Neurooncology 2005;7:370.<!-- HIGHWIRE =
ID=3D"66:16:7843:9" --><!-- /HIGHWIRE --><A name=3DB10><!-- null --></A>
  <LI value=3D10>Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous =
stem cells=20
  can arise from pediatric brain tumors. Proc Natl Acad Sci U S A=20
  2003;100:15178=9683.<!-- HIGHWIRE ID=3D"66:16:7843:10" --><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/ijlink?linkType=3DABST&amp;=
journalCode=3Dpnas&amp;resid=3D100/25/15178"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DB11><!-- null --></A>
  <LI value=3D11>Singh SK, Clarke ID, Terasaki M, et al. Identification =
of a=20
  cancer stem cell in human brain tumors. Cancer Res =
2003;63:5821=968.<!-- HIGHWIRE ID=3D"66:16:7843:11" --><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/ijlink?linkType=3DABST&amp;=
journalCode=3Dcanres&amp;resid=3D63/18/5821"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DB12><!-- null --></A>
  <LI value=3D12>Galli R, Binda E, Orfanelli U, et al. Isolation and=20
  characterization of tumorigenic, stem-like neural precursors from =
human=20
  glioblastoma. Cancer Res=20
  2004;64:7011=9621.<!-- HIGHWIRE ID=3D"66:16:7843:12" --><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/ijlink?linkType=3DABST&amp;=
journalCode=3Dcanres&amp;resid=3D64/19/7011"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DB13><!-- null --></A>
  <LI value=3D13>Singh SK, Hawkins C, Clarke ID, et al. Identification =
of human=20
  brain tumor initiating cells. Nature 2004;432:396=96401.<!-- HIGHWIRE =
ID=3D"66:16:7843:13" --><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3D1=
0.1038/nature03128&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3D1=
5549107&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DB14><!-- null --></A>
  <LI value=3D14>Taylor MD, Poppleton H, Fuller C, et al. Radial glia =
cells are=20
  candidate stem cells of ependymoma. Cancer Cell 2005;8:323=9635.<!-- =
HIGHWIRE ID=3D"66:16:7843:14" --><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3D1=
0.1016/j.ccr.2005.09.001&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3D1=
6226707&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DB15><!-- null --></A>
  <LI value=3D15>Izant JG, Weatherbee JA, McIntosh JR. A =
microtubule-associated=20
  protein antigen unique to mitotic spindle microtubules in PtK1 cells. =
J Cell=20
  Biol 1983;96:424=9634.<!-- HIGHWIRE ID=3D"66:16:7843:15" --><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/ijlink?linkType=3DABST&amp;=
journalCode=3Djcb&amp;resid=3D96/2/424"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DB16><!-- null --></A>
  <LI value=3D16>Lee A, Kessler JD, Read TA, et al. Isolation of neural =
stem cells=20
  from the postnatal cerebellum. Nat Neurosci 2005;8:723=969.<!-- =
HIGHWIRE ID=3D"66:16:7843:16" --><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3D1=
0.1038/nn1473&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3D1=
5908947&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DB17><!-- null --></A>
  <LI value=3D17>Detwiller KY, Fernando NT, Segal NH, Ryeom SW, D'Amore =
PA, Yoon=20
  SS. Analysis of hypoxia-related gene expression in sarcomas and effect =
of=20
  hypoxia on RNA interference of vascular endothelial cell growth factor =
A.=20
  Cancer Res 2005;65:5881=969.<!-- HIGHWIRE ID=3D"66:16:7843:17" --><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/ijlink?linkType=3DABST&amp;=
journalCode=3Dcanres&amp;resid=3D65/13/5881"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DB18><!-- null --></A>
  <LI value=3D18>Jubb AM, Hurwitz HI, Bai W, et al. Impact of vascular =
endothelial=20
  growth factor-A expression, thrombospondin-2 expression, and =
microvessel=20
  density on the treatment effect of bevacizumab in metastatic =
colorectal=20
  cancer. J Clin Oncol 2006;24:217=9627.<!-- HIGHWIRE =
ID=3D"66:16:7843:18" --><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/ijlink?linkType=3DABST&amp;=
journalCode=3Djco&amp;resid=3D24/2/217"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DB19><!-- null --></A>
  <LI value=3D19>Jain RK. Normalization of tumor vasculature: an =
emerging concept=20
  in antiangiogenic therapy. Science 2005;307:58=9662.<!-- HIGHWIRE =
ID=3D"66:16:7843:19" --><A=20
  =
href=3D"http://cancerres.aacrjournals.org/cgi/ijlink?linkType=3DABST&amp;=
journalCode=3Dsci&amp;resid=3D307/5706/58"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --></LI></OL><BR=20
clear=3Dall><FONT face=3D""></FONT><BR clear=3Dall><BR clear=3Dall><A=20
name=3Dotherarticles><!-- null --></A>
<P><FONT size=3D+2><STRONG>This article has been cited by other=20
articles:</STRONG></FONT>=20
<P>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D600 border=3D0>
  <TBODY>
  <TR bgColor=3D#d9d4c5>
    <TD vAlign=3Dtop align=3Dmiddle width=3D25><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D25><BR></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle width=3D61><A=20
      href=3D"http://www.genesdev.org/"><IMG height=3D80 alt=3D"Home =
page"=20
      src=3D"http://www.genesdev.org/portal_imgs/search_result.gif" =
width=3D59=20
      vspace=3D5 border=3D1></A><BR></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD>
    <TD vAlign=3Dtop noWrap width=3D499><A =
href=3D"http://www.genesdev.org/"><IMG=20
      height=3D16 alt=3D"Genes Dev."=20
      =
src=3D"http://cancerres.aacrjournals.org/icons/shared/searchall/journals/=
genesdev.gif"=20
      width=3D450 vspace=3D5 border=3D0><IMG height=3D16 alt=3D"Home =
page"=20
      =
src=3D"http://cancerres.aacrjournals.org/icons/shared/search/homelink.gif=
"=20
      width=3D49 vspace=3D5 border=3D0></A><BR><FONT =
face=3Dverdana,arial,helvetica=20
      size=3D-1>F. B. Furnari, T. Fenton, R. M. Bachoo, A. Mukasa, J. M. =
Stommel,=20
      A. Stegh, W. C. Hahn, K. L. Ligon, D. N. Louis, C. Brennan, <EM>et =

      al.</EM><BR><STRONG>Malignant astrocytic glioma: genetics, =
biology, and=20
      paths to treatment</STRONG><BR>Genes &amp; Dev.,=20
      November&nbsp;1,&nbsp;2007; 21(21): 2683 - 2710. <BR><A=20
      =
href=3D"http://www.genesdev.org/cgi/content/abstract/21/21/2683">[Abstrac=
t]</A>=20
      <A =
href=3D"http://www.genesdev.org/cgi/content/full/21/21/2683">[Full=20
      Text]</A> <A=20
      href=3D"http://www.genesdev.org/cgi/reprint/21/21/2683">[PDF]</A> =
<BR><IMG=20
      height=3D1 alt=3D"" =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
      width=3D499> </FONT></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD></TR>
  <TR>
    <TD colSpan=3D6>
      <HR align=3Dleft width=3D600 color=3D#828282 noShade SIZE=3D1>
    </TD></TR></TBODY></TABLE>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D600 border=3D0>
  <TBODY>
  <TR bgColor=3D#d9d4c5>
    <TD vAlign=3Dtop align=3Dmiddle width=3D25><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D25><BR></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle width=3D61><A=20
      href=3D"http://jco.ascopubs.org/"><IMG height=3D80 alt=3D"Home =
page"=20
      src=3D"http://jco.ascopubs.org/portal_imgs/search_result.gif" =
width=3D59=20
      vspace=3D5 border=3D1></A><BR></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD>
    <TD vAlign=3Dtop noWrap width=3D499><A =
href=3D"http://jco.ascopubs.org/"><IMG=20
      height=3D16 alt=3DJCO=20
      =
src=3D"http://cancerres.aacrjournals.org/icons/shared/searchall/journals/=
jco.gif"=20
      width=3D450 vspace=3D5 border=3D0><IMG height=3D16 alt=3D"Home =
page"=20
      =
src=3D"http://cancerres.aacrjournals.org/icons/shared/search/homelink.gif=
"=20
      width=3D49 vspace=3D5 border=3D0></A><BR><FONT =
face=3Dverdana,arial,helvetica=20
      size=3D-1>W. Chen, S. Delaloye, D. H.S. Silverman, C. Geist, J. =
Czernin, J.=20
      Sayre, N. Satyamurthy, W. Pope, A. Lai, M. E. Phelps, <EM>et=20
      al.</EM><BR><STRONG>Predicting Treatment Response of Malignant =
Gliomas to=20
      Bevacizumab and Irinotecan by Imaging Proliferation With [18F]=20
      Fluorothymidine Positron Emission Tomography: A Pilot =
Study</STRONG><BR>J.=20
      Clin. Oncol., October&nbsp;20,&nbsp;2007; 25(30): 4714 - 4721. =
<BR><A=20
      =
href=3D"http://jco.ascopubs.org/cgi/content/abstract/25/30/4714">[Abstrac=
t]</A>=20
      <A =
href=3D"http://jco.ascopubs.org/cgi/content/full/25/30/4714">[Full=20
      Text]</A> <A=20
      href=3D"http://jco.ascopubs.org/cgi/reprint/25/30/4714">[PDF]</A> =
<BR><IMG=20
      height=3D1 alt=3D"" =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
      width=3D499> </FONT></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD></TR>
  <TR>
    <TD colSpan=3D6>
      <HR align=3Dleft width=3D600 color=3D#828282 noShade SIZE=3D1>
    </TD></TR></TBODY></TABLE>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D600 border=3D0>
  <TBODY>
  <TR bgColor=3D#d9d4c5>
    <TD vAlign=3Dtop align=3Dmiddle width=3D25><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D25><BR></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle width=3D61><A=20
      href=3D"http://jco.ascopubs.org/"><IMG height=3D80 alt=3D"Home =
page"=20
      src=3D"http://jco.ascopubs.org/portal_imgs/search_result.gif" =
width=3D59=20
      vspace=3D5 border=3D1></A><BR></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD>
    <TD vAlign=3Dtop noWrap width=3D499><A =
href=3D"http://jco.ascopubs.org/"><IMG=20
      height=3D16 alt=3DJCO=20
      =
src=3D"http://cancerres.aacrjournals.org/icons/shared/searchall/journals/=
jco.gif"=20
      width=3D450 vspace=3D5 border=3D0><IMG height=3D16 alt=3D"Home =
page"=20
      =
src=3D"http://cancerres.aacrjournals.org/icons/shared/search/homelink.gif=
"=20
      width=3D49 vspace=3D5 border=3D0></A><BR><FONT =
face=3Dverdana,arial,helvetica=20
      size=3D-1>J. J. Vredenburgh, A. Desjardins, J. E. Herndon II, J. =
Marcello,=20
      D. A. Reardon, J. A. Quinn, J. N. Rich, S. Sathornsumetee, S. =
Gururangan,=20
      J. Sampson, <EM>et al.</EM><BR><STRONG>Bevacizumab Plus Irinotecan =
in=20
      Recurrent Glioblastoma Multiforme</STRONG><BR>J. Clin. Oncol.,=20
      October&nbsp;20,&nbsp;2007; 25(30): 4722 - 4729. <BR><A=20
      =
href=3D"http://jco.ascopubs.org/cgi/content/abstract/25/30/4722">[Abstrac=
t]</A>=20
      <A =
href=3D"http://jco.ascopubs.org/cgi/content/full/25/30/4722">[Full=20
      Text]</A> <A=20
      href=3D"http://jco.ascopubs.org/cgi/reprint/25/30/4722">[PDF]</A> =
<BR><IMG=20
      height=3D1 alt=3D"" =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
      width=3D499> </FONT></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD></TR>
  <TR>
    <TD colSpan=3D6>
      <HR align=3Dleft width=3D600 color=3D#828282 noShade SIZE=3D1>
    </TD></TR></TBODY></TABLE>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D600 border=3D0>
  <TBODY>
  <TR bgColor=3D#d9d4c5>
    <TD vAlign=3Dtop align=3Dmiddle width=3D25><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D25><BR></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle width=3D61><A=20
      href=3D"http://cancerres.aacrjournals.org/"><IMG height=3D80 =
alt=3D"Home page"=20
      =
src=3D"http://cancerres.aacrjournals.org/portal_imgs/search_result.gif"=20
      width=3D59 vspace=3D5 border=3D1></A><BR></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD>
    <TD vAlign=3Dtop noWrap width=3D499><A=20
      href=3D"http://cancerres.aacrjournals.org/"><IMG height=3D16 =
alt=3D"Cancer Res."=20
      =
src=3D"http://cancerres.aacrjournals.org/icons/shared/searchall/journals/=
canres.gif"=20
      width=3D450 vspace=3D5 border=3D0><IMG height=3D16 alt=3D"Home =
page"=20
      =
src=3D"http://cancerres.aacrjournals.org/icons/shared/search/homelink.gif=
"=20
      width=3D49 vspace=3D5 border=3D0></A><BR><FONT =
face=3Dverdana,arial,helvetica=20
      size=3D-1>J. N. Rich<BR><STRONG>Cancer Stem Cells in Radiation=20
      Resistance</STRONG><BR>Cancer Res., October&nbsp;1,&nbsp;2007; =
67(19):=20
      8980 - 8984. <BR><A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/abstract/67/19/8980=
">[Abstract]</A>=20
      <A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/67/19/8980">[F=
ull=20
      Text]</A> <A=20
      =
href=3D"http://cancerres.aacrjournals.org/cgi/reprint/67/19/8980">[PDF]</=
A>=20
      <BR><IMG height=3D1 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D499>=20
    </FONT></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD></TR>
  <TR>
    <TD colSpan=3D6>
      <HR align=3Dleft width=3D600 color=3D#828282 noShade SIZE=3D1>
    </TD></TR></TBODY></TABLE>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D600 border=3D0>
  <TBODY>
  <TR bgColor=3D#d9d4c5>
    <TD vAlign=3Dtop align=3Dmiddle width=3D25><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D25><BR></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle width=3D61><A=20
      href=3D"http://theoncologist.alphamedpress.org/"><IMG height=3D80=20
      alt=3D"Home page"=20
      =
src=3D"http://theoncologist.alphamedpress.org/portal_imgs/search_result.g=
if"=20
      width=3D59 vspace=3D5 border=3D1></A><BR></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD>
    <TD vAlign=3Dtop noWrap width=3D499><A=20
      href=3D"http://theoncologist.alphamedpress.org/"><IMG height=3D16=20
      alt=3D"The Oncologist"=20
      =
src=3D"http://cancerres.aacrjournals.org/icons/shared/searchall/journals/=
theoncologist.gif"=20
      width=3D450 vspace=3D5 border=3D0><IMG height=3D16 alt=3D"Home =
page"=20
      =
src=3D"http://cancerres.aacrjournals.org/icons/shared/search/homelink.gif=
"=20
      width=3D49 vspace=3D5 border=3D0></A><BR><FONT =
face=3Dverdana,arial,helvetica=20
      size=3D-1>S. Senan and E. F. Smit<BR><STRONG>Design of Clinical =
Trials of=20
      Radiation Combined with Antiangiogenic =
Therapy</STRONG><BR>Oncologist,=20
      April&nbsp;1,&nbsp;2007; 12(4): 465 - 477. <BR><A=20
      =
href=3D"http://theoncologist.alphamedpress.org/cgi/content/abstract/12/4/=
465">[Abstract]</A>=20
      <A=20
      =
href=3D"http://theoncologist.alphamedpress.org/cgi/content/full/12/4/465"=
>[Full=20
      Text]</A> <A=20
      =
href=3D"http://theoncologist.alphamedpress.org/cgi/reprint/12/4/465">[PDF=
]</A>=20
      <BR><IMG height=3D1 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D499>=20
    </FONT></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD></TR>
  <TR>
    <TD colSpan=3D6>
      <HR align=3Dleft width=3D600 color=3D#828282 noShade SIZE=3D1>
    </TD></TR></TBODY></TABLE>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D600 border=3D0>
  <TBODY>
  <TR bgColor=3D#d9d4c5>
    <TD vAlign=3Dtop align=3Dmiddle width=3D25><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D25><BR></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle width=3D61><A=20
      href=3D"http://clincancerres.aacrjournals.org/"><IMG height=3D80=20
      alt=3D"Home page"=20
      =
src=3D"http://clincancerres.aacrjournals.org/portal_imgs/search_result.gi=
f"=20
      width=3D59 vspace=3D5 border=3D1></A><BR></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD>
    <TD vAlign=3Dtop noWrap width=3D499><A=20
      href=3D"http://clincancerres.aacrjournals.org/"><IMG height=3D16=20
      alt=3D"Clin. Cancer Res."=20
      =
src=3D"http://cancerres.aacrjournals.org/icons/shared/searchall/journals/=
clincanres.gif"=20
      width=3D450 vspace=3D5 border=3D0><IMG height=3D16 alt=3D"Home =
page"=20
      =
src=3D"http://cancerres.aacrjournals.org/icons/shared/search/homelink.gif=
"=20
      width=3D49 vspace=3D5 border=3D0></A><BR><FONT =
face=3Dverdana,arial,helvetica=20
      size=3D-1>J. J. Vredenburgh, A. Desjardins, J. E. Herndon II, J. =
M. Dowell,=20
      D. A. Reardon, J. A. Quinn, J. N. Rich, S. Sathornsumetee, S. =
Gururangan,=20
      M. Wagner, <EM>et al.</EM><BR><STRONG>Phase II Trial of =
Bevacizumab and=20
      Irinotecan in Recurrent Malignant Glioma</STRONG><BR>Clin. Cancer =
Res.,=20
      February&nbsp;15,&nbsp;2007; 13(4): 1253 - 1259. <BR><A=20
      =
href=3D"http://clincancerres.aacrjournals.org/cgi/content/abstract/13/4/1=
253">[Abstract]</A>=20
      <A=20
      =
href=3D"http://clincancerres.aacrjournals.org/cgi/content/full/13/4/1253"=
>[Full=20
      Text]</A> <A=20
      =
href=3D"http://clincancerres.aacrjournals.org/cgi/reprint/13/4/1253">[PDF=
]</A>=20
      <BR><IMG height=3D1 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D499>=20
    </FONT></TD>
    <TD width=3D5><IMG height=3D5 alt=3D""=20
      src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif" =
width=3D5></TD></TR>
  <TR>
    <TD colSpan=3D6>
      <HR align=3Dleft width=3D600 color=3D#828282 noShade SIZE=3D1>
    </TD></TR></TBODY></TABLE><BR clear=3Dall>
<TABLE class=3Dcontent_box_outer_table align=3Dright>
  <TBODY>
  <TR>
    <TD><!-- beginning of inner table -->
      <TABLE class=3Dcontent_box_inner_table><!-- citation -->
        <TBODY>
        <TR>
          <TD class=3Dcontent_box_title_highlight colSpan=3D2>This =
Article</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content/abstract/66/16/7843=
">Abstract</A></STRONG>=20
            <IMG height=3D7 alt=3D"Freely available"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/toc/free.gif"=20
            width=3D32 border=3D0> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/reprint/66/16/7843"><STRONG=
>Full=20
            Text</STRONG> (PDF)</A> </STRONG></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843/DC1=
">Supplementary=20
            Data</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/alerts/ctalert?alertType=3D=
citedby&amp;addAlert=3Dcited_by&amp;saveAlert=3Dno&amp;cited_by_criteria_=
resid=3Dcanres;66/16/7843&amp;return_type=3Darticle&amp;return_url=3Dhttp=
%3A%2F%2Fcancerres.aacrjournals.org%2Fcgi%2Fcontent%2Ffull%2F66%2F16%2F78=
43">Alert=20
            me when this article is cited</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/alerts/ctalert?alertType=3D=
correction&amp;addAlert=3Dcorrection&amp;saveAlert=3Dno&amp;correction_cr=
iteria_value=3D66/16/7843&amp;return_type=3Darticle&amp;return_url=3Dhttp=
%3A%2F%2Fcancerres.aacrjournals.org%2Fcgi%2Fcontent%2Ffull%2F66%2F16%2F78=
43">Alert=20
            me if a correction is posted</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>Services</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/search?qbe=3Dcanres;66/16/7=
843&amp;journalcode=3Dcanres&amp;minscore=3D5000">Similar=20
            articles in this journal</A> </STRONG></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3D1=
6912155&amp;link_type=3DMED_NBRS">Similar=20
            articles in PubMed</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/alerts/etoc">Alert me to=20
            new issues of the journal</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/citmgr?gca=3Dcanres;66/16/7=
843">Download=20
            to citation manager</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?&amp;link_type=
=3DPERMISSIONDIRECT"=20
            target=3D_new><IMG alt=3D"reprints &amp; permissions"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/misc/permissions.gif"=20
            border=3D0></A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>Citing =
Articles</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/content/full/66/16/7843#oth=
erarticles">Citing=20
            Articles via HighWire</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3Dh=
ttp://cancerres.aacrjournals.org/cgi/content/abstract/66/16/7843&amp;link=
_type=3DGOOGLESCHOLAR"=20
            target=3D_blank>Citing Articles via Google =
Scholar</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>Google =
Scholar</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://scholar.google.com/scholar?q=3D%22author%3AS.+author%3ABao=
%22"=20
            target=3D_blank>Articles by Bao, S.</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            href=3D"http://scholar.google.com/scholar?q=3D%22author%3AJ. =
N.+author%3ARich%22"=20
            target=3D_blank>Articles by Rich, J. N.</A></STRONG> =
</TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3Dh=
ttp://cancerres.aacrjournals.org/cgi/content/abstract/66/16/7843&amp;link=
_type=3DGOOGLESCHOLARRELATED"=20
            target=3D_blank>Search for Related Content</A></STRONG> =
</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>PubMed</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://cancerres.aacrjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3D1=
6912155&amp;link_type=3DPUBMED">PubMed=20
            Citation</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3DB=
ao+S&amp;link_type=3DAUTHORSEARCH"=20
            target=3D_blank>Articles by Bao, S.</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif=
"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://cancerres.aacrjournals.org/cgi/external_ref?access_num=3DR=
ich+JN&amp;link_type=3DAUTHORSEARCH"=20
            target=3D_blank>Articles by Rich, J. N.</A></STRONG>=20
        =
</TD></TR></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE><BR =
clear=3Dall>
<P>
<HR align=3Dleft width=3D450 noShade SIZE=3D1>

<TABLE cellSpacing=3D2 cellPadding=3D2 width=3D450>
  <TBODY>
  <TR>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://cancerres.aacrjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff=20
      size=3D-2>HOME</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://cancerres.aacrjournals.org/help/" =
target=3D_top><FONT=20
      face=3Darial,helvetica color=3D#ffffff =
size=3D-2>HELP</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://cancerres.aacrjournals.org/cgi/feedback" =
target=3D_top><FONT=20
      face=3Darial,helvetica color=3D#ffffff =
size=3D-2>FEEDBACK</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://cancerres.aacrjournals.org/subscriptions/" =
target=3D_top><FONT=20
      face=3Darial,helvetica color=3D#ffffff =
size=3D-2>SUBSCRIPTIONS</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none"=20
      =
href=3D"http://cancerres.aacrjournals.org/contents-by-date.0.shtml"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff=20
      size=3D-2>ARCHIVE</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://cancerres.aacrjournals.org/search.dtl" =
target=3D_top><FONT=20
      face=3Darial,helvetica color=3D#ffffff =
size=3D-2>SEARCH</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://cancerres.aacrjournals.org/content/vol66/issue16/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>TABLE OF=20
      CONTENTS</FONT></A></TD></TR></TBODY></TABLE>
<TABLE cellSpacing=3D2 cellPadding=3D2 width=3D450>
  <TBODY>
  <TR>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#e1e1e1><FONT=20
      face=3Darial,helvetica color=3D#000000 size=3D-2>Cancer =
Research</FONT></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://clincancerres.aacrjournals.org/" =
target=3D_top><FONT=20
      face=3Darial,helvetica color=3D#ffffff size=3D-2>Clinical Cancer=20
      Research</FONT></A></TD></TR>
  <TR>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://cebp.aacrjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>Cancer=20
      Epidemiology Biomarkers &amp; Prevention</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://mct.aacrjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>Molecular=20
      Cancer Therapeutics</FONT></A></TD></TR>
  <TR>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://mcr.aacrjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>Molecular=20
      Cancer Research</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#000099><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://cgd.aacrjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>Cell Growth=20
      &amp; Differentiation</FONT></A></TD></TR></TBODY></TABLE>
<SCRIPT src=3D"http://www.google-analytics.com/urchin.js"=20
type=3Dtext/javascript>=0A=
</SCRIPT>

<SCRIPT type=3Dtext/javascript>=0A=
=0A=
_uacct =3D "UA-847603-1";=0A=
_udn=3D"aacrjournals.org";=0A=
=0A=
urchinTracker();=0A=
</SCRIPT>
</BODY></HTML>

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/banner/title.gif
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------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: application/octet-stream
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/adsystem/graphics/1200405603390/canres/UbiquitinConf_256x80.gif?ad=16609&adview=true

R0lGODlhAAFQAPcAAAsHBQsJBSMfIQ0LBw0JBwkHBQsFBwsLB21lD9TOeg0HB94rK8G7RamfAauh
AebktFBJBIuCAn53ApGHBKGXASoQDkhCBId/CRIKCZWLAdAoKIUfHBIOB0E7BRYTBTUvBjo2BCsl
Bi8rAwsHB2dgA2q1SJAhHhoVBg8PCSMPDaOZAuwsLSIdBnRsAkdDF8QnJwYHBrqyK64lI6edATsU
EBYNCltXATo1HDESD0EVER4OC0cVEvX04gAAAKUkIngeGpsjIBYLCqWbAW0dGR0aBzUUELwlJAIH
BRoLCxALBw0NCRISCrUmJIN6AxIXDQ4NByYTDBckEw0JBWxjBJqRAYl9A1QWEy0pHw8JB5+VAWYZ
FXVtDXtxA00WEndvA3i7RszGaBQdEB0LCyYhBy0UDiMhAVwWExsrFm4YFVtUBBIOCR8TC29oAwMK
B52TAWJaBA0HCUcxC5eOARkPCZmRBTUcDlRNBAgLBw8NCRoOCw8QC1EcE1U8CwgJB11WAxATDX93
C1FLFVcaFTwoDGNdETIhCyscDQ8LCV8aFVlTE3NjBhcZDmNWBrGnERAWCkEdEVdRBEobEsw4JFqw
SQsLASQZCw0LCQEGA2I2DoowGRseDwkHBwUPCFMtDYFxBQoOCRYWCnMvE7bSOozDQsW/Vk0kEQ8h
EqRcEqDEP+BCJw0PCBoTCxYSCoxwB+PfL18fF5qOAmpWCLxXGAoTCpppC7o4In9KDYxZDpFJE2Un
E6Y4HAsLBWFICh43GzyHPNReJAYXDGtBDg0HBXFcCKhwDn1iCFlTBbp7D2GTPbNlEh4ODQkFBZl3
CJKuO9WFLbBIIFxMBz2lR4AQFvCcKDcKCoSVOAcJBamVBA8JCUhrMA0MBSpmMKKFB2RVJo6mGQ8H
B6aXOHw/I9sbJolmCgoKCRALC5SXFql7LU8NDxsNDQoOBwgMBYxaK4lxMa2jEQEBAV9ZDYWKFlEy
H5mNFQwOC4qbEwsFBWVsM397B5V1FyEFBwsJB////6uhAAAAAAAAACH5BAAAAAAALAAAAAAAAVAA
AAj/APsJHEiwoMGDCBMqXMiwocOHECMKbDBDRRYqGSI08TLFjx0LHT6EGEPkhAcOT3bVKLIDRxEa
OgqMSIcDR44cNeAEgVKkC40UG5jsUdPmDoc5eWokwRMgyR4ZG/DcOYCHUxsoQ174gNJmxwsNGmQg
8rHixYYfL2QAAdJmlRNOP0ysWqKpLhGJePPq3cu3L0KKFuVMqMKFzRtjEEKKIGmSQ5IBAXQUqaCD
Bg0kAbBUyFEBh5kdGGBgQIJjgwkTRZQcGDBgdY0aeAZcwiHDyJAB+wjgPpBnDxANj6Ds+L3iRx0T
LxDt0bDgx54udzjNIuMDCCsUi6IQ0eS3u/fv4PE2/2gghAJGjRzffAQhkgWRk4+l1KhQAYmYmkj2
YehZAVuODSnAUMQPORjhAxlFHbDPgrkdQsAybeTA3Abk9HFIAPsccIcWQJjg2wJGfLXBS1r8IMMC
Q3CyCg2rsKLFECb8sAYKYUQRxSLh5ajjjt9RVN55ErRAQhqJiVRGSRw4JgUBYqSQQhBI0BcaBjug
YUUNSKCBAwwVoIHOBma0hgJurA0AwD4DbLIPDSb4YEUbByiBmxIRAjGEDwss4IMMWm0Q1AorbAWF
iTQ8wgQicUUCiiZnRAEKj5BGKilDgGUBy2CFvQEJSO01lgcHACiAhA7pBIEBBqYWEEQOZmhBzah5
7P8Dwx2dzQHHAE8EQACaZhaAIQE1kEFDEEosqIQSAWxyyAZ5LpBWnkZoAOgKem5ghIF75LDHK0Zs
UMeijYYx6bjkSkoRBVkI1gQXU6hnAQgjsWDSKjpgAcAyGOigQxAEYAiHAjqJkQMaQ9CAQR+aFQEF
CoeMeWaxmdmL5gEwwLCgFAG0RoCq/5lhLXMLaPBVs3mGZUIOQ2jxwgJaOOJEFGecwV25NNfc3Xgz
UOBGRhtNYUNi8I5hUg1r5GFvAQBgIIYYQQSgAKpKp5DDWlZYYcYPRliRxxMHrLbragcsSQAAZ44w
gkwAHKIgAAdIRs0N3UiSCrUjh2wEyT7ssUBZglT/EoYTYZzRyxk2F264RD6al1GQJEBSZAjynuQY
AFIAUIBOSNRwCBZNVtAFGhv4oMUcP+xtxA417BOArrwOQIAwuq6+zwgYoknAE/sYoCoN1GTzhSgM
OKOLCUwwZ8QevnXrw90LmLDGEk4AHnMvh1dvfUKAKV4F45uyV0bkHAwgDNkBFFAABk7yiz6rZlht
Rh4brGAETGrIyaDqBESpwyEM7tI1mpbI0K32gQRquKAEohgFKlzxi1c84is0aEMkEBEJGaxAA0DY
gBaKALjACe56IAxhpQRDGMOsZzHvqcEc1BAAA6hOCgYYARJSgJnzpaACKcDAfzbzAibgAAorVAPX
/5wWgDzQYAcVsEQeioCDARSAAKvJja7O1Ad91AEZoijBKFwxjbOsbANLKIK1ALUAJkTiB4J4Gcx6
Qb2ESIACCskIQSKQAYJkQAL9uKME6kgQCrzRIRmwgUFEEIGC7HEhEhABCUJ4EPLoTA7o6cgJSeIB
erFwBKoj2/mQwC8DbMIAKcDBaAShAwkxgQw6WMMqFgEKOW1MDF3oQh76gIQjpqA1CwJAvwigAAMM
4BuLyEYztOiKczDBWRrYADAMYQK6LQAIjqBBJLJjIza60QMQUIgIPADHflCgDGUQCAVEIAIbmNMD
NqBECwbSAnQKsiGBNEgP8CgQEmDTAt1EiAiyyf/IgiTuPE1ogc8eJ68TQCEFh5DCCAwQKgIQAAsY
+AZDRyMGGnThStQJ2QahkAdNrKEGKMDDPg7BqiYaAH0pwIICcskaKMLhVpwYwjlK8IVRNAMczkhF
GX9wzGeawAhkWMMO/ObBRiXEAjbwgEAUKYJ1CiQD2FxkP0hggTLU0QYiGAhW+7HVpfIzAki1QCHB
aoE6RgACIIhAViXwLjzOcyCUoKc331VICNgABDYgASU8EAEKoBWPiiSBX0EAWBI0tR9nBQEFWoDX
fIKnUkAS0qZCArlKQAEKayAAQxUAgJNycmzLgAMOdqCDFMAIEccElG1SMIc1QGEuqvhEDWoyB8j/
pC0JAMgYa1i3KzgsgxOI6MYkvrBAUaAip5K4W1n2UIcNWEGD1IyZjRJCiSyUYZ09sEELKKFVCLQg
nP0AARsgkE28ahWdZZCrBCgBgjvOc6t8vWs/1JkFCfSgH3tMaj/eitj7DqSc6x2nYnugVkEiNQLc
7QEEMnDgBGuXu/SFKgXMG57EuQGS62rXekRiCENctgaVG58BDBAEGiqgAMvYRAouStodnEgDRthg
DtWQB8wuQRV4uGEQNrG6XfFyH0800z7kNAA5fUIHLkBGCRAoCuI6oxZAAJRQXjGEaO1hCTWKwuAI
d5B2SgAEFtivBOw7kDJotwcZoEAPWqBfpGr1/7potiMIPEBm+0agByIowzz9W2cIWOC+/M2AfwXy
1nmWU8yHpkQZRLBnPCqa0fYd854Fks5tZrXCFbnI4oTkEZCIIAR1qAMqORAAAIyAswDAQg0wgDQC
HEIMRWgVIvzkEzLgoQ++soQaanCdkIZSDLtE0/1KvQzd4Io1nFiDDJwxii84uwQLzGkqQlQ8E8hA
A4jAco1ixmWDgACvHUiwpAWC4HOa08w2ILA9u7lVEPDTm/3Yrn0z8F01Z+GpBMbvfePKBkDLFZ0D
8QAJBJ2BQxtakNcdyFsTTmhJC7qQ392RhSFZwiFBIA4gKITGRZ2HysWw1JTbh+Xyt5lWSUODKf84
wh2mkiEMjQCKuRlAHuiTAjFgQUEiRzUA7GGAfuWWTmpgQiqqIYosLpCLknhFDk7zg5cgwgpr2Pb0
DqJmPqpznmTuh58pDU6pupurizZnVu355jKQwL4W8MA6DbvPqYb9vjYow5/FPJAMgACcfgSnIA2e
SEGqlZx0/3tWsX5fEiz6rOSUao8yDaT02AECfIjDIAZRB8zWoF8MXR3ZNAmHFBzRDKDPwQ+VYYkD
4E7kp8Zkv/KlL/rUADdLUkCpa5ehBW2CE4JgTjtQgQoEuoKL4QCGB2JZBOlAwQyVsBG3u224rPeT
ZhbmWaYcZ4FOSL4OhphD+MZmPs3v48QF2IT/wGhAH1i3aQgHKADO0SSFBbXmEJk7RBD21ctf5S4A
u5hd7Y8AhReI4xfDNFyi4AqiUA03QAZoUB1dMAufsAo5oAlSZ1TV43zPNy4TNwERECQdATQgMAiG
UAlrwAFSgDHmAyUYUDuhUgBisAM7kAJ90AdoUBZmcAdqInIYkluydyYOdWoOVTu4cWrk40IBcABX
IQMyQHQ1FQOuMAqTUALtEC0LIAN1MAt/oAdYFgVhoAk2EgUV2IWQkj0A5QWGMVkiwRiOMQBLgkmZ
Yy8j0Fm5hQH0gQQqZkEaMAS4E0Ui11lCOGIykXP9khu5dQCdNYQLggWfAAzo0A3IMAoxgArT//AL
yDBc4LA3LxAJqqAHKDALjmAINpJl4hIRCZAAYFAQMRCKDCARYBCKB8EAoRgDPJKKCVA9F7g9QkIk
HQACnyYvjpEE/YI0+4AFWJCHvYRJBQADR/AOlsAszAEEqpAhZZIbMbRb5BMAcCBywsBLgZg7BaAE
BHAHVPIKO5ANw/UFyMAO7BCJX1ANRrACJsAKd4ACd7AEexAJMLOFpoAQYPAADxADDhAD+jiK/MAP
D+AABMEAARmLEfEAATkQpSgQCRCQp7gjCskPB0EKD8AD/MADCClxQmARsMAzAtVpuAg5jfEYuzI7
SKN5BqAAvVQA+jF/gvACK1BtyCJyDPKHrP8hiLk1AMG4kry0KwVQOfvwem1ABjLwC+fQDM02CdkQ
DtWwZEy5jjJgBZ/ACTXwOYNQI6awlcxHEA/JDwzgAAbJD7EYkA9AEA7QCKaIiqrYDxMpEKyYAK6o
Iw7wlmj5lQEpkBIXfRFQcY6jGGZ4hjWgLxigO7nlhkgDB8pgBaADMsxhAnfgNEIoRRhTagzFKyO2
IDtoAJkxmDUwHKkwDb83CiUQDezAbDQVDdtgQXqiSijzCDaiCXVQCKUwBAjxlac4lmUpkKU4imnJ
AAwwl6zIAI0AnI1QnMHZD8DJjzEAnMo5kcHZnAzgDsoZnQlACgbRj6TQiv3Qj8GplmDQCAP/kYr+
uJAD0Y8ByQNh2QjCmYpg4IreGQPgKZ4CUYrc2Y/c2Q/I6Q6kQAofmYEh6WcjCT5JkATBkgMwAQcg
p0lYoAPKUAGMaUHTsgAb0AZ+eH8BIGI+uVK5cya5xDYDMAedUQHM0g4lQIBLVgLV0AxfoEUl0A1G
IA4+QCA5sAN1oIWmYAhD8AobkAu3CZHKeZD9kJ4YKZANoJsNAAZ5CZ1IapZ1uZB5eZBKCpZDKpB5
mQAEyZBRSpZumZFFygMN0KVeap4D8ZWkEKYOQJBTmpenqJA88KVhipdUOpEBOYpjeZEPEAEaMX2c
Ajnv4QHxYUQ5UARiwEms1kIAoANk8CSW/5ACCWgC0nBtMpADQYA0K5VbPvZ9LJlbHWo5IzaElhAl
ZNAlMhCJ0NaiKUpTwPMLF9QFq1ABQQUKldAoUVAKe/AIXVmmQKqbVcoPFhmQzSmkGMkDpFCkwCmk
TvqWCVCkCcCKQHqlRWoQctkIbvqkAgmdMWCWpJCXaGmXBBED4VmeZzmR+giR2SqQ/QmuGRkD5xqs
b3qdeso4fgA0KNQYWDAASZACk4EE6FMBYnAqWBAEOMRqMJA/87ci62gCebAJnOpQ9zNiDHUIpzI2
m8dLXtMHNOADz7Bk0aCUzqZALCoK05AKMqAFKMAJKzcLa8CJNmIKYbCVP0qlvGqWQUqWuv95rliK
mzMrkNYqEHaJm1X6AO7grRMBrqEYkNbqALgJtN6apkTbnfiZAAo5kBOptBBppgJhteo5lmCgmxPw
tesyhn3qHvCBhvD3JBiwD53DRKU1sEhjjDSwATSwBDK5AU6kK6yhOpnUhj03mDqQtpw6J5DRB10g
CeAAlcZVdODwC9OACs2AC9KAAwyIB13zB4twuXUBgWHwidK6q8iql7oZukKqs59LtQvZs/0AtDT7
tA+pkVWrrFcLkag7ERM5lwPhplLLs7ALlkDbnXSal12bkWBAByBJAvN6i/WaJGiIMQSAAdhAANag
H56DRJ1RBMpgPkeQAkDABBXACniCCJ//oCtf81C5QbE9V2I68HpSVCYA0BoY0A2p6mxNdg+MOwq+
IA+Rywn0QBUHoAd/8AdOcLmLUCMzYxBTOooHXKU80A9TSgq62QgHaa3HyqXJap4/+6y6S6YCgZGk
4ABTKqapC5Hbyg+jGK0EMcI8QJ/sGpDiObU9i5sJ7JAZiZYMgJFg8LW02Dhj+x67GLAYECoAC3+d
gQNOggPkhwUFcAQk2gVLACMLYAZd4zouqUuZ2ocEACXloH+roQRPFAAo8AnZkKpL9gWT4Asu6guZ
IA4pcgAowDBxEsAAHD1ZiBCNMKwXmZHimZdvCqy66QBFCgbGeq57nMEUaa3NqrqEjJZm/7msSLu7
wUmk3FoQdIqnOPuVpkuRuFnHGRmK72mWDJCPRyq8OMwFiiCSI4EkSSAF+UIZcAAASJAHN3REFVAD
2CCwXUCpy1AABlCNRdBTP1AsOFdqH+qGs2MA7Tc7sjcxxmIKZhy/LRoN0VACTBkUOQAnccLGjiDA
mws9OHIQ/Vik6yoQBzmRYBDKZPnNGQmdDUCuLmyXMcCsiHzJBbGmX/nCEJmki6zB3amW4PwA65ye
7byQQFvDV9oPxarHQlDDPAAGGTABPWOLnXISrzFzRaADumQfFUADoCdKLkQNVkCp5lOMs4ID6wgE
atAHXdOGmSQM31c7uuOLNtiDxaIHYf/QzCnqbKgaDfcgD2aQA58QxWjyBJYLCgMcBqCgB06AEGka
n1B7nmJpu2hZnGoJpDPArlC71FkKtcbpzUttEA3QnA2QpleNEM3Z1dmZps3Jjw7w1TEwHled1QaR
1gPx1ae41ipAB3TwtRHgCS2gKe9ShiA4BzdEc6YCQGJQASxYAcqABARQAUxUAaxmOd9QYj+lAV0A
AwoC1FDkcx56mLmkOhmDJo5wBjY9xs+GDOFwbS+QA0dwAJagBK2sBADsMlk4F0uwEFidnf0QpgrR
u1lrPWgK1wWB1bydtcKtEARZ3BOx2zPwIw1dBZ6gCO4ykh6GWY5NxKaCASe2IN+ABJz/5NidcUQ7
IAabMAJHgAQ/UDA0YAQmgA0ZAzZLcnpk4zoupDquE0C4QgBw4ATb0IRQSVxkjAy1YALD8cRt8Ams
4UsH4AR/sARWuAhLoAZJzSO+7YXQVxHaQxhTwAjQoBgaBwVkAAX0oQwYYAkvt3m+GH6I3T5WgA5F
cHlBUAOW0AU+YAKWgDI1oCBD2C85WWoA01I3qSC6sQ8oEAU2PQnDRZq+8AwvsAfAIAio0QYD0MZP
oAT++wdK8ARWiALQY+FevhcUkWmXAt2KQAKxwAt8MAiVdVltq92mFiqqhyHmgwRVggZaYAUVAANB
8CI1oDI7cATqUAR4YA1mIju2xSAr/5XgqqcEuqQAA6AHveDf8VsNtZA12+AL4YAGrPAJKCDbS/AE
XI4CauC/0PO/X37qEYEzzo0eJMAIvIDmcUASrjUHWFIDJ7agmfR9umMJ1KAFrYIGNGAxVmACpmEF
eLADG/ACQ4AEqhEnAYBJGNJCnNnSYzOEkKEAB2AKkV6a0eDfXwAOkiANhuALmG4EXcAJf4ACSG2F
atDuKMAKSL0IE47q9L4Q49GRljIYQaIpkJfmkTMHT8CTluCGh0k2MaRJm2ATFUANSKQAI4ADWrAB
aHAHOAAyxaEHOPeHuvR932BsoW07uvEHYdALvrAN24AMvTcJo5BTTPAIW2kIe2AIs/+AiS6DiWSi
BEuAB6ygCd1c7z7fSBjuBmNOyhxuAXFgfYZwAo6BBSN4Jiy5kp1Vf+RTAEigDNktBQWgAEFgRD+Q
AkkwBEAgkz5AFK0G2qrDUKuBS2civlkOOFGwlc8ADizqDL8gNyYABdJhCk7wxVa4BG1sel48AEsA
CqzwKD9/+HPtSBTwnwGlCGcOEnFQCnWg9KyBAsJsKmTDWb7ShkGoAA710p21D5JRA0cQBGCvAT6w
ATswFQG08WTz2QPvkmVyOwD8soMAZeeQjuFQ6TIQCpUADH/jMg6+BH+AG6Au6qoACnSB+MxvYWMe
3cMQC8HAB9ZXCo9QB7WFAk/gK0//A7iYtCBZr9IUu3mWUwA6oAWnsQPkUAP3EWUaIAh4oARJ8H0L
Yui8ZD7/cwCHMAAiDxCmFslgguYXqm1RTLwAUgtIHWBO6mjZoebJExQDUDxhtQQUqBNE+o0kWdLk
SZQpVa5k2dLlS5gxSTaYoYKCmwwRmnhSFIsXL0yYSg2KFCnFoQEBAuwTRmAfHAAjAAQoAMBA1X37
FFg1YNUqBhpDNuywdunIJUELVvhQc+TAAQNdvTrd9/bAPhht9DgJ48SRIxk+imzodgaYoUcbNCzY
QIRTJCY+cKhDgUINiiUcQBHhLFLmZ9ChRY8O3aCBEBVZYE2o4qnFMEa8+HTK1anO/6NIUAYAKKCV
QACpShUEALAVwNStxEfsk7Iv7r4gOrBgyDHkB+QVTMj0adNmRAC7AQYMIKDkyYEjasg4cuKkcpsh
QKzI/wvMERANJtD8EFR9LCsUOPDIA5A4Y4EF0hJUcEEGXTJNiJty2kkRRuyQrZNMMnkECjLy2KcA
ELEIAgMMljqOOOem0iquE4kD4EMYjuhDEB8QWeiFFTRgQoYfyDhLPDwGuGsAJbqDwoQN6lhDFUeU
KEAHHLSQIZL2gFnCBw32gMK6IpYoYgcoOHiCwJAOZCGEEBpUc002S5sBQipyksALEtKAgI+gMnxk
jTWQIBGDfUaYrgYCDNhqBKmCA/9uq31ezEoBuarCYYcaUtDCCBlW0PSFsQ4wax8lDuAuvS6A2CCS
Hv9oz0kYoKBhjSrrkEEGMmapxJBVPlkCCl7XKJOFMdAU4YM2izX22JJoSi3OKrhg4w07LLAgjlJK
iYSMOeYQQwcdUvATC2xqwKKq445LrlGlHN3HxKyOKwCGGPfZIYeFVngBkVc2MCOFO55YolIzgCBo
A0FMIINJv976hBNVqnzEhB/WUGeWWSxbYokT6jDkwGBD+OADEDpAdmSSGTyNAtVY42KKNyCw4AMR
xiDiBA84CAKJm1NIoYIUdFAGA6u22uo3Bb5bygATCQCAgAEaJaAApT48wgAx6GX/AggfXmDohw2Q
lOGFHXUUBJEK9NjrD8w2ekJVR9awYoc5UNBjgEMC1IyFjYP9OGRpS/b778/eRHm1ZqfwA4IOYC6D
Zg5qqEGML3vOoQsraAiCOBeVqsqpqNcNgAAFFGj6c61ULIA7TkBB5IUFFvMhlx+Y0FSDr3O0Aoo5
HPnjYlXkPoBItJ+YQ4dyBnhiADw4UN4DIoD1mG8L7IAEcOqrV0nwlFubwgbEPwiBBZqHhxINE7oQ
owsk0UgH3ROv6gpSA5Y7UQHmPAduBAMa1WgWYGTVdAUZvKIUPlhB6xbQOtpZgQO9q8xbMmKJtzjl
ALtQghKWgDYO/MURzQuBCPgG/wFj+OEN1iNhCbEnITrZKXHf84AHdFCBChTBDGjYQBe6oDUgVABe
MAARV+KCv65IwVzFmYpVlhMAA9hjH0I6ACdysIGvfU0DPpCdWhbAhB/IwAg/mENWlKAKPGDjCXh4
QqiUgAIyokBVS1DFEh6RiVKUoYMhg4AdjPGGKbBhJS4gxMgQcAMB9LEfgbjCFbZgkj8Gsh8TcEEj
BVkSQADSBSpYJCAFSQgB3GAC/aCDCwTgAjogS3A4iYAEWlAnC6wQfC7cWQV0MJgf5EBrLxhCCsSA
AalwhTcw6IqLvNLDoKUrf1ShSh4qgIMiQAERi3nBYg4oA/JtQAuXW5cacCCGvv+gQAkaYc8SKoPG
NuZiBZIIxbA6EL00kIANLfDCSj45skQkEhD9cAECriAASpIknoAExAUEEM9DIpIQgVDkDa6AAAEA
AhAC+OMNBnmDC9wgEKKEk4ROqULvgY8DSahBHsQQhPOhgQZaQIMR8rMBRCDhKrw5AAyxcASYxugS
l9hhAIZDRPp1ZR8E6MMR2uDTTwzBCD6QgTONYCpp7IADd4FBELpQgTCEISPr2svcfuevJRgiE7XI
BMgsAIF0ssELEmiCO13QD0Lcc5KMtKcmGXlIPqJVrSrYQj0ZOkl6IsAk/tTrSBB6gZPw1Z+ANSsd
GNqPfyZCAA1AKB0C4dAbJIL/ohSIk05S2L3vEcEDScBAR2sQBBqgQYcV2EAB15KCAnSlAHfoQix1
QAMa6IAMRXhhDlC7HEhhJX9LbNrSDtCGwXhtqCQ1QxegkIQPFQALO8DBZSrYtAHoQZsM5EALiTAI
kHUAApB4g1glUIUImLUf/UQoAvx5A3gIIBB8RexZyctQhN4AAQvdgj8DShKEbnIkLrgCSvLrz0zq
N7AMZe8nPdmPv07gCje4QSiPNUoUbg+zLKhDHY6JAxzA1gwmyMERgqCFBYiDMThAguaOUIEfmGAh
W8SPD7A0BB4SAANPK+LS4ECAA9jUAAdAQQ5+YIbqdOESakgmBoRYNHLQgBo1/1hiZZSwjyfoQQ2s
uIxHiDCGTsQBBF/1wxTG2oQIZEC8dC1vgV1g5n6QGb4JbUA/rhBPfJZEwWcdyRYOS4hGjmTOnLyA
nSd6EhUYVAVmPvBft1BIAdy3WCdzgxwsK+EOgOB7hdhDJHJgBTNsAAgC2wAGkJBFk6JhCDgYQB9i
9AkryC5HXXOmBrTQBiwgoWe8adSHNjECOOQSAHc4AAZi9FkYYEAHGJDLcfpAAyukYDzn4eEBLFED
KqPAuoPIRCikxQhFsIELYM6AHMyqgiusl8CH/aSZwS1uBPx1JIm4gQv+PJJAX8HBCnZoP7aQ7jQb
1MH7FQBKFDvPCZA7EARFsP8A6N0PBiOLJjeRwwSasDJovUwEi3uElsRAgx+wbgFGgKE0TTDFH/Dr
AJOyQhY3LggxXFwQzC3HJoKwsyIEwTgF2ETpugKVpsHgc/CSAhwCBbqoBOAINJCPGj6hil08DlDL
RoE2MFYITAQjGLG4BS08AeYJyMENKbkAQhPhT0AE3LzkPrN67Vz2sK+ZsAs9LEkIal46UMCg/czn
SN5+ATqoQO8LRvA8/frPC2yy3fa18wVc4FC+J/xYyspCw6sggWdFCwQxo9keXjEHmgpCxC/IAQ42
QFQNaKAIbaiBFYr6AmjuoAg1iBFMYzqdQ6SgCBXA5QhgsAMalCgrWlFK/m7//CIF9OYpXdkEDgg4
BDz04Q5IEMQeWF+cfexCGx44wRjigAlcyCIZtGAGMyIwASpkISUIvcIEAp3Jcev1nYBk8CTZr3Z4
C0AA+0as/Mdtf8KOxP4MtbMArgAIw7ovT5K/s+q/G6CA80u0Bug/BVy8msgCZjElEoAECwCBjPKA
SCgfmCoCgvCBHEACNDggcXgBMlCCHzggIBCEVWgDmhoP4hiPASiA8TiAJ3ghYgs2HxgCX2sa+smK
pVAApSmXdlGAZTiEjzOBNVC+A9iBLkgBubiKGsiBSACWqDuFX0gGYmAGbsg6N6g7kxi0fKKA/OM6
CiAJMVQJxUuQCVi7OFMJ/zoYQ7wzwwsoQ4UTnMqSwMNRJeobAuSDgRt6AWnAAWX4AdMygjlIi3tR
ArM4ACHaKedAngEwAJ87jwDAgq44gicqAvxxFyyggSLItUcpF3OpCjWgAWWAFyHBAleKsREgABzI
OCAohEHAhE4IhmTYPi3MgGvYRb+ZAEBStAWhAwErIQeBEFJqAi8wHMSZvDIgAm0ggyGwgiCwAhxh
AjMgrdbJkUggiB2IEQLgnKXICqaBg62QwW36HQDYhSOwAhOggeQKABg4AD4sBxj4xnUZAaF5kSfo
g5lKrehbxyHQgSPYhyMgAyZ4gT04gUIIhU7YsqrzBC3khl1ss5KhAwQARv9ipB7GczxnibjJkxkP
oIRIAAIzsAJnYgIr2AAj+DgNMIIXEIRPgIG6sKndyzHkqbUj2imkOIA7KAIfAAIa2AQYuLUAqAFf
QwIc0IF1KRog3A1fOg7nGLodCAIYsARrqIF8oQFtKIVMwIRzuoVimIImqIIMgAVePJY39MKMLCHG
owLWkEAKVKUT0AYObEf8yBEt0IIX+AEXW4EhUIM+cBQAGA/ewIrjKRqkEcfdKIAU6IInko8UmLEC
OAIYSIGSs4Ik4KGr8LllWJpyAToCgIFLGIFJgYIjEAMTAAIK2yoL4IVbGIYW+K6sowAhUIktYL+Y
qKtGQgBKUjfS8EX/Cyj/BHABjFzLlaCJiiqlU8rDjAqfHdCClNSAHPmBIria2DGBPCAHIWmX3Yqf
dRkAS0gRp6m1PkgBrikCILiiGkmCFNiAFzCB2fsGrDgAHvKTQpmf3gCAS6gBIHiBHTgCHGCdXCiE
TsAEELCFUygGL/CEKgC/LFBLkjAsiNoCCFUJr1Msh0pL0qCDQkq3viokOjPOl2A0R3u4yKvAmNEs
VliDHTCD2Ak9IBgMKyADGdiBAxC+t1CRIyoXpDGiuPDHXQgAHTCBwPiBH9CADciBWRkCRMABHqq1
xuwCDzyCqvjBXDrNH0CEI0gBEyggE8iFXAAZ11SEVsC68KvQfvCnd6Mn//nrI0IYKEXCLwEALMXq
MxfYpLTSpDTzJDw7pDzFSIRStIBTLDQV0ZPYyLd8FgqcvMyqhNnCsCwyASMQNRpAsTzogxzNircQ
R3HswVq7C3MZgclMAZekARiwDh9YAC2AglmpgUvYJRwwKQ3YgRSQAhCpCvk5sQ+8hBxwyQ0IBSAI
BS2zAGyjhSpo0DNFw0/Sr/pSLEb6J0ASMHXjK0MzuIErOAR4OzvL1vkziQMribQKuOI01EO1Qzlp
AUiTtDFgAUelASgIAjPwATRAg4CxAvRMAXKooA8RR58Tx28kD6hsmt1bIk9BBFWFjyvCmoVgAlc9
gmUoAGwQhOwAAiPogv8+CEwhBABhKJpgwwEyIIJXqDYQ2DJGKIZWaIXvS9aUeFZ54yQEqNNCm1M5
BSxqnVPFGs5+O7CF4tY0bTuS+FaSiCw3W1NyVQkSdbiOlLyMqoQ1oIEcmIMukCZ0GAxBSLEa6IOb
csTiiAtDEQ+NrbXnqItAgcdPkFSKzZFXGIIF4LwAyDC8gAExYIIDAiATGILnaxSohAEksIIcWAdV
qINQCFOSNVkzfVCWKDO1i9n8UzeEAoS/ejt809m76jf2AleZ1bP966+iZQlEVc466Z6YAR8y6AKn
lYZ53bAUM5i3MJR1mQri2NhE8cEX4QpxrIoBuAQcgFEfwBSKcFIFOMH/ITiCd8CAj4uM+BAEXysi
QyGASxCDIRCEddCGSuiETvgA7SqGcaCFwq1Nriu4e8Onv1JcOZ2vQlKBv5pWtGIoyJ3T/Lo3kgi4
/7sAQMCkfqLfzT1Oc300P1DaEJCZE6ABRMiBsdEClWQC3KMBPAgAYZACAmBg8viNz2lgAjgEKfgc
KQDC5giAXSCPAKAHLTjIZlpbE/hPMUhVJK2BTRgpHMiDJNCBPHAKKajgGBYiKaiBJNgF5hmE6gUB
CADLVgCvDAg/7kUJ+1urewIkw+s33yw4/wuETforFRjAs4q3m01AyRJakjg0+WsozH2k+0WJk2k8
lbkol7HAQggBIigE/0HYk5HCkgUYAiiAmw1OAiwYgCRIgidIAikwnjtOAjEZgD0G5DvGiI3ggDtY
AhOwogNytTkYAh/YgSHgkQSeAzyYgzu4gwHAgjrOZDvWZA1WgznggOvKBUzgAwhgBC/zhJTNgiE+
iTcUMGFUQ8LKp0DVs1CigIT6wgsYwy92kPxFRpaJSxAYhEEYg0IohUc4AUNwZBwxASjogjV4AuXZ
KOXx443K42n24zum5mnmgMrggC3RuANiAuswgUewhiTYA1qxBmvgAEQYgkiogTwe5I2643V4mD3g
ABYIBV3QBVsAIXWSgDCjAtq0nj/ypBtQyzPs5QRBToZ7y+WMlg6INP9iLoVcGANDCAUZkIQVyIRK
eIRKqK6aaaE5aKHlqa5pbiGVHunlWQMyqDACOqDW0SIm2IANeARDmBIUIAMPIIM9eARWQOmTnuZS
2IBB8IBC0IVUeIZ/hgQSiM2BLujqkYN02wI6ZGg2cejKMlES2F9piQOw7oRQKIVCyAVJOGsZOOZH
mJmZOQG3fuu3bmu4Dgnqq4S2rgSNqYMfqIVUSIUCOuuzBoJSOIEMyYVMmMu5Tuy6NgTOKIRMeAam
ToNhGIdti+pWBhyKxOpFm4GaaDQJcZautoM74QOwxoQ4GIQ46OdQkASh6AQzMZPmeW1gOZDYhm1j
LoQDMYRCINBcUGr/SejnTHiFUAiFQbDrVzjraguFQjgBM6kEFmie2uYMOfKgYJAFWTgFWiCGJmgC
LpRqzf5umXBonJiAUgJtP0gDaBjtoCht0+5nsBYBNEGTjolv+q5v+Q4BYkaTQogD6sWQVNCFUhju
/g2BMiiDMRiEWpCEBK+FQTDwAb/v+e6gYfkAPjgFCycG7W5QrVOBGQBvD4cJ06gJysqJUvICNiCB
N2AEaLADaLAFXLCFYOADPugAXpCEYLDAj8lxHYeZCd/xHcfxOJBxLUvtWijlUJDxj4mDDwhy7EsF
XDBQERiWKI9ymPlxHrYFW4gFRchCID7TDv9wMD9Oh4ZAEn84dCUB/xJghFiwhVvAhVPA8liAB1nA
hVSaaDu/85Cx8zy/cz4/JxmfaBCo7jnHBVxg6mCA8RsHAT4odFzgg5AZ2Ufv83NqzVtA8SlghmOI
gDBzA9r88jD/9ENFzmXJAPJuAgngAnSdgmFY9WHQvnHA7ny4hRWHAFqvdVu/dVz/KmhIb1uXlq+6
hV/4heu27uyThVvwdQu4bpeRFl5Y9q/6qlqXHkYYBhLwMkzPgG7jdCHwdFDv9pEIcQiBQDnIiSow
dS9oAXRXhGLI7niYh2Mwh3jYAkbwAz+wgTSw9zTId31PAz9gBDWPBX/vdzVnBH03BoM3hjQwhlg4
hesehmKw8FNIhuRbQHiAj/hYgATJPoVbIPh8twGMp/c3eINq964q4AZsJ2gO53Zv73ZwRxnPJu9y
P3UuONmTnQdvMAdvuPmVqfYpmAI093k0//kpUPdiUISeVwSkV4SgX/qfb4XtYxkSUHelj3pioAVa
SIZxmIJxIIZj2L6pD/qezyN22jbwmoAgzoJOz+yVZ3lwtwk3oIJxJ+8IOFa618J6yPm7Nwd88AK+
Zye+P3e/9wIu8ATC5wLDP/y+R3fFR3dPaAWuJwZPYIPGbwE2ECuub3xmmPlj2PxjaIXF93vDJysw
CzNYoAJtnwHTCAgAOw==

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/spacer.gif

R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAQAICRAEAOw==

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: application/octet-stream
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/adsystem/graphics/1200405603390/canres/stemcellconf_256x80.gif?ad=16616&adview=true
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------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/shared/misc/arrowTtrim.gif

R0lGODlhBAAJAIABAGZmZv///yH5BAEAAAEALAAAAAAEAAkAAAIKjAMHidsLm2HHFAA7

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/shared/toc/free.gif

R0lGODlhIAAHAIABANYTNP///yH5BAEAAAEALAAAAAAgAAcAQAIjjI+pqwDpTAzzVPjQ3Nl2Boah
Q0pkd2YpVq1mW2IypZ5vVQAAOw==

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/misc/permissions.gif
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------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/toc/rarrow.gif

R0lGODlhCgAVALMAAC4uqx8fpQoKnS4vq+vs9vz9/e7u+AUFmx0dpSkpqQAAmf///wAAAAAAAAAA
AAAAACH5BAAAAAAALAAAAAAKABUAQAQ7cMlJkbrqJCNt3pXGUYuHfQQwkovKdpdYnXFCmGhRIPLr
ByCWpTcxEXEfDvIiGCA1hB0GqpMSJcAVJQIAOw==

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/toc/uarrow.gif

R0lGODlhCwAJAKIAAN/f8r6+5QkJnYaGzwAAmf///wAAAAAAACH5BAAAAAAALAAAAAALAAkAQAMW
WLrczkEQMl4BLs5NrY1Vo23hyE1DAgA7

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/toc/dot.gif

R0lGODlhCwAJAIAAAP///0JCSiH5BAAAAAAALAAAAAALAAkAQAIMhI+pGb2PWoC0yooKADs=

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/toc/darrow.gif

R0lGODlhCwAJAKIAAN/f8r6+5QkJnYaGzwAAmf///wAAAAAAACH5BAAAAAAALAAAAAALAAkAQAMW
WLrcBS4IQutwWEl6c9tV2IFcJHRKAgA7

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/content/vol66/issue16/images/small/7843fig01c.gif
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------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/content/vol66/issue16/images/small/7843fig02g.gif
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------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/content/vol66/issue16/images/small/7843fig03g.gif
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------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/content/vol66/issue16/images/small/7843fig04c.gif
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==

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/back.gif

R0lGODlhDAAMAIAAAP///wAAmSH5BAAAAAAALAAAAAAMAAwAQAISjI9pAHrMnFRx2vuag1BWDBoF
ADs=

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://www.genesdev.org/portal_imgs/search_result.gif
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------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/shared/searchall/journals/genesdev.gif
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=

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/shared/search/homelink.gif

R0lGODlhMQAQAJECAAAAANYTNP///wAAACH5BAEAAAIALAAAAAAxABAAQAJQlI+py80BwwG0AkPn
FbZj64TiSJbmiaYOlGTfC1fa5jYsUrs5TcebCgwKh0SgpPXbyWCaD0gRwSV5TY7sWXvcmLrp60pd
KXYzstS5LKrXqAIAOw==

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://jco.ascopubs.org/portal_imgs/search_result.gif
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------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/shared/searchall/journals/jco.gif
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------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/portal_imgs/search_result.gif
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------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/shared/searchall/journals/canres.gif
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------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://theoncologist.alphamedpress.org/portal_imgs/search_result.gif
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==

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/shared/searchall/journals/theoncologist.gif

R0lGODlhwgEQAMQAAKyDrMGjwcyzzKJ0ouzj7LGLsdK70v////Hq8b2cvd3M3aZ5puLU4p1tnal9
qbaRtrmWuZtom9nG2fXw9dbB1sapxvj0+OXY5ejd6Jlnmcmuyfv4+5xqnP37/aBwoJlmmSH5BAAA
AAAALAAAAADCARAAQAX/4CeOZGmeaKqubOu+cCzPdG3feK7vfF8vj0XDcHg0HgJUYXLoLFSVw4HB
WTAOhkKBmBwYFIWFg0IocDSEgGNRYCAqkUigk+RUCJV1QTLRcCISFgUDBQQdFQsREBMWDh8OHQoA
CwkQGQsYRU8+nJ2en6ChoqOkKgAXHQgOESYNEBsWEg0+EQABAhA3DhICHqW/wMHCw8TFJZcCGAEc
ex4BBhUaDwCzIw8SFxQBCQkV2AYAIxljeAMNdwoDHwUKCBcS2rMNAhcBAAUUAhzjAgQGCxkaaLhQ
QYsAA744GEBAoSEFAwEWcIDAAAMEDqfUANDQ60MAAhICGBtJsqTJkyhF/1xjQKFCgFvfwqWcSbOm
zZs4U0xM8OABhJ4BCrAysaTJJhRRpnBo4MEDhwEAqJUQs6bEAAdYfX3IIOdAkhFXsaojcckBAA8R
PDTI4GFBIrBYJX4YEMDi0Zx48+rdK0NAhwIfHpQREAACBJesHDBIBSBDqwQdLBjgIEJAEREANkjw
6LXaBw4eABxAoFUEAicZEhzQ8AHABAR3L2wokKHAuwIACI9YQEDVB6YJFBDAUMHXFUd8kytfzry5
OAFvHuCOCkGm8+vYs2sXEaECBgTgCSjItb28+fPoRQFQMIFBmAbwPThIAN6A5/T48+vHznUE5RQD
KCCFSChkIOAGBPIQwf8CAmzw1Q+E3XeCVPtVaKFzYwTwAAVvFCBABf+VAIEFB2xQ2gmqHYCBfAKE
1I0E/4hAl4YQKGCAI65oYFgFBly0lWpfTaQjBAFQkEA1C7j0QAASaJAAAMwIIIA6DWzjgIeWFLLa
Axd26WVeQ32gwWzrSLAANQtW5YEEUlSQQgZXICgCEQlgdoACH6jmpggNFCBfBxOQUEAHGwyQQQCr
PYLABGM9YoEFUC5mhIGQiuAAARM44oFwChQ0loB3fSnqqCkpdECWBMwjHk8JaLUABRNY5MAATZ1Z
AXgaDNUABQckEEEGD0RSC6YaTBdUA4FMudQDCBgQwTlYPGuABQII0SdpSLMAkM82g8ySAQCYNlZA
cREUgMEE4QgYBKnstmtMBAPQaq1a5jwC5QkDPJDANgmYUUKaYjQ1yRqOPSLdiXMZtu4HCw7swH/5
9oRcbQb06xORDARQC1ZoQqXFXQ4s7O7IJJds8sko6xUCADs=

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://clincancerres.aacrjournals.org/portal_imgs/search_result.gif
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------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://cancerres.aacrjournals.org/icons/shared/searchall/journals/clincanres.gif
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------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: application/octet-stream
Content-Transfer-Encoding: quoted-printable
Content-Location: http://cancerres.aacrjournals.org/javascript/ajax/xmlhttprequest.js

/*=0A=
=0A=
Cross-Browser XMLHttpRequest v1.2=0A=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=0A=
=0A=
Emulate Gecko 'XMLHttpRequest()' functionality in IE and Opera. Opera =
requires=0A=
the Sun Java Runtime Environment <http://www.java.com/>.=0A=
=0A=
by Andrew Gregory=0A=
http://www.scss.com.au/family/andrew/webdesign/xmlhttprequest/=0A=
=0A=
This work is licensed under the Creative Commons Attribution License. To =
view a=0A=
copy of this license, visit =
http://creativecommons.org/licenses/by-sa/2.5/ or=0A=
send a letter to Creative Commons, 559 Nathan Abbott Way, Stanford, =
California=0A=
94305, USA.=0A=
=0A=
Attribution: Leave my name and web address in this script intact.=0A=
=0A=
Not Supported in Opera=0A=
----------------------=0A=
* user/password authentication=0A=
* responseXML data member=0A=
=0A=
Not Fully Supported in Opera=0A=
----------------------------=0A=
* async requests=0A=
* abort()=0A=
* getAllResponseHeaders(), getAllResponseHeader(header)=0A=
=0A=
*/=0A=
// IE support=0A=
if (window.ActiveXObject && !window.XMLHttpRequest) {=0A=
  window.XMLHttpRequest =3D function() {=0A=
    var msxmls =3D new Array(=0A=
      'Msxml2.XMLHTTP.5.0',=0A=
      'Msxml2.XMLHTTP.4.0',=0A=
      'Msxml2.XMLHTTP.3.0',=0A=
      'Msxml2.XMLHTTP',=0A=
      'Microsoft.XMLHTTP');=0A=
    for (var i =3D 0; i < msxmls.length; i++) {=0A=
      try {=0A=
        return new ActiveXObject(msxmls[i]);=0A=
      } catch (e) {=0A=
      }=0A=
    }=0A=
    return null;=0A=
  };=0A=
}=0A=
// Gecko support=0A=
/* ;-) */=0A=
// Opera support=0A=
if (window.opera && !window.XMLHttpRequest) {=0A=
  window.XMLHttpRequest =3D function() {=0A=
    this.readyState =3D 0; // =
0=3Duninitialized,1=3Dloading,2=3Dloaded,3=3Dinteractive,4=3Dcomplete=0A=
    this.status =3D 0; // HTTP status codes=0A=
    this.statusText =3D '';=0A=
    this._headers =3D [];=0A=
    this._aborted =3D false;=0A=
    this._async =3D true;=0A=
    this._defaultCharset =3D 'ISO-8859-1';=0A=
    this._getCharset =3D function() {=0A=
      var charset =3D _defaultCharset;=0A=
      var contentType =3D =
this.getResponseHeader('Content-type').toUpperCase();=0A=
      val =3D contentType.indexOf('CHARSET=3D');=0A=
      if (val !=3D -1) {=0A=
        charset =3D contentType.substring(val);=0A=
      }=0A=
      val =3D charset.indexOf(';');=0A=
      if (val !=3D -1) {=0A=
        charset =3D charset.substring(0, val);=0A=
      }=0A=
      val =3D charset.indexOf(',');=0A=
      if (val !=3D -1) {=0A=
        charset =3D charset.substring(0, val);=0A=
      }=0A=
      return charset;=0A=
    };=0A=
    this.abort =3D function() {=0A=
      this._aborted =3D true;=0A=
    };=0A=
    this.getAllResponseHeaders =3D function() {=0A=
      return this.getAllResponseHeader('*');=0A=
    };=0A=
    this.getAllResponseHeader =3D function(header) {=0A=
      var ret =3D '';=0A=
      for (var i =3D 0; i < this._headers.length; i++) {=0A=
        if (header =3D=3D '*' || this._headers[i].h =3D=3D header) {=0A=
          ret +=3D this._headers[i].h + ': ' + this._headers[i].v + '\n';=0A=
        }=0A=
      }=0A=
      return ret;=0A=
    };=0A=
    this.getResponseHeader =3D function(header) {=0A=
      var ret =3D getAllResponseHeader(header);=0A=
      var i =3D ret.indexOf('\n');=0A=
      if (i !=3D -1) {=0A=
        ret =3D ret.substring(0, i);=0A=
      }=0A=
      return ret;=0A=
    };=0A=
    this.setRequestHeader =3D function(header, value) {=0A=
      this._headers[this._headers.length] =3D {h:header, v:value};=0A=
    };=0A=
    this.open =3D function(method, url, async, user, password) {=0A=
      this.method =3D method;=0A=
      this.url =3D url;=0A=
      this._async =3D true;=0A=
      this._aborted =3D false;=0A=
      this._headers =3D [];=0A=
      if (arguments.length >=3D 3) {=0A=
        this._async =3D async;=0A=
      }=0A=
      if (arguments.length > 3) {=0A=
        opera.postError('XMLHttpRequest.open() - user/password not =
supported');=0A=
      }=0A=
      this.readyState =3D 1;=0A=
      if (this.onreadystatechange) {=0A=
        this.onreadystatechange();=0A=
      }=0A=
    };=0A=
    this.send =3D function(data) {=0A=
      if (!navigator.javaEnabled()) {=0A=
        alert("XMLHttpRequest.send() - Java must be installed and =
enabled.");=0A=
        return;=0A=
      }=0A=
      if (this._async) {=0A=
        setTimeout(this._sendasync, 0, this, data);=0A=
        // this is not really asynchronous and won't execute until the =
current=0A=
        // execution context ends=0A=
      } else {=0A=
        this._sendsync(data);=0A=
      }=0A=
    }=0A=
    this._sendasync =3D function(req, data) {=0A=
      if (!req._aborted) {=0A=
        req._sendsync(data);=0A=
      }=0A=
    };=0A=
    this._sendsync =3D function(data) {=0A=
      this.readyState =3D 2;=0A=
      if (this.onreadystatechange) {=0A=
        this.onreadystatechange();=0A=
      }=0A=
      // open connection=0A=
      var url =3D new java.net.URL(new =
java.net.URL(window.location.href), this.url);=0A=
      var conn =3D url.openConnection();=0A=
      for (var i =3D 0; i < this._headers.length; i++) {=0A=
        conn.setRequestProperty(this._headers[i].h, this._headers[i].v);=0A=
      }=0A=
      this._headers =3D [];=0A=
      if (this.method =3D=3D 'POST') {=0A=
        // POST data=0A=
        conn.setDoOutput(true);=0A=
        var wr =3D new =
java.io.OutputStreamWriter(conn.getOutputStream(), this._getCharset());=0A=
        wr.write(data);=0A=
        wr.flush();=0A=
        wr.close();=0A=
      }=0A=
      // read response headers=0A=
      // NOTE: the getHeaderField() methods always return nulls for me :(=0A=
      var gotContentEncoding =3D false;=0A=
      var gotContentLength =3D false;=0A=
      var gotContentType =3D false;=0A=
      var gotDate =3D false;=0A=
      var gotExpiration =3D false;=0A=
      var gotLastModified =3D false;=0A=
      for (var i =3D 0; ; i++) {=0A=
        var hdrName =3D conn.getHeaderFieldKey(i);=0A=
        var hdrValue =3D conn.getHeaderField(i);=0A=
        if (hdrName =3D=3D null && hdrValue =3D=3D null) {=0A=
          break;=0A=
        }=0A=
        if (hdrName !=3D null) {=0A=
          this._headers[this._headers.length] =3D {h:hdrName, =
v:hdrValue};=0A=
          switch (hdrName.toLowerCase()) {=0A=
            case 'content-encoding': gotContentEncoding =3D true; break;=0A=
            case 'content-length'  : gotContentLength   =3D true; break;=0A=
            case 'content-type'    : gotContentType     =3D true; break;=0A=
            case 'date'            : gotDate            =3D true; break;=0A=
            case 'expires'         : gotExpiration      =3D true; break;=0A=
            case 'last-modified'   : gotLastModified    =3D true; break;=0A=
          }=0A=
        }=0A=
      }=0A=
      // try to fill in any missing header information=0A=
      var val;=0A=
      val =3D conn.getContentEncoding();=0A=
      if (val !=3D null && !gotContentEncoding) =
this._headers[this._headers.length] =3D {h:'Content-encoding', v:val};=0A=
      val =3D conn.getContentLength();=0A=
      if (val !=3D -1 && !gotContentLength) =
this._headers[this._headers.length] =3D {h:'Content-length', v:val};=0A=
      val =3D conn.getContentType();=0A=
      if (val !=3D null && !gotContentType) =
this._headers[this._headers.length] =3D {h:'Content-type', v:val};=0A=
      val =3D conn.getDate();=0A=
      if (val !=3D 0 && !gotDate) this._headers[this._headers.length] =
=3D {h:'Date', v:(new Date(val)).toUTCString()};=0A=
      val =3D conn.getExpiration();=0A=
      if (val !=3D 0 && !gotExpiration) =
this._headers[this._headers.length] =3D {h:'Expires', v:(new =
Date(val)).toUTCString()};=0A=
      val =3D conn.getLastModified();=0A=
      if (val !=3D 0 && !gotLastModified) =
this._headers[this._headers.length] =3D {h:'Last-modified', v:(new =
Date(val)).toUTCString()};=0A=
      // read response data=0A=
      var reqdata =3D '';=0A=
      var stream =3D conn.getInputStream();=0A=
      if (stream) {=0A=
        var reader =3D new java.io.BufferedReader(new =
java.io.InputStreamReader(stream, this._getCharset()));=0A=
        var line;=0A=
        while ((line =3D reader.readLine()) !=3D null) {=0A=
          if (this.readyState =3D=3D 2) {=0A=
            this.readyState =3D 3;=0A=
            if (this.onreadystatechange) {=0A=
              this.onreadystatechange();=0A=
            }=0A=
          }=0A=
          reqdata +=3D line + '\n';=0A=
        }=0A=
        reader.close();=0A=
        this.status =3D 200;=0A=
        this.statusText =3D 'OK';=0A=
        this.responseText =3D reqdata;=0A=
        this.readyState =3D 4;=0A=
        if (this.onreadystatechange) {=0A=
          this.onreadystatechange();=0A=
        }=0A=
        if (this.onload) {=0A=
          this.onload();=0A=
        }=0A=
      } else {=0A=
        // error=0A=
        this.status =3D 404;=0A=
        this.statusText =3D 'Not Found';=0A=
        this.responseText =3D '';=0A=
        this.readyState =3D 4;=0A=
        if (this.onreadystatechange) {=0A=
          this.onreadystatechange();=0A=
        }=0A=
        if (this.onerror) {=0A=
          this.onerror();=0A=
        }=0A=
      }=0A=
    };=0A=
  };=0A=
}=0A=
// ActiveXObject emulation=0A=
if (!window.ActiveXObject && window.XMLHttpRequest) {=0A=
  window.ActiveXObject =3D function(type) {=0A=
    switch (type.toLowerCase()) {=0A=
      case 'microsoft.xmlhttp':=0A=
      case 'msxml2.xmlhttp':=0A=
      case 'msxml2.xmlhttp.3.0':=0A=
      case 'msxml2.xmlhttp.4.0':=0A=
      case 'msxml2.xmlhttp.5.0':=0A=
        return new XMLHttpRequest();=0A=
    }=0A=
    return null;=0A=
  };=0A=
}=0A=

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: application/octet-stream
Content-Transfer-Encoding: quoted-printable
Content-Location: http://cancerres.aacrjournals.org/javascript/ajax/utility.js

/************************************************************************=
*****=0A=
 * javascript/ajax/utility.js=0A=
 *=0A=
 * Utility functions for working with XMLHttpRequest data.=0A=
 *=0A=
 * Copyright 2006 Board of Trustees of the Leland Stanford Junior =
University.=0A=
 =
*************************************************************************=
***/=0A=
=0A=
/*=0A=
 * Copy XML nodes into an HTMLElement. This effectively=0A=
 * clones XML markup which uses XHTML naming conventions=0A=
 * into an HTML DOM.=0A=
 */=0A=
function copy_xml_to_html(src, dst) {=0A=
  if (src.nodeType =3D=3D 1) { /* Node.ELEMENT_NODE */=0A=
    var e =3D document.createElement(src.nodeName);=0A=
    for (var i =3D 0; i < src.childNodes.length; i++) {=0A=
	  copy_xml_to_html(src.childNodes[i], e);=0A=
    }=0A=
    for (var i =3D 0; i < src.attributes.length; i++) {=0A=
      var n =3D src.attributes[i].name;=0A=
      var v =3D unescape_xml_string(src.attributes[i].value);      =0A=
      e.setAttribute(n, v);=0A=
      if (n =3D=3D "class") {=0A=
        e.className =3D v;=0A=
      }=0A=
      else if (n =3D=3D "style") {=0A=
        set_css_style(v, e, "");=0A=
      }=0A=
    }=0A=
    dst.appendChild(e);=0A=
  }=0A=
  else if (src.nodeType =3D=3D 3) { /* Node.TEXT_NODE */=0A=
    dst.appendChild(document.createTextNode(src.nodeValue));=0A=
  }=0A=
}=0A=
=0A=
/* =0A=
 * It is unclear that this is the right thing to be calling=0A=
 * from copy_xml_to_html, but it appears that Safari decides=0A=
 * to convert &amp; to the NCR &#35;, and then encodes that=0A=
 * NCR to &%26%2338;.  So, I'm going to treat the DOM Attr=0A=
 * value as a plain string, and run our XML string input=0A=
 * through the decoding routine below.=0A=
 */=0A=
function unescape_xml_string(s) {=0A=
  return s.replace(/&apos;/g, "'")=0A=
          .replace(/&#39;/g,  "'")=0A=
          .replace(/&quot;/g, "\"")=0A=
          .replace(/&#34;/g,  "\"")=0A=
          .replace(/&gt;/g,   ">")=0A=
          .replace(/&#62;/g,  ">")=0A=
          .replace(/&lt;/g,   "<")=0A=
          .replace(/&#60;/g,  "<")=0A=
          .replace(/&amp;/g,  "&")=0A=
          .replace(/&#38;/g,  "&");=0A=
}=0A=
=0A=
/*=0A=
 * Parse set of CSS rules and apply them to an element.=0A=
 * This is quite horrifying, but I'm unable to determine=0A=
 * how else to handle this with IE 6.  FireFox and other=0A=
 * sane browsers let you simply set the style attribute=0A=
 * or use e.style.setProperty(rule, value, priority),=0A=
 * IE 6 appears to have neither of these capabilities..=0A=
 */=0A=
function set_css_style(css, e, priority) {=0A=
  var rules =3D css.split(";");=0A=
  for (var i =3D 0; i < rules.length; i++) {=0A=
    var nvpair =3D rules[i].split(":");=0A=
    if (nvpair.length =3D=3D 2) {=0A=
      try {=0A=
        var name  =3D nvpair[0]; /* style attribute */=0A=
        var value =3D nvpair[1]; /* attribute value */=0A=
  =0A=
        /*=0A=
         * For each possible style attribute, set the=0A=
         * appropriate style property in the element.=0A=
         */=0A=
        if (name =3D=3D "background") {=0A=
           e.style.background =3D value;=0A=
        }=0A=
        else if (name =3D=3D "background-attachment") {=0A=
          e.style.backgroundAttachment =3D value;=0A=
        }=0A=
        else if (name =3D=3D "background-color") {=0A=
          e.style.backgroundColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "background-image") {=0A=
          e.style.backgroundImage =3D value;=0A=
        }=0A=
        else if (name =3D=3D "background-position") {=0A=
          e.style.backgroundPosition =3D value;=0A=
        }=0A=
        else if (name =3D=3D "background-position-x") {=0A=
          e.style.backgroundPositionX =3D value;=0A=
        }=0A=
        else if (name =3D=3D "background-position-y") {=0A=
          e.style.backgroundPositionY =3D value;=0A=
        }=0A=
        else if (name =3D=3D "background-repeat") {=0A=
          e.style.backgroundRepeat =3D value;=0A=
        }=0A=
        else if (name =3D=3D "behavior") {=0A=
          e.style.behavior =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border") {=0A=
          e.style.border =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-bottom") {=0A=
          e.style.borderBottom =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-bottom-color") {=0A=
          e.style.borderBottomColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-bottom-style") {=0A=
          e.style.borderBottomStyle =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-bottom-width") {=0A=
          e.style.borderBottomWidth =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-collapse") {=0A=
          e.style.borderCollapse =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-color") {=0A=
          e.style.borderColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-left") {=0A=
          e.style.borderLeft =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-left-color") {=0A=
          e.style.borderLeftColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-left-style") {=0A=
          e.style.borderLeftStyle =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-left-width") {=0A=
          e.style.borderLeftWidth =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-right") {=0A=
          e.style.borderRight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-right-color") {=0A=
          e.style.borderRightColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-right-style") {=0A=
          e.style.borderRightStyle =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-right-width") {=0A=
          e.style.borderRightWidth =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-style") {=0A=
          e.style.borderStyle =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-top") {=0A=
          e.style.borderTop =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-top-color") {=0A=
          e.style.borderTopColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-top-style") {=0A=
          e.style.borderTopStyle =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-top-width") {=0A=
          e.style.borderTopWidth =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-width") {=0A=
          e.style.borderWidth =3D value;=0A=
        }=0A=
        else if (name =3D=3D "bottom") {=0A=
          e.style.bottom =3D value;=0A=
        }=0A=
        else if (name =3D=3D "clear") {=0A=
          e.style.clear =3D value;=0A=
        }=0A=
        else if (name =3D=3D "clip") {=0A=
          e.style.clip =3D value;=0A=
        }=0A=
        else if (name =3D=3D "color") {=0A=
          e.style.color =3D value;=0A=
        }=0A=
        else if (name =3D=3D "cssText") {=0A=
          e.style.Sets =3D value;=0A=
        }=0A=
        else if (name =3D=3D "cursor") {=0A=
          e.style.cursor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "direction") {=0A=
          e.style.direction =3D value;=0A=
        }=0A=
        else if (name =3D=3D "display") {=0A=
          e.style.display =3D value;=0A=
        }=0A=
        else if (name =3D=3D "font") {=0A=
          e.style.font =3D value;=0A=
        }=0A=
        else if (name =3D=3D "font-family") {=0A=
          e.style.fontFamily =3D value;=0A=
        }=0A=
        else if (name =3D=3D "font-size") {=0A=
          e.style.fontSize =3D value;=0A=
        }=0A=
        else if (name =3D=3D "font-style") {=0A=
          e.style.fontStyle =3D value;=0A=
        }=0A=
        else if (name =3D=3D "font-variant") {=0A=
          e.style.fontVariant =3D value;=0A=
        }=0A=
        else if (name =3D=3D "font-weight") {=0A=
          e.style.fontWeight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "height") {=0A=
          e.style.height =3D value;=0A=
        }=0A=
        else if (name =3D=3D "ime-mode") {=0A=
          e.style.imeMode =3D value;=0A=
        }=0A=
        else if (name =3D=3D "layout-flow") {=0A=
          e.style.layoutFlow =3D value;=0A=
        }=0A=
        else if (name =3D=3D "layout-grid") {=0A=
          e.style.layoutGrid =3D value;=0A=
        }=0A=
        else if (name =3D=3D "layout-grid-char") {=0A=
          e.style.layoutGridChar =3D value;=0A=
        }=0A=
        else if (name =3D=3D "layout-grid-line") {=0A=
          e.style.layoutGridLine =3D value;=0A=
        }=0A=
        else if (name =3D=3D "layout-grid-mode") {=0A=
          e.style.layoutGridMode =3D value;=0A=
        }=0A=
        else if (name =3D=3D "layout-grid-type") {=0A=
          e.style.layoutGridType =3D value;=0A=
        }=0A=
        else if (name =3D=3D "left") {=0A=
          e.style.left =3D value;=0A=
        }=0A=
        else if (name =3D=3D "letter-spacing") {=0A=
          e.style.letterSpacing =3D value;=0A=
        }=0A=
        else if (name =3D=3D "line-break") {=0A=
          e.style.lineBreak =3D value;=0A=
        }=0A=
        else if (name =3D=3D "line-height") {=0A=
          e.style.lineHeight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "list-style") {=0A=
          e.style.listStyle =3D value;=0A=
        }=0A=
        else if (name =3D=3D "list-style-image") {=0A=
          e.style.listStyleImage =3D value;=0A=
        }=0A=
        else if (name =3D=3D "list-style-position") {=0A=
          e.style.listStylePosition =3D value;=0A=
        }=0A=
        else if (name =3D=3D "list-style-type") {=0A=
          e.style.listStyleType =3D value;=0A=
        }=0A=
        else if (name =3D=3D "margin") {=0A=
          e.style.margin =3D value;=0A=
        }=0A=
        else if (name =3D=3D "margin-bottom") {=0A=
          e.style.marginBottom =3D value;=0A=
        }=0A=
        else if (name =3D=3D "margin-left") {=0A=
          e.style.marginLeft =3D value;=0A=
        }=0A=
        else if (name =3D=3D "margin-right") {=0A=
          e.style.marginRight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "margin-top") {=0A=
          e.style.marginTop =3D value;=0A=
        }=0A=
        else if (name =3D=3D "min-height") {=0A=
          e.style.minHeight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "overflow") {=0A=
          e.style.overflow =3D value;=0A=
        }=0A=
        else if (name =3D=3D "overflow-x") {=0A=
          e.style.overflowX =3D value;=0A=
        }=0A=
        else if (name =3D=3D "overflow-y") {=0A=
          e.style.overflowY =3D value;=0A=
        }=0A=
        else if (name =3D=3D "padding") {=0A=
          e.style.padding =3D value;=0A=
        }=0A=
        else if (name =3D=3D "padding-bottom") {=0A=
          e.style.paddingBottom =3D value;=0A=
        }=0A=
        else if (name =3D=3D "padding-left") {=0A=
          e.style.paddingLeft =3D value;=0A=
        }=0A=
        else if (name =3D=3D "padding-right") {=0A=
          e.style.paddingRight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "padding-top") {=0A=
          e.style.paddingTop =3D value;=0A=
        }=0A=
        else if (name =3D=3D "page-break-after") {=0A=
          e.style.pageBreakAfter =3D value;=0A=
        }=0A=
        else if (name =3D=3D "page-break-before") {=0A=
          e.style.pageBreakBefore =3D value;=0A=
        }=0A=
        else if (name =3D=3D "pixelBottom") {=0A=
          e.style.pixelBottom =3D value;=0A=
        }=0A=
        else if (name =3D=3D "pixelHeight") {=0A=
          e.style.pixelHeight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "pixelLeft") {=0A=
          e.style.pixelLeft =3D value;=0A=
        }=0A=
        else if (name =3D=3D "pixelRight") {=0A=
          e.style.pixelRight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "pixelTop") {=0A=
          e.style.pixelTop =3D value;=0A=
        }=0A=
        else if (name =3D=3D "pixelWidth") {=0A=
          e.style.pixelWidth =3D value;=0A=
        }=0A=
        else if (name =3D=3D "posBottom") {=0A=
          e.style.posBottom =3D value;=0A=
        }=0A=
        else if (name =3D=3D "posHeight") {=0A=
          e.style.posHeight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "position") {=0A=
          e.style.position =3D value;=0A=
        }=0A=
        else if (name =3D=3D "posLeft") {=0A=
          e.style.posLeft =3D value;=0A=
        }=0A=
        else if (name =3D=3D "posRight") {=0A=
          e.style.posRight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "posTop") {=0A=
          e.style.posTop =3D value;=0A=
        }=0A=
        else if (name =3D=3D "posWidth") {=0A=
          e.style.posWidth =3D value;=0A=
        }=0A=
        else if (name =3D=3D "right") {=0A=
          e.style.right =3D value;=0A=
        }=0A=
        else if (name =3D=3D "ruby-align") {=0A=
          e.style.rubyAlign =3D value;=0A=
        }=0A=
        else if (name =3D=3D "ruby-overhang") {=0A=
          e.style.rubyOverhang =3D value;=0A=
        }=0A=
        else if (name =3D=3D "ruby-position") {=0A=
          e.style.rubyPosition =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-3dlight-color") {=0A=
          e.style.scrollbar3dLightColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-arrow-color") {=0A=
          e.style.scrollbarArrowColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-base-color") {=0A=
          e.style.scrollbarBaseColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-darkshadow-color") {=0A=
          e.style.scrollbarDarkShadowColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-face-color") {=0A=
          e.style.scrollbarFaceColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-highlight-color") {=0A=
          e.style.scrollbarHighlightColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-shadow-color") {=0A=
          e.style.scrollbarShadowColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-track-color") {=0A=
          e.style.scrollbarTrackColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "float") {=0A=
          e.style.styleFloat =3D value;=0A=
        }=0A=
        else if (name =3D=3D "table-layout") {=0A=
          e.style.tableLayout =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-align") {=0A=
          e.style.textAlign =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-align-last") {=0A=
          e.style.textAlignLast =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-autospace") {=0A=
          e.style.textAutospace =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-decoration") {=0A=
          e.style.textDecoration =3D value;=0A=
        }=0A=
        else if (name =3D=3D "textDecorationBlink") {=0A=
          e.style.textDecorationBlink =3D value;=0A=
        }=0A=
        else if (name =3D=3D "textDecorationLineThrough") {=0A=
          e.style.textDecorationLineThrough =3D value;=0A=
        }=0A=
        else if (name =3D=3D "textDecorationNone") {=0A=
          e.style.textDecorationNone =3D value;=0A=
        }=0A=
        else if (name =3D=3D "textDecorationOverline") {=0A=
          e.style.textDecorationOverline =3D value;=0A=
        }=0A=
        else if (name =3D=3D "textDecorationUnderline") {=0A=
          e.style.textDecorationUnderline =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-indent") {=0A=
          e.style.textIndent =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-justify") {=0A=
          e.style.textJustify =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-kashida-space") {=0A=
          e.style.textKashidaSpace =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-overflow") {=0A=
          e.style.textOverflow =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-transform") {=0A=
          e.style.textTransform =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-underline-position") {=0A=
          e.style.textUnderlinePosition =3D value;=0A=
        }=0A=
        else if (name =3D=3D "top") {=0A=
          e.style.top =3D value;=0A=
        }=0A=
        else if (name =3D=3D "unicode-bidi") {=0A=
          e.style.unicodeBidi =3D value;=0A=
        }=0A=
        else if (name =3D=3D "vertical-align") {=0A=
          e.style.verticalAlign =3D value;=0A=
        }=0A=
        else if (name =3D=3D "visibility") {=0A=
          e.style.visibility =3D value;=0A=
        }=0A=
        else if (name =3D=3D "white-space") {=0A=
          e.style.whiteSpace =3D value;=0A=
        }=0A=
        else if (name =3D=3D "width") {=0A=
          e.style.width =3D value;=0A=
        }=0A=
        else if (name =3D=3D "word-break") {=0A=
          e.style.wordBreak =3D value;=0A=
        }=0A=
        else if (name =3D=3D "word-spacing") {=0A=
          e.style.wordSpacing =3D value;=0A=
        }=0A=
        else if (name =3D=3D "word-wrap") {=0A=
          e.style.wordWrap =3D value;=0A=
        }=0A=
        else if (name =3D=3D "writing-mode") {=0A=
          e.style.writingMode =3D value;=0A=
        }=0A=
        else if (name =3D=3D "z-index") {=0A=
          e.style.zIndex =3D value;=0A=
        }=0A=
        else if (name =3D=3D "zoom") {=0A=
          e.style.zoom =3D value;=0A=
        }=0A=
      }=0A=
      catch (e) {=0A=
        /* ignore error on attempt to set e.style.[property] */=0A=
      }=0A=
    }=0A=
  }=0A=
}=0A=

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: application/octet-stream
Content-Transfer-Encoding: quoted-printable
Content-Location: http://cancerres.aacrjournals.org/javascript/entrez/callback.js

/************************************************************************=
*****=0A=
 * javascript/entrez/callback.js=0A=
 *=0A=
 * Entrez Linking callback to populate content box.=0A=
 *=0A=
 * Copyright 2006 Board of Trustees of the Leland Stanford Junior =
University.=0A=
 =
*************************************************************************=
***/=0A=
=0A=
/*=0A=
 * Execute callback to fill content box with Entrez Linking information.=0A=
 */=0A=
function entrez_callback(pmid, callback_url) {=0A=
  /*=0A=
   * MSIE 5.5 and below have issues with the JavaScript=0A=
   * used for Entrez Linking. For now we have to disable=0A=
   * the callback until we can track down a proper fix=0A=
   * (or everybody sanely upgrades to version 6 or 7!).=0A=
   */=0A=
  if (navigator) {=0A=
    var appname =3D navigator.appName;=0A=
    if (appname =3D=3D "Microsoft Internet Explorer") {=0A=
      var userAgent =3D navigator["userAgent"];=0A=
      var s =3D "MSIE ";=0A=
      var n =3D -1;      =0A=
      if ((n =3D userAgent.indexOf(s)) !=3D -1) {=0A=
        var v =3D parseFloat(userAgent.substring(n+s.length));=0A=
        if (v < 6) {=0A=
          return;=0A=
        }=0A=
      }=0A=
    }=0A=
  }=0A=
=0A=
  /*=0A=
   * Acquire table row element to update, initiate callback=0A=
   * to update table with Entrez Links.=0A=
   */=0A=
  var tr =3D document.getElementById('entrez_callback_'+pmid);=0A=
  if (!tr) {=0A=
    return;=0A=
  }=0A=
  var req =3D new XMLHttpRequest();=0A=
  if (!req) {=0A=
    return;=0A=
  }=0A=
  req.onreadystatechange =3D function() {=0A=
    if (req.readyState =3D=3D 4 && (req.status =3D=3D 200 || req.status =
=3D=3D 304)) {=0A=
      var src =3D req.responseXML.documentElement;=0A=
      var dst =3D document.createDocumentFragment();=0A=
      for (var i =3D 0; i < src.childNodes.length; i++) {=0A=
      	copy_xml_to_html(src.childNodes[i], dst);=0A=
      }=0A=
      var tbl =3D tr.parentNode;=0A=
      tbl.replaceChild(dst, tr);=0A=
    }=0A=
  }=0A=
  req.open('GET', callback_url, true);=0A=
  req.send(null);=0A=
}=0A=

------=_NextPart_000_0000_01C85787.6EAC82A0
Content-Type: application/octet-stream
Content-Transfer-Encoding: quoted-printable
Content-Location: http://www.google-analytics.com/urchin.js

//-- Google Analytics Urchin Module=0A=
//-- Copyright 2007 Google, All Rights Reserved.=0A=
=0A=
//-- Urchin On Demand Settings ONLY=0A=
var _uacct=3D"";			// set up the Urchin Account=0A=
var _userv=3D1;			// service mode (0=3Dlocal,1=3Dremote,2=3Dboth)=0A=
=0A=
//-- UTM User Settings=0A=
var _ufsc=3D1;			// set client info flag (1=3Don|0=3Doff)=0A=
var _udn=3D"auto";		// (auto|none|domain) set the domain name for cookies=0A=
var _uhash=3D"on";		// (on|off) unique domain hash for cookies=0A=
var _utimeout=3D"1800";   	// set the inactive session timeout in seconds=0A=
var _ugifpath=3D"/__utm.gif";	// set the web path to the __utm.gif file=0A=
var _utsp=3D"|";			// transaction field separator=0A=
var _uflash=3D1;			// set flash version detect option (1=3Don|0=3Doff)=0A=
var _utitle=3D1;			// set the document title detect option =
(1=3Don|0=3Doff)=0A=
var _ulink=3D0;			// enable linker functionality (1=3Don|0=3Doff)=0A=
var _uanchor=3D0;			// enable use of anchors for campaign =
(1=3Don|0=3Doff)=0A=
var _utcp=3D"/";			// the cookie path for tracking=0A=
var _usample=3D100;		// The sampling % of visitors to track (1-100).=0A=
=0A=
//-- UTM Campaign Tracking Settings=0A=
var _uctm=3D1;			// set campaign tracking module (1=3Don|0=3Doff)=0A=
var _ucto=3D"15768000";		// set timeout in seconds (6 month default)=0A=
var _uccn=3D"utm_campaign";	// name=0A=
var _ucmd=3D"utm_medium";		// medium (cpc|cpm|link|email|organic)=0A=
var _ucsr=3D"utm_source";		// source=0A=
var _uctr=3D"utm_term";		// term/keyword=0A=
var _ucct=3D"utm_content";	// content=0A=
var _ucid=3D"utm_id";		// id number=0A=
var _ucno=3D"utm_nooverride";	// don't override=0A=
=0A=
//-- Auto/Organic Sources and Keywords=0A=
var _uOsr=3Dnew Array();=0A=
var _uOkw=3Dnew Array();=0A=
_uOsr[0]=3D"google";	_uOkw[0]=3D"q";=0A=
_uOsr[1]=3D"yahoo";	_uOkw[1]=3D"p";=0A=
_uOsr[2]=3D"msn";		_uOkw[2]=3D"q";=0A=
_uOsr[3]=3D"aol";		_uOkw[3]=3D"query";=0A=
_uOsr[4]=3D"aol";		_uOkw[4]=3D"encquery";=0A=
_uOsr[5]=3D"lycos";	_uOkw[5]=3D"query";=0A=
_uOsr[6]=3D"ask";		_uOkw[6]=3D"q";=0A=
_uOsr[7]=3D"altavista";	_uOkw[7]=3D"q";=0A=
_uOsr[8]=3D"netscape";	_uOkw[8]=3D"query";=0A=
_uOsr[9]=3D"cnn";	_uOkw[9]=3D"query";=0A=
_uOsr[10]=3D"looksmart";	_uOkw[10]=3D"qt";=0A=
_uOsr[11]=3D"about";	_uOkw[11]=3D"terms";=0A=
_uOsr[12]=3D"mamma";	_uOkw[12]=3D"query";=0A=
_uOsr[13]=3D"alltheweb";	_uOkw[13]=3D"q";=0A=
_uOsr[14]=3D"gigablast";	_uOkw[14]=3D"q";=0A=
_uOsr[15]=3D"voila";	_uOkw[15]=3D"rdata";=0A=
_uOsr[16]=3D"virgilio";	_uOkw[16]=3D"qs";=0A=
_uOsr[17]=3D"live";	_uOkw[17]=3D"q";=0A=
_uOsr[18]=3D"baidu";	_uOkw[18]=3D"wd";=0A=
_uOsr[19]=3D"alice";	_uOkw[19]=3D"qs";=0A=
_uOsr[20]=3D"yandex";	_uOkw[20]=3D"text";=0A=
_uOsr[21]=3D"najdi";	_uOkw[21]=3D"q";=0A=
_uOsr[22]=3D"aol";	_uOkw[22]=3D"q";=0A=
_uOsr[23]=3D"club-internet"; _uOkw[23]=3D"q";=0A=
_uOsr[24]=3D"mama";	_uOkw[24]=3D"query";=0A=
_uOsr[25]=3D"seznam";	_uOkw[25]=3D"q";=0A=
_uOsr[26]=3D"search";	_uOkw[26]=3D"q";=0A=
_uOsr[27]=3D"szukaj";	_uOkw[27]=3D"szukaj";=0A=
_uOsr[28]=3D"szukaj";	_uOkw[28]=3D"qt";=0A=
_uOsr[29]=3D"netsprint";	_uOkw[29]=3D"q";=0A=
_uOsr[30]=3D"google.interia";	_uOkw[30]=3D"q";=0A=
_uOsr[31]=3D"szukacz";	_uOkw[31]=3D"q";=0A=
_uOsr[32]=3D"yam";	_uOkw[32]=3D"k";=0A=
_uOsr[33]=3D"pchome";	_uOkw[33]=3D"q";=0A=
=0A=
=0A=
//-- Auto/Organic Keywords to Ignore=0A=
var _uOno=3Dnew Array();=0A=
//_uOno[0]=3D"urchin";=0A=
//_uOno[1]=3D"urchin.com";=0A=
//_uOno[2]=3D"www.urchin.com";=0A=
=0A=
//-- Referral domains to Ignore=0A=
var _uRno=3Dnew Array();=0A=
//_uRno[0]=3D".urchin.com";=0A=
=0A=
//-- **** Don't modify below this point ***=0A=
var =
_uff,_udh,_udt,_ubl=3D0,_udo=3D"",_uu,_ufns=3D0,_uns=3D0,_ur=3D"-",_ufno=3D=
0,_ust=3D0,_ubd=3Ddocument,_udl=3D_ubd.location,_udlh=3D"",_uwv=3D"1";=0A=
var _ugifpath2=3D"http://www.google-analytics.com/__utm.gif";=0A=
if (_udl.hash) _udlh=3D_udl.href.substring(_udl.href.indexOf('#'));=0A=
if (_udl.protocol=3D=3D"https:") =
_ugifpath2=3D"https://ssl.google-analytics.com/__utm.gif";=0A=
if (!_utcp || _utcp=3D=3D"") _utcp=3D"/";=0A=
function urchinTracker(page) {=0A=
 if (_udl.protocol=3D=3D"file:") return;=0A=
 if (_uff && (!page || page=3D=3D"")) return;=0A=
 var a,b,c,xx,v,z,k,x=3D"",s=3D"",f=3D0;=0A=
 var nx=3D" expires=3D"+_uNx()+";";=0A=
 var dc=3D_ubd.cookie;=0A=
 _udh=3D_uDomain();=0A=
 if (!_uVG()) return;=0A=
 _uu=3DMath.round(Math.random()*2147483647);=0A=
 _udt=3Dnew Date();=0A=
 _ust=3DMath.round(_udt.getTime()/1000);=0A=
 a=3Ddc.indexOf("__utma=3D"+_udh);=0A=
 b=3Ddc.indexOf("__utmb=3D"+_udh);=0A=
 c=3Ddc.indexOf("__utmc=3D"+_udh);=0A=
 if (_udn && _udn!=3D"") { _udo=3D" domain=3D"+_udn+";"; }=0A=
 if (_utimeout && _utimeout!=3D"") {=0A=
  x=3Dnew Date(_udt.getTime()+(_utimeout*1000));=0A=
  x=3D" expires=3D"+x.toGMTString()+";";=0A=
 }=0A=
 if (_ulink) {=0A=
  if (_uanchor && _udlh && _udlh!=3D"") s=3D_udlh+"&";=0A=
  s+=3D_udl.search;=0A=
  if(s && s!=3D"" && s.indexOf("__utma=3D")>=3D0) {=0A=
   if (!(_uIN(a=3D_uGC(s,"__utma=3D","&")))) a=3D"-";=0A=
   if (!(_uIN(b=3D_uGC(s,"__utmb=3D","&")))) b=3D"-";=0A=
   if (!(_uIN(c=3D_uGC(s,"__utmc=3D","&")))) c=3D"-";=0A=
   v=3D_uGC(s,"__utmv=3D","&");=0A=
   z=3D_uGC(s,"__utmz=3D","&");=0A=
   k=3D_uGC(s,"__utmk=3D","&");=0A=
   xx=3D_uGC(s,"__utmx=3D","&");=0A=
   if ((k*1) !=3D ((_uHash(a+b+c+xx+z+v)*1)+(_udh*1))) =
{_ubl=3D1;a=3D"-";b=3D"-";c=3D"-";xx=3D"-";z=3D"-";v=3D"-";}=0A=
   if (a!=3D"-" && b!=3D"-" && c!=3D"-") f=3D1;=0A=
   else if(a!=3D"-") f=3D2;=0A=
  }=0A=
 }=0A=
 if(f=3D=3D1) {=0A=
  _ubd.cookie=3D"__utma=3D"+a+"; path=3D"+_utcp+";"+nx+_udo;=0A=
  _ubd.cookie=3D"__utmb=3D"+b+"; path=3D"+_utcp+";"+x+_udo;=0A=
  _ubd.cookie=3D"__utmc=3D"+c+"; path=3D"+_utcp+";"+_udo;=0A=
 } else if (f=3D=3D2) {=0A=
  a=3D_uFixA(s,"&",_ust);=0A=
  _ubd.cookie=3D"__utma=3D"+a+"; path=3D"+_utcp+";"+nx+_udo;=0A=
  _ubd.cookie=3D"__utmb=3D"+_udh+"; path=3D"+_utcp+";"+x+_udo;=0A=
  _ubd.cookie=3D"__utmc=3D"+_udh+"; path=3D"+_utcp+";"+_udo;=0A=
  _ufns=3D1;=0A=
 } else if (a>=3D0 && b>=3D0 && c>=3D0) {=0A=
  _ubd.cookie=3D"__utmb=3D"+_udh+"; path=3D"+_utcp+";"+x+_udo;=0A=
 } else {=0A=
  if (a>=3D0) a=3D_uFixA(_ubd.cookie,";",_ust);=0A=
  else a=3D_udh+"."+_uu+"."+_ust+"."+_ust+"."+_ust+".1";=0A=
  _ubd.cookie=3D"__utma=3D"+a+"; path=3D"+_utcp+";"+nx+_udo;=0A=
  _ubd.cookie=3D"__utmb=3D"+_udh+"; path=3D"+_utcp+";"+x+_udo;=0A=
  _ubd.cookie=3D"__utmc=3D"+_udh+"; path=3D"+_utcp+";"+_udo;=0A=
  _ufns=3D1;=0A=
 }=0A=
 if (_ulink && xx && xx!=3D"" && xx!=3D"-") {=0A=
   xx=3D_uUES(xx);=0A=
   if (xx.indexOf(";")=3D=3D-1) _ubd.cookie=3D"__utmx=3D"+xx+"; =
path=3D"+_utcp+";"+nx+_udo;=0A=
 }=0A=
 if (_ulink && v && v!=3D"" && v!=3D"-") {=0A=
  v=3D_uUES(v);=0A=
  if (v.indexOf(";")=3D=3D-1) _ubd.cookie=3D"__utmv=3D"+v+"; =
path=3D"+_utcp+";"+nx+_udo;=0A=
 }=0A=
 _uInfo(page);=0A=
 _ufns=3D0;=0A=
 _ufno=3D0;=0A=
 if (!page || page=3D=3D"") _uff=3D1;=0A=
}=0A=
function _uInfo(page) {=0A=
 var p,s=3D"",dm=3D"",pg=3D_udl.pathname+_udl.search;=0A=
 if (page && page!=3D"") pg=3D_uES(page,1);=0A=
 _ur=3D_ubd.referrer;=0A=
 if (!_ur || _ur=3D=3D"") { _ur=3D"-"; }=0A=
 else {=0A=
  dm=3D_ubd.domain;=0A=
  if(_utcp && _utcp!=3D"/") dm+=3D_utcp;=0A=
  p=3D_ur.indexOf(dm);=0A=
  if ((p>=3D0) && (p<=3D8)) { _ur=3D"0"; }=0A=
  if (_ur.indexOf("[")=3D=3D0 && =
_ur.lastIndexOf("]")=3D=3D(_ur.length-1)) { _ur=3D"-"; }=0A=
 }=0A=
 s+=3D"&utmn=3D"+_uu;=0A=
 if (_ufsc) s+=3D_uBInfo();=0A=
 if (_uctm) s+=3D_uCInfo();=0A=
 if (_utitle && _ubd.title && _ubd.title!=3D"") =
s+=3D"&utmdt=3D"+_uES(_ubd.title);=0A=
 if (_udl.hostname && _udl.hostname!=3D"") =
s+=3D"&utmhn=3D"+_uES(_udl.hostname);=0A=
 s+=3D"&utmr=3D"+_ur;=0A=
 s+=3D"&utmp=3D"+pg;=0A=
 if ((_userv=3D=3D0 || _userv=3D=3D2) && _uSP()) {=0A=
  var i=3Dnew Image(1,1);=0A=
  i.src=3D_ugifpath+"?"+"utmwv=3D"+_uwv+s;=0A=
  i.onload=3Dfunction() {_uVoid();}=0A=
 }=0A=
 if ((_userv=3D=3D1 || _userv=3D=3D2) && _uSP()) {=0A=
  var i2=3Dnew Image(1,1);=0A=
  =
i2.src=3D_ugifpath2+"?"+"utmwv=3D"+_uwv+s+"&utmac=3D"+_uacct+"&utmcc=3D"+=
_uGCS();=0A=
  i2.onload=3Dfunction() { _uVoid(); }=0A=
 }=0A=
 return;=0A=
}=0A=
function _uVoid() { return; }=0A=
function _uCInfo() {=0A=
 if (!_ucto || _ucto=3D=3D"") { _ucto=3D"15768000"; }=0A=
 if (!_uVG()) return;=0A=
 var =
c=3D"",t=3D"-",t2=3D"-",t3=3D"-",o=3D0,cs=3D0,cn=3D0,i=3D0,z=3D"-",s=3D""=
;=0A=
 if (_uanchor && _udlh && _udlh!=3D"") s=3D_udlh+"&";=0A=
 s+=3D_udl.search;=0A=
 var x=3Dnew Date(_udt.getTime()+(_ucto*1000));=0A=
 var dc=3D_ubd.cookie;=0A=
 x=3D" expires=3D"+x.toGMTString()+";";=0A=
 if (_ulink && !_ubl) {=0A=
  z=3D_uUES(_uGC(s,"__utmz=3D","&"));=0A=
  if (z!=3D"-" && z.indexOf(";")=3D=3D-1) { =
_ubd.cookie=3D"__utmz=3D"+z+"; path=3D"+_utcp+";"+x+_udo; return ""; }=0A=
 }=0A=
 z=3Ddc.indexOf("__utmz=3D"+_udh);=0A=
 if (z>-1) { z=3D_uGC(dc,"__utmz=3D"+_udh,";"); }=0A=
 else { z=3D"-"; }=0A=
 t=3D_uGC(s,_ucid+"=3D","&");=0A=
 t2=3D_uGC(s,_ucsr+"=3D","&");=0A=
 t3=3D_uGC(s,"gclid=3D","&");=0A=
 if ((t!=3D"-" && t!=3D"") || (t2!=3D"-" && t2!=3D"") || (t3!=3D"-" && =
t3!=3D"")) {=0A=
  if (t!=3D"-" && t!=3D"") c+=3D"utmcid=3D"+_uEC(t);=0A=
  if (t2!=3D"-" && t2!=3D"") { if (c !=3D "") c+=3D"|"; =
c+=3D"utmcsr=3D"+_uEC(t2); }=0A=
  if (t3!=3D"-" && t3!=3D"") { if (c !=3D "") c+=3D"|"; =
c+=3D"utmgclid=3D"+_uEC(t3); }=0A=
  t=3D_uGC(s,_uccn+"=3D","&");=0A=
  if (t!=3D"-" && t!=3D"") c+=3D"|utmccn=3D"+_uEC(t);=0A=
  else c+=3D"|utmccn=3D(not+set)";=0A=
  t=3D_uGC(s,_ucmd+"=3D","&");=0A=
  if (t!=3D"-" && t!=3D"") c+=3D"|utmcmd=3D"+_uEC(t);=0A=
  else  c+=3D"|utmcmd=3D(not+set)";=0A=
  t=3D_uGC(s,_uctr+"=3D","&");=0A=
  if (t!=3D"-" && t!=3D"") c+=3D"|utmctr=3D"+_uEC(t);=0A=
  else { t=3D_uOrg(1); if (t!=3D"-" && t!=3D"") =
c+=3D"|utmctr=3D"+_uEC(t); }=0A=
  t=3D_uGC(s,_ucct+"=3D","&");=0A=
  if (t!=3D"-" && t!=3D"") c+=3D"|utmcct=3D"+_uEC(t);=0A=
  t=3D_uGC(s,_ucno+"=3D","&");=0A=
  if (t=3D=3D"1") o=3D1;=0A=
  if (z!=3D"-" && o=3D=3D1) return "";=0A=
 }=0A=
 if (c=3D=3D"-" || c=3D=3D"") { c=3D_uOrg(); if (z!=3D"-" && =
_ufno=3D=3D1)  return ""; }=0A=
 if (c=3D=3D"-" || c=3D=3D"") { if (_ufns=3D=3D1)  c=3D_uRef(); if =
(z!=3D"-" && _ufno=3D=3D1)  return ""; }=0A=
 if (c=3D=3D"-" || c=3D=3D"") {=0A=
  if (z=3D=3D"-" && _ufns=3D=3D1) { =
c=3D"utmccn=3D(direct)|utmcsr=3D(direct)|utmcmd=3D(none)"; }=0A=
  if (c=3D=3D"-" || c=3D=3D"") return "";=0A=
 }=0A=
 if (z!=3D"-") {=0A=
  i=3Dz.indexOf(".");=0A=
  if (i>-1) i=3Dz.indexOf(".",i+1);=0A=
  if (i>-1) i=3Dz.indexOf(".",i+1);=0A=
  if (i>-1) i=3Dz.indexOf(".",i+1);=0A=
  t=3Dz.substring(i+1,z.length);=0A=
  if (t.toLowerCase()=3D=3Dc.toLowerCase()) cs=3D1;=0A=
  t=3Dz.substring(0,i);=0A=
  if ((i=3Dt.lastIndexOf(".")) > -1) {=0A=
   t=3Dt.substring(i+1,t.length);=0A=
   cn=3D(t*1);=0A=
  }=0A=
 }=0A=
 if (cs=3D=3D0 || _ufns=3D=3D1) {=0A=
  t=3D_uGC(dc,"__utma=3D"+_udh,";");=0A=
  if ((i=3Dt.lastIndexOf(".")) > 9) {=0A=
   _uns=3Dt.substring(i+1,t.length);=0A=
   _uns=3D(_uns*1);=0A=
  }=0A=
  cn++;=0A=
  if (_uns=3D=3D0) _uns=3D1;=0A=
  _ubd.cookie=3D"__utmz=3D"+_udh+"."+_ust+"."+_uns+"."+cn+"."+c+"; =
path=3D"+_utcp+"; "+x+_udo;=0A=
 }=0A=
 if (cs=3D=3D0 || _ufns=3D=3D1) return "&utmcn=3D1";=0A=
 else return "&utmcr=3D1";=0A=
}=0A=
function _uRef() {=0A=
 if (_ur=3D=3D"0" || _ur=3D=3D"" || _ur=3D=3D"-") return "";=0A=
 var i=3D0,h,k,n;=0A=
 if ((i=3D_ur.indexOf("://"))<0) return "";=0A=
 h=3D_ur.substring(i+3,_ur.length);=0A=
 if (h.indexOf("/") > -1) {=0A=
  k=3Dh.substring(h.indexOf("/"),h.length);=0A=
  if (k.indexOf("?") > -1) k=3Dk.substring(0,k.indexOf("?"));=0A=
  h=3Dh.substring(0,h.indexOf("/"));=0A=
 }=0A=
 h=3Dh.toLowerCase();=0A=
 n=3Dh;=0A=
 if ((i=3Dn.indexOf(":")) > -1) n=3Dn.substring(0,i);=0A=
 for (var ii=3D0;ii<_uRno.length;ii++) {=0A=
  if ((i=3Dn.indexOf(_uRno[ii].toLowerCase())) > -1 && =
n.length=3D=3D(i+_uRno[ii].length)) { _ufno=3D1; break; }=0A=
 }=0A=
 if (h.indexOf("www.")=3D=3D0) h=3Dh.substring(4,h.length);=0A=
 return =
"utmccn=3D(referral)|utmcsr=3D"+_uEC(h)+"|"+"utmcct=3D"+_uEC(k)+"|utmcmd=3D=
referral";=0A=
}=0A=
function _uOrg(t) {=0A=
 if (_ur=3D=3D"0" || _ur=3D=3D"" || _ur=3D=3D"-") return "";=0A=
 var i=3D0,h,k;=0A=
 if ((i=3D_ur.indexOf("://")) < 0) return "";=0A=
 h=3D_ur.substring(i+3,_ur.length);=0A=
 if (h.indexOf("/") > -1) {=0A=
  h=3Dh.substring(0,h.indexOf("/"));=0A=
 }=0A=
 for (var ii=3D0;ii<_uOsr.length;ii++) {=0A=
  if (h.toLowerCase().indexOf(_uOsr[ii].toLowerCase()) > -1) {=0A=
   if ((i=3D_ur.indexOf("?"+_uOkw[ii]+"=3D")) > -1 || =
(i=3D_ur.indexOf("&"+_uOkw[ii]+"=3D")) > -1) {=0A=
    k=3D_ur.substring(i+_uOkw[ii].length+2,_ur.length);=0A=
    if ((i=3Dk.indexOf("&")) > -1) k=3Dk.substring(0,i);=0A=
    for (var yy=3D0;yy<_uOno.length;yy++) {=0A=
     if (_uOno[yy].toLowerCase()=3D=3Dk.toLowerCase()) { _ufno=3D1; =
break; }=0A=
    }=0A=
    if (t) return _uEC(k);=0A=
    else return =
"utmccn=3D(organic)|utmcsr=3D"+_uEC(_uOsr[ii])+"|"+"utmctr=3D"+_uEC(k)+"|=
utmcmd=3Dorganic";=0A=
   }=0A=
  }=0A=
 }=0A=
 return "";=0A=
}=0A=
function _uBInfo() {=0A=
 var sr=3D"-",sc=3D"-",ul=3D"-",fl=3D"-",cs=3D"-",je=3D1;=0A=
 var n=3Dnavigator;=0A=
 if (self.screen) {=0A=
  sr=3Dscreen.width+"x"+screen.height;=0A=
  sc=3Dscreen.colorDepth+"-bit";=0A=
 } else if (self.java) {=0A=
  var j=3Djava.awt.Toolkit.getDefaultToolkit();=0A=
  var s=3Dj.getScreenSize();=0A=
  sr=3Ds.width+"x"+s.height;=0A=
 }=0A=
 if (n.language) { ul=3Dn.language.toLowerCase(); }=0A=
 else if (n.browserLanguage) { ul=3Dn.browserLanguage.toLowerCase(); }=0A=
 je=3Dn.javaEnabled()?1:0;=0A=
 if (_uflash) fl=3D_uFlash();=0A=
 if (_ubd.characterSet) cs=3D_uES(_ubd.characterSet);=0A=
 else if (_ubd.charset) cs=3D_uES(_ubd.charset);=0A=
 return =
"&utmcs=3D"+cs+"&utmsr=3D"+sr+"&utmsc=3D"+sc+"&utmul=3D"+ul+"&utmje=3D"+j=
e+"&utmfl=3D"+fl;=0A=
}=0A=
function __utmSetTrans() {=0A=
 var e;=0A=
 if (_ubd.getElementById) e=3D_ubd.getElementById("utmtrans");=0A=
 else if (_ubd.utmform && _ubd.utmform.utmtrans) =
e=3D_ubd.utmform.utmtrans;=0A=
 if (!e) return;=0A=
 var l=3De.value.split("UTM:");=0A=
 var i,i2,c;=0A=
 if (_userv=3D=3D0 || _userv=3D=3D2) i=3Dnew Array();=0A=
 if (_userv=3D=3D1 || _userv=3D=3D2) { i2=3Dnew Array(); c=3D_uGCS(); }=0A=
=0A=
 for (var ii=3D0;ii<l.length;ii++) {=0A=
  l[ii]=3D_uTrim(l[ii]);=0A=
  if (l[ii].charAt(0)!=3D'T' && l[ii].charAt(0)!=3D'I') continue;=0A=
  var r=3DMath.round(Math.random()*2147483647);=0A=
  if (!_utsp || _utsp=3D=3D"") _utsp=3D"|";=0A=
  var f=3Dl[ii].split(_utsp),s=3D"";=0A=
  if (f[0].charAt(0)=3D=3D'T') {=0A=
   s=3D"&utmt=3Dtran"+"&utmn=3D"+r;=0A=
   f[1]=3D_uTrim(f[1]); if(f[1]&&f[1]!=3D"") =
s+=3D"&utmtid=3D"+_uES(f[1]);=0A=
   f[2]=3D_uTrim(f[2]); if(f[2]&&f[2]!=3D"") =
s+=3D"&utmtst=3D"+_uES(f[2]);=0A=
   f[3]=3D_uTrim(f[3]); if(f[3]&&f[3]!=3D"") =
s+=3D"&utmtto=3D"+_uES(f[3]);=0A=
   f[4]=3D_uTrim(f[4]); if(f[4]&&f[4]!=3D"") =
s+=3D"&utmttx=3D"+_uES(f[4]);=0A=
   f[5]=3D_uTrim(f[5]); if(f[5]&&f[5]!=3D"") =
s+=3D"&utmtsp=3D"+_uES(f[5]);=0A=
   f[6]=3D_uTrim(f[6]); if(f[6]&&f[6]!=3D"") =
s+=3D"&utmtci=3D"+_uES(f[6]);=0A=
   f[7]=3D_uTrim(f[7]); if(f[7]&&f[7]!=3D"") =
s+=3D"&utmtrg=3D"+_uES(f[7]);=0A=
   f[8]=3D_uTrim(f[8]); if(f[8]&&f[8]!=3D"") =
s+=3D"&utmtco=3D"+_uES(f[8]);=0A=
  } else {=0A=
   s=3D"&utmt=3Ditem"+"&utmn=3D"+r;=0A=
   f[1]=3D_uTrim(f[1]); if(f[1]&&f[1]!=3D"") =
s+=3D"&utmtid=3D"+_uES(f[1]);=0A=
   f[2]=3D_uTrim(f[2]); if(f[2]&&f[2]!=3D"") =
s+=3D"&utmipc=3D"+_uES(f[2]);=0A=
   f[3]=3D_uTrim(f[3]); if(f[3]&&f[3]!=3D"") =
s+=3D"&utmipn=3D"+_uES(f[3]);=0A=
   f[4]=3D_uTrim(f[4]); if(f[4]&&f[4]!=3D"") =
s+=3D"&utmiva=3D"+_uES(f[4]);=0A=
   f[5]=3D_uTrim(f[5]); if(f[5]&&f[5]!=3D"") =
s+=3D"&utmipr=3D"+_uES(f[5]);=0A=
   f[6]=3D_uTrim(f[6]); if(f[6]&&f[6]!=3D"") =
s+=3D"&utmiqt=3D"+_uES(f[6]);=0A=
  }=0A=
  if ((_userv=3D=3D0 || _userv=3D=3D2) && _uSP()) {=0A=
   i[ii]=3Dnew Image(1,1);=0A=
   i[ii].src=3D_ugifpath+"?"+"utmwv=3D"+_uwv+s;=0A=
   i[ii].onload=3Dfunction() { _uVoid(); }=0A=
  }=0A=
  if ((_userv=3D=3D1 || _userv=3D=3D2) && _uSP()) {=0A=
   i2[ii]=3Dnew Image(1,1);=0A=
   =
i2[ii].src=3D_ugifpath2+"?"+"utmwv=3D"+_uwv+s+"&utmac=3D"+_uacct+"&utmcc=3D=
"+c;=0A=
   i2[ii].onload=3Dfunction() { _uVoid(); }=0A=
  }=0A=
 }=0A=
 return;=0A=
}=0A=
function _uFlash() {=0A=
 var f=3D"-",n=3Dnavigator;=0A=
 if (n.plugins && n.plugins.length) {=0A=
  for (var ii=3D0;ii<n.plugins.length;ii++) {=0A=
   if (n.plugins[ii].name.indexOf('Shockwave Flash')!=3D-1) {=0A=
    f=3Dn.plugins[ii].description.split('Shockwave Flash ')[1];=0A=
    break;=0A=
   }=0A=
  }=0A=
 } else if (window.ActiveXObject) {=0A=
  for (var ii=3D10;ii>=3D2;ii--) {=0A=
   try {=0A=
    var fl=3Deval("new =
ActiveXObject('ShockwaveFlash.ShockwaveFlash."+ii+"');");=0A=
    if (fl) { f=3Dii + '.0'; break; }=0A=
   }=0A=
   catch(e) {}=0A=
  }=0A=
 }=0A=
 return f;=0A=
}=0A=
function __utmLinker(l,h) {=0A=
 if (!_ulink) return;=0A=
 var p,k,a=3D"-",b=3D"-",c=3D"-",x=3D"-",z=3D"-",v=3D"-";=0A=
 var dc=3D_ubd.cookie;=0A=
 if (!l || l=3D=3D"") return;=0A=
 var iq =3D l.indexOf("?"); =0A=
 var ih =3D l.indexOf("#"); =0A=
 if (dc) {=0A=
  a=3D_uES(_uGC(dc,"__utma=3D"+_udh,";"));=0A=
  b=3D_uES(_uGC(dc,"__utmb=3D"+_udh,";"));=0A=
  c=3D_uES(_uGC(dc,"__utmc=3D"+_udh,";"));=0A=
  x=3D_uES(_uGC(dc,"__utmx=3D"+_udh,";"));=0A=
  z=3D_uES(_uGC(dc,"__utmz=3D"+_udh,";"));=0A=
  v=3D_uES(_uGC(dc,"__utmv=3D"+_udh,";"));=0A=
  k=3D(_uHash(a+b+c+x+z+v)*1)+(_udh*1);=0A=
  =
p=3D"__utma=3D"+a+"&__utmb=3D"+b+"&__utmc=3D"+c+"&__utmx=3D"+x+"&__utmz=3D=
"+z+"&__utmv=3D"+v+"&__utmk=3D"+k;=0A=
 }=0A=
 if (p) {=0A=
  if (h && ih>-1) return;=0A=
  if (h) { _udl.href=3Dl+"#"+p; }=0A=
  else {=0A=
   if (iq=3D=3D-1 && ih=3D=3D-1) _udl.href=3Dl+"?"+p;=0A=
   else if (ih=3D=3D-1) _udl.href=3Dl+"&"+p;=0A=
   else if (iq=3D=3D-1) =
_udl.href=3Dl.substring(0,ih-1)+"?"+p+l.substring(ih);=0A=
   else _udl.href=3Dl.substring(0,ih-1)+"&"+p+l.substring(ih);=0A=
  }=0A=
 } else { _udl.href=3Dl; }=0A=
}=0A=
function __utmLinkPost(f,h) {=0A=
 if (!_ulink) return;=0A=
 var p,k,a=3D"-",b=3D"-",c=3D"-",x=3D"-",z=3D"-",v=3D"-";=0A=
 var dc=3D_ubd.cookie;=0A=
 if (!f || !f.action) return;=0A=
 var iq =3D f.action.indexOf("?"); =0A=
 var ih =3D f.action.indexOf("#"); =0A=
 if (dc) {=0A=
  a=3D_uES(_uGC(dc,"__utma=3D"+_udh,";"));=0A=
  b=3D_uES(_uGC(dc,"__utmb=3D"+_udh,";"));=0A=
  c=3D_uES(_uGC(dc,"__utmc=3D"+_udh,";"));=0A=
  x=3D_uES(_uGC(dc,"__utmx=3D"+_udh,";"));=0A=
  z=3D_uES(_uGC(dc,"__utmz=3D"+_udh,";"));=0A=
  v=3D_uES(_uGC(dc,"__utmv=3D"+_udh,";"));=0A=
  k=3D(_uHash(a+b+c+x+z+v)*1)+(_udh*1);=0A=
  =
p=3D"__utma=3D"+a+"&__utmb=3D"+b+"&__utmc=3D"+c+"&__utmx=3D"+x+"&__utmz=3D=
"+z+"&__utmv=3D"+v+"&__utmk=3D"+k;=0A=
 }=0A=
 if (p) {=0A=
  if (h && ih>-1) return;=0A=
  if (h) { f.action+=3D"#"+p; }=0A=
  else {=0A=
   if (iq=3D=3D-1 && ih=3D=3D-1) f.action+=3D"?"+p;=0A=
   else if (ih=3D=3D-1) f.action+=3D"&"+p;=0A=
   else if (iq=3D=3D-1) =
f.action=3Df.action.substring(0,ih-1)+"?"+p+f.action.substring(ih);=0A=
   else =
f.action=3Df.action.substring(0,ih-1)+"&"+p+f.action.substring(ih);=0A=
  }=0A=
 }=0A=
 return;=0A=
}=0A=
function __utmSetVar(v) {=0A=
 if (!v || v=3D=3D"") return;=0A=
 if (!_udo || _udo =3D=3D "") {=0A=
  _udh=3D_uDomain();=0A=
  if (_udn && _udn!=3D"") { _udo=3D" domain=3D"+_udn+";"; }=0A=
 }=0A=
 if (!_uVG()) return;=0A=
 var r=3DMath.round(Math.random() * 2147483647);=0A=
 _ubd.cookie=3D"__utmv=3D"+_udh+"."+_uES(v)+"; path=3D"+_utcp+"; =
expires=3D"+_uNx()+";"+_udo;=0A=
 var s=3D"&utmt=3Dvar&utmn=3D"+r;=0A=
 if ((_userv=3D=3D0 || _userv=3D=3D2) && _uSP()) {=0A=
  var i=3Dnew Image(1,1);=0A=
  i.src=3D_ugifpath+"?"+"utmwv=3D"+_uwv+s;=0A=
  i.onload=3Dfunction() { _uVoid(); }=0A=
 }=0A=
 if ((_userv=3D=3D1 || _userv=3D=3D2) && _uSP()) {=0A=
  var i2=3Dnew Image(1,1);=0A=
  =
i2.src=3D_ugifpath2+"?"+"utmwv=3D"+_uwv+s+"&utmac=3D"+_uacct+"&utmcc=3D"+=
_uGCS();=0A=
  i2.onload=3Dfunction() { _uVoid(); }=0A=
 }=0A=
}=0A=
function _uGCS() {=0A=
 var t,c=3D"",dc=3D_ubd.cookie;=0A=
 if ((t=3D_uGC(dc,"__utma=3D"+_udh,";"))!=3D"-") =
c+=3D_uES("__utma=3D"+t+";+");=0A=
 if ((t=3D_uGC(dc,"__utmb=3D"+_udh,";"))!=3D"-") =
c+=3D_uES("__utmb=3D"+t+";+");=0A=
 if ((t=3D_uGC(dc,"__utmc=3D"+_udh,";"))!=3D"-") =
c+=3D_uES("__utmc=3D"+t+";+");=0A=
 if ((t=3D_uGC(dc,"__utmx=3D"+_udh,";"))!=3D"-") =
c+=3D_uES("__utmx=3D"+t+";+");=0A=
 if ((t=3D_uGC(dc,"__utmz=3D"+_udh,";"))!=3D"-") =
c+=3D_uES("__utmz=3D"+t+";+");=0A=
 if ((t=3D_uGC(dc,"__utmv=3D"+_udh,";"))!=3D"-") =
c+=3D_uES("__utmv=3D"+t+";");=0A=
 if (c.charAt(c.length-1)=3D=3D"+") c=3Dc.substring(0,c.length-1);=0A=
 return c;=0A=
}=0A=
function _uGC(l,n,s) {=0A=
 if (!l || l=3D=3D"" || !n || n=3D=3D"" || !s || s=3D=3D"") return "-";=0A=
 var i,i2,i3,c=3D"-";=0A=
 i=3Dl.indexOf(n);=0A=
 i3=3Dn.indexOf("=3D")+1;=0A=
 if (i > -1) {=0A=
  i2=3Dl.indexOf(s,i); if (i2 < 0) { i2=3Dl.length; }=0A=
  c=3Dl.substring((i+i3),i2);=0A=
 }=0A=
 return c;=0A=
}=0A=
function _uDomain() {=0A=
 if (!_udn || _udn=3D=3D"" || _udn=3D=3D"none") { _udn=3D""; return 1; }=0A=
 if (_udn=3D=3D"auto") {=0A=
  var d=3D_ubd.domain;=0A=
  if (d.substring(0,4)=3D=3D"www.") {=0A=
   d=3Dd.substring(4,d.length);=0A=
  }=0A=
  _udn=3Dd;=0A=
 }=0A=
 _udn =3D _udn.toLowerCase(); =0A=
 if (_uhash=3D=3D"off") return 1;=0A=
 return _uHash(_udn);=0A=
}=0A=
function _uHash(d) {=0A=
 if (!d || d=3D=3D"") return 1;=0A=
 var h=3D0,g=3D0;=0A=
 for (var i=3Dd.length-1;i>=3D0;i--) {=0A=
  var c=3DparseInt(d.charCodeAt(i));=0A=
  h=3D((h << 6) & 0xfffffff) + c + (c << 14);=0A=
  if ((g=3Dh & 0xfe00000)!=3D0) h=3D(h ^ (g >> 21));=0A=
 }=0A=
 return h;=0A=
}=0A=
function _uFixA(c,s,t) {=0A=
 if (!c || c=3D=3D"" || !s || s=3D=3D"" || !t || t=3D=3D"") return "-";=0A=
 var a=3D_uGC(c,"__utma=3D"+_udh,s);=0A=
 var lt=3D0,i=3D0;=0A=
 if ((i=3Da.lastIndexOf(".")) > 9) {=0A=
  _uns=3Da.substring(i+1,a.length);=0A=
  _uns=3D(_uns*1)+1;=0A=
  a=3Da.substring(0,i);=0A=
  if ((i=3Da.lastIndexOf(".")) > 7) {=0A=
   lt=3Da.substring(i+1,a.length);=0A=
   a=3Da.substring(0,i);=0A=
  }=0A=
  if ((i=3Da.lastIndexOf(".")) > 5) {=0A=
   a=3Da.substring(0,i);=0A=
  }=0A=
  a+=3D"."+lt+"."+t+"."+_uns;=0A=
 }=0A=
 return a;=0A=
}=0A=
function _uTrim(s) {=0A=
  if (!s || s=3D=3D"") return "";=0A=
  while ((s.charAt(0)=3D=3D' ') || (s.charAt(0)=3D=3D'\n') || =
(s.charAt(0,1)=3D=3D'\r')) s=3Ds.substring(1,s.length);=0A=
  while ((s.charAt(s.length-1)=3D=3D' ') || =
(s.charAt(s.length-1)=3D=3D'\n') || (s.charAt(s.length-1)=3D=3D'\r')) =
s=3Ds.substring(0,s.length-1);=0A=
  return s;=0A=
}=0A=
function _uEC(s) {=0A=
  var n=3D"";=0A=
  if (!s || s=3D=3D"") return "";=0A=
  for (var i=3D0;i<s.length;i++) {if (s.charAt(i)=3D=3D" ") n+=3D"+"; =
else n+=3Ds.charAt(i);}=0A=
  return n;=0A=
}=0A=
function __utmVisitorCode(f) {=0A=
 var r=3D0,t=3D0,i=3D0,i2=3D0,m=3D31;=0A=
 var a=3D_uGC(_ubd.cookie,"__utma=3D"+_udh,";");=0A=
 if ((i=3Da.indexOf(".",0))<0) return;=0A=
 if ((i2=3Da.indexOf(".",i+1))>0) r=3Da.substring(i+1,i2); else return =
"";  =0A=
 if ((i=3Da.indexOf(".",i2+1))>0) t=3Da.substring(i2+1,i); else return =
"";  =0A=
 if (f) {=0A=
  return r;=0A=
 } else {=0A=
  var c=3Dnew =
Array('A','B','C','D','E','F','G','H','J','K','L','M','N','P','R','S','T'=
,'U','V','W','X','Y','Z','1','2','3','4','5','6','7','8','9');=0A=
  return =
c[r>>28&m]+c[r>>23&m]+c[r>>18&m]+c[r>>13&m]+"-"+c[r>>8&m]+c[r>>3&m]+c[((r=
&7)<<2)+(t>>30&3)]+c[t>>25&m]+c[t>>20&m]+"-"+c[t>>15&m]+c[t>>10&m]+c[t>>5=
&m]+c[t&m];=0A=
 }=0A=
}=0A=
function _uIN(n) {=0A=
 if (!n) return false;=0A=
 for (var i=3D0;i<n.length;i++) {=0A=
  var c=3Dn.charAt(i);=0A=
  if ((c<"0" || c>"9") && (c!=3D".")) return false;=0A=
 }=0A=
 return true;=0A=
}=0A=
function _uES(s,u) {=0A=
 if (typeof(encodeURIComponent) =3D=3D 'function') {=0A=
  if (u) return encodeURI(s);=0A=
  else return encodeURIComponent(s);=0A=
 } else {=0A=
  return escape(s);=0A=
 }=0A=
}=0A=
function _uUES(s) {=0A=
 if (typeof(decodeURIComponent) =3D=3D 'function') {=0A=
  return decodeURIComponent(s);=0A=
 } else {=0A=
  return unescape(s);=0A=
 }=0A=
}=0A=
function _uVG() {=0A=
 if((_udn.indexOf("www.google.") =3D=3D 0 || _udn.indexOf(".google.") =
=3D=3D 0 || _udn.indexOf("google.") =3D=3D 0) && _utcp=3D=3D'/' && =
_udn.indexOf("google.org")=3D=3D-1) {=0A=
  return false;=0A=
 }=0A=
 return true;=0A=
}=0A=
function _uSP() {=0A=
 var s=3D100;=0A=
 if (_usample) s=3D_usample;=0A=
 if(s>=3D100 || s<=3D0) return true;=0A=
 return ((__utmVisitorCode(1)%10000)<(s*100));=0A=
}=0A=
function urchinPathCopy(p){=0A=
 var d=3Ddocument,nx,tx,sx,i,c,cs,t,h,o;=0A=
 cs=3Dnew Array("a","b","c","v","x","z");=0A=
 h=3D_uDomain(); if (_udn && _udn!=3D"") o=3D" domain=3D"+_udn+";";=0A=
 nx=3D_uNx()+";";=0A=
 tx=3Dnew Date(); tx.setTime(tx.getTime()+(_utimeout*1000));=0A=
 tx=3Dtx.toGMTString()+";";=0A=
 sx=3Dnew Date(); sx.setTime(sx.getTime()+(_ucto*1000));=0A=
 sx=3Dsx.toGMTString()+";";=0A=
 for (i=3D0;i<6;i++){=0A=
  t=3D" expires=3D";=0A=
  if (i=3D=3D1) t+=3Dtx; else if (i=3D=3D2) t=3D""; else if (i=3D=3D5) =
t+=3Dsx; else t+=3Dnx;=0A=
  c=3D_uGC(d.cookie,"__utm"+cs[i]+"=3D"+h,";");=0A=
  if (c!=3D"-") d.cookie=3D"__utm"+cs[i]+"=3D"+c+"; path=3D"+p+";"+t+o;=0A=
 }=0A=
}=0A=
function _uCO() {=0A=
 if (!_utk || _utk=3D=3D"" || _utk.length<10) return;=0A=
 var d=3D'www.google.com';=0A=
 if (_utk.charAt(0)=3D=3D'!') d=3D'analytics.corp.google.com';=0A=
 _ubd.cookie=3D"GASO=3D"+_utk+"; path=3D"+_utcp+";"+_udo;=0A=
 var sc=3Ddocument.createElement('script');=0A=
 sc.type=3D'text/javascript';=0A=
 sc.id=3D"_gasojs";=0A=
 =
sc.src=3D'https://'+d+'/analytics/reporting/overlay_js?gaso=3D'+_utk+'&'+=
Math.random();=0A=
 document.getElementsByTagName('head')[0].appendChild(sc);  =0A=
}=0A=
function _uGT() {=0A=
 var h=3Dlocation.hash, a;=0A=
 if (h && h!=3D"" && h.indexOf("#gaso=3D")=3D=3D0) {=0A=
  a=3D_uGC(h,"gaso=3D","&");=0A=
 } else {=0A=
  a=3D_uGC(_ubd.cookie,"GASO=3D",";");=0A=
 }=0A=
 return a;=0A=
}=0A=
var _utk=3D_uGT();=0A=
if (_utk && _utk!=3D"" && _utk.length>10) {=0A=
 if (window.addEventListener) {=0A=
  window.addEventListener('load', _uCO, false); =0A=
 } else if (window.attachEvent) { =0A=
  window.attachEvent('onload', _uCO);=0A=
 }=0A=
}=0A=
=0A=
function _uNx() {=0A=
  return (new Date((new Date()).getTime()+63072000000)).toGMTString();=0A=
}=0A=

------=_NextPart_000_0000_01C85787.6EAC82A0--

